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ABSTRACT 
The overarching aim of the thesis research was to investigate mechanisms altered by 
protein-energy malnutrition (PEM), a common stroke co-morbidity factor that could affect the 
extent of brain damage and recovery following stroke. To model stroke, the rat 2-vessel 
occlusion model of global brain ischemia was employed. To characterize the effects of PEM, 
three states of malnutrition were assessed: PEM co-existing with brain ischemia (Study 1), 
effects of PEM independent of brain ischemia (Study 2), and PEM developing after brain 
ischemia (Study 3).  
The first hypothesis tested was co-existing PEM triggers an exacerbated glial response to 
global brain ischemia. The failure to achieve a consistent model of global ischemia prevented us 
from drawing conclusions on whether co-existing PEM exacerbates reactive gliosis. Nonetheless, 
this study demonstrated that mean temperature and temperature fluctuation are increased within 
the first 24hr of exposure to a low protein diet.  
The second hypothesis tested was PEM causes sustained changes in core temperature 
that are associated with an inflammatory response. Exposure to a low protein diet caused an 
immediate small and transient increase in mean temperature and a larger sustained increase in 
temperature amplitude. As malnutrition evolved, mean temperature declined. PEM stimulated an 
acute-phase response, characterized by an increase in the positive acute-phase protein, alpha-2-
macroglobulin (A2M), and a decrease in the negative acute-phase protein, albumin. This 
response appeared to be aberrant, since the positive acute-phase protein, alpha-1-acid 
glycoprotein (AGP), was decreased with PEM.  
The final hypothesis tested was PEM developing after global brain ischemia exacerbates 
systemic and hippocampal inflammation, which is associated with diminished neuroplasticity. 
The effects of PEM on the acute-phase response are persistent following brain ischemia, as 
demonstrated by decreased serum albumin and increased serum A2M. A decrease in the positive 
acute-phase protein, haptoglobin, strengthened the evidence that PEM triggers an atypical 
reaction. The strong glial response elicited by global ischemia was unaltered by PEM. However, 
PEM influenced hippocampal neuroplasticity mechanisms, as GAP-43 and synaptophysin were 
significantly lower at d21.   
In summary, it has been demonstrated that PEM affects core temperature, the systemic 
acute-phase reaction and the neuroplasticity response to global brain ischemia. 
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CHAPTER 1: 
INTRODUCTION 
 
 
1.1 Rationale  
 Stroke is the third leading cause of death in Canada, with approximately 300,000 
Canadians living with the detrimental effects of stroke (Heart and Stroke Foundation, 2011). 
Effective treatments for stroke are scarce, resulting in only 10% of victims completely 
recovering from the insult. A stroke occurs every ten minutes in Canada, costing the economy 
$3.6 billion a year in medical expenses (Heart and Stroke Foundation, 2011). A stroke is defined 
as an interruption of blood supply to any area of the brain, which can be the result of either an 
ischemic or hemorrhagic episode. Ischemic strokes are four times more common, and arise when 
a vessel supplying blood to the brain is occluded. Occlusion can occur when a blood clot forms 
in an artery that is already very narrow, resulting in a thrombotic stroke, or the clot may originate 
in a distal location in the body and travel to the brain, causing an embolic stroke.  
The pathogenesis of ischemic stroke is intricate and involves various complex 
mechanisms. Reduction in glucose and oxygen supply to the brain can result in a range of 
unfavorable outcomes, including energy failure, glutamate excitotoxicity, disrupted calcium 
homeostasis, and increased generation of reactive oxygen species (ROS). In addition, a robust 
inflammatory response is triggered immediately following brain ischemia and can be a long-
lasting event, which profoundly affects the extent of brain injury and recovery (Xia et al., 2010). 
Activated microglia and macroglia are the predominant responders to ischemia injury, and in 
some incidences they are the sole source of inflammatory cells. Although there is extensive cell 
death following ischemia, the brain is plastic and can actively undergo remodeling. 
Neuroplasticity refers to the structural and functional changes that occur to surviving neurons, 
including axonal and dendritic sprouting, with an attempt to return synaptic activity to pre-stroke 
levels (Kriz & Lalancette-Hébert, 2009; Murphy & Corbett, 2009).
 2 
Animal models of brain ischemia are necessary to elucidate the cellular processes 
involved in the pathogenesis of human stroke. Models of ischemic brain injury are classified 
based on the location of occlusion (focal or global) and the extent of blood blockage (transient or 
permanent). Whereas reduction of blood flow to a specific brain region is termed focal ischemia, 
global ischemia is the result of deprivation of blood supply to the entire brain (Traystman, 2003). 
A global ischemia model, while being a mimic of ischemic brain injury due to cardiac arrest, has 
advantages of high reproducibility and induces many of the same pathophysiological 
mechanisms of focal stroke (Traystman, 2003). Thus, a global ischemia model was used in this 
thesis to investigate pathophysiological and biochemical mechanisms relevant to human stroke.  
Despite years of animal research focusing on the pathophysiology of ischemic brain 
injury, little work has been translated into effective treatments in human stroke victims (Hackam 
& Redelmeier, 2006). Tissue plasminogen activator (t-PA), which restores blood flow by 
dissolving blood clots, is currently the only validated and approved stroke therapy (Fisher et al., 
2009). The majority of pre-clinical experiments have focused on pharmacological agents that 
could decrease stroke-induced brain damage by targeting a single mechanism within the complex 
secondary cellular cascade of events that results in neuronal death. The focus on a single 
mechanism at least partially explains their failure in clinical trials. In response to the plethora of 
failed clinical trials, the Stroke Treatment Academic Industry Roundtable (STAIR) committee 
has recommended that stroke researchers broaden the scope of pre-clinical experiments (Albers 
et al., 2011). These recommendations include developing neuroprotective drugs that target 
multiple pathways, assessing the role of rehabilitation on recovery, and studying the effects of 
co-morbidity factors on stroke outcome (Albers et al., 2011; Fisher et al., 2009). Therefore, my 
laboratory is focused on elucidating the influences of pre- and post-ischemic nutritional status, as 
a way to improve stroke outcome with targeted nutritional treatments. Protein-energy 
malnutrition (PEM), a type of malnutrition commonly seen among elderly in North America, is 
characterized by deficits in both protein and energy status. At least 16% of stroke patients are 
protein-energy malnourished at the time of admission to hospital (Davis et al., 2004; Martineau 
et al., 2005; Yoo et al., 2008), with prevalence rates reaching as high as 49% on admission to a 
rehabilitation setting (Finestone et al., 1995; Poels et al., 2006). Clinical studies have repeatedly 
demonstrated a strong correlation between nutritional status and outcome following stroke, 
suggesting the PEM may be an important co-morbidity factor. More specifically, protein-energy 
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malnourished stroke patients are more likely to experience post-stroke complications, as well as 
have longer hospital stays, increased functional dependency and decreased chances of survival 
(Axelsson et al., 1988; Davalos et al., 1996; FOOD Trial Collaboration, 2003; Gariballa et al., 
1998; Olsen et al., 2008; Pandian et al., 2011). However, as a result of various methodological 
limitations, clinical studies have yet to show substantive proof of causation. In addition, the 
notion that PEM may exert direct effects on ischemic neuronal death pathways and/or brain 
remodeling is not very prevalent in the clinical literature. For these reasons, the use of animal 
models is crucial to further our knowledge of how PEM affects stroke outcome on both a cellular 
and functional level.   
With the use of a gerbil model of global brain ischemia, my laboratory demonstrated that 
co-existing PEM (PEM that is present at the time of brain ischemia) worsens functional outcome 
(Bobyn et al., 2005). In addition, the data suggested, but did not prove, that co-existing PEM 
increased the neuroinflammatory response to brain ischemia (Bobyn et al., 2005; Ji et al., 2008). 
Therefore, the central focus of this thesis has been to investigate the inflammatory response to 
either co-existing or post-ischemic PEM.  
The study described in Chapter 3 of this thesis was the first experiment performed in my 
laboratory using the rat 2-vessel occlusion (2-VO) model of global brain ischemia. Therefore, a 
primary objective was to investigate whether the 2-VO rat model would replicate previous 
findings of enhanced reactive gliosis in response to global ischemia in protein-energy 
malnourished gerbils (Bobyn et al., 2005). Hippocampal protein expression of ED-1, OX-42 and 
glial fibrillary acidic protein (GFAP) were examined by immunohistochemistry to assess the 
effects of co-existing PEM on the glial response to global brain ischemia in the rat. Since 
temperature regulation can directly alter the glial response following global ischemia 
(Ceulemans et al., 2010; Silasi & Colbourne, 2011), the effect of PEM on pre- and post-ischemic 
core temperature was also examined. 
PEM may exert some of its effects on outcome after brain ischemia by altering key 
physiological determinants of ischemic brain injury. Changes in body temperature during the 
acute ischemic period can radically alter the cascade of cellular events. Post-ischemic 
hypothermia can markedly reduce neuronal damage (MacLellan et al., 2009; van der Worp et al., 
2007), while hyperthermia can aggravate injury (Wang et al., 2009). Since changes in core 
temperature in the face of PEM had been identified in the first study, the study described in 
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Chapter 4 assessed the duration and severity of temperature changes that can occur with 
prolonged PEM. A second goal was to examine whether PEM is an independent stimulus of 
inflammation. Previously it has been demonstrated that activation of the major inflammatory 
transcription factor, nuclear factor kappa B (NFB), is increased in the hippocampus of non-
operated malnourished gerbils (Ji et al., 2008). Given that pro-inflammatory mediators are 
predominantly regulated at the level of transcription by NFB, these results suggest that PEM 
can independently induce hippocampal inflammation. This was assessed in the second study of 
this thesis by examining the mRNA expression of pro-inflammatory genes regulated by the 
NFB cascade in the hippocampus of malnourished rats. Lastly, there is compelling evidence 
that PEM can be an independent stimulus of systemic inflammation (Ling et al., 2004; Lyoumi et 
al., 1998). Therefore, serum concentrations of acute-phase proteins were assessed to determine if 
the PEM model used in this research elicits a systemic inflammatory response.  
Given that compromised nutritional status often develops in patients within the weeks 
following stroke, the focus of the final study of this thesis was to assess the effects of PEM when 
it develops after brain ischemia (post-ischemic PEM). In addition to being clinically significant, 
the results from this study are also novel, since the mechanistic effects of post-ischemic PEM 
have never been studied. A primary objective was to investigate the influence of post-ischemic 
PEM on systemic and neuroinflammation following global brain ischemia. Serum concentrations 
of various acute-phase proteins were measured to assess systemic inflammation, while 
hippocampal inflammation was examined by staining for GFAP (astrocytic marker) and ionized 
calcium-binding adapter molecule 1 (Iba-1; activated microglia marker). Given that the 
inflammatory response after brain ischemia can affect recovery processes (Banati, 2002; Katsuki 
et al., 1990; Kriz & Lalancette-Hébert, 2009), an additional goal was to assess the effects of post-
ischemic PEM on neuroplasticity markers. Immuno-staining of hippocampal plasticity-
associated proteins, including growth-associated protein-43 (GAP-43) and synaptophysin, 
provided insight on the effects of post-ischemic PEM on neuronal plasticity following global 
brain ischemia. 
1.2 Hypotheses & Objectives  
Study 1 (Chapter 3):  
Hypothesis: Co-existing PEM triggers an exacerbated glial response to global brain ischemia.   
Objectives: 
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1. Investigate if the astrocytic (GFAP) and microglial (ED-1 and OX-42) responses after 
global brain ischemia are altered by co-existing PEM.  
2. Determine if PEM affects core temperature during the pre- and post-ischemic periods. 
  
Study 2 (Chapter 4):  
Hypothesis: PEM causes sustained changes in core temperature that are associated with an 
inflammatory response.  
Objectives: 
1. Investigate whether acute and chronic PEM affect NFB mediated signaling in the 
hippocampus.  
2. Determine if our model of PEM is an independent stimulus of an acute-phase response, 
as reflected by serum albumin, alpha-2-macroglobulin (A2M), and alpha-1-acid 
glycoprotein (AGP) concentrations.  
3. Determine whether PEM-induced alterations to core temperature are sustained long term.  
4. Examine if the immediate increase in temperature previously reported in rats fed a low 
protein diet is caused by a temporary stress-induced increase in activity.  
 
Study 3 (Chapter 5):  
Hypothesis: PEM developing after global brain ischemia exacerbates systemic and hippocampal 
inflammation, which in turn is associated with a diminished neuroplastic response to 
hippocampal injury.   
Objectives: 
1. Examine whether post-ischemic PEM exacerbates hippocampal inflammation following 
global brain ischemia, as reflected by increased astrocytic (GFAP) and microglial (Iba-1) 
responses.  
2. Determine if the ability of PEM to induce an acute-phase response differs following 
global brain ischemia. 
3. Investigate whether PEM following global brain ischemia alters the expression of 
plasticity-associated proteins (GAP-43 and synaptophysin). 
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  CHAPTER 2: 
REVIEW OF THE LITERATURE 
 
 
2.1 Introduction  
Stroke, defined as an interruption of blood supply to any area of the brain, is the third 
leading cause of death in Canada (Heart and Stroke Foundation, 2011). There are over 50,000 
strokes each year in Canada, with only 10% of victims completely recovering from the insult. 
Approximately 75% of stroke victims suffer from some form of disability including paralysis, 
learning impairments, aphasia, memory loss, vision problems, dysphagia, and depression (Heart 
and Stroke Foundation, 2011). Ischemia, which accounts for 80% of stroke cases, occurs when 
there is disruption of blood flow to the brain due to a clot.  
Despite years of animal research focused on developing effective stroke treatments, t-PA 
is the only validated and approved stroke therapy included in the Canadian Best Practice 
Recommendations for Stroke Care (Lindsay et al., 2010). However, since the therapeutic time 
window is short and many patients do not meet the criteria to receive the treatment, less than 2% 
of Canadian stroke victims receive this type of intervention (Yip & Demaerschalk, 2007). Due to 
the ongoing challenges of developing effective treatments for stroke victims, my laboratory has 
taken a different approach to research that is focused on enhancing the outcome of stroke. This 
promising area of research investigates the implications of stroke co-morbidity factors, such as 
compromised nutritional status, with the intent to highlight novel targeted treatments. A 
significant proportion of stroke patients are protein-energy malnourished at the time of admission 
to hospital (Davis et al., 2004; Martineau et al., 2005; Yoo et al., 2008), with this subset of 
malnourished patients drastically rising by the time of admission to a rehabilitation unit 
(Finestone et al., 1995; Poels et al., 2006). Using an experimental model of brain ischemia, 
studies from my laboratory have demonstrated that co-existing PEM impairs functional outcome 
 7 
(Bobyn et al., 2005) and alters mechanisms underlying both neuronal death and neuroplasticity 
(Bobyn et al., 2005; Ji et al., 2008; Prosser-Loose et al., 2010). The research described in this 
thesis examined whether the inflammatory and neuroplasticity responses to global brain ischemia 
are altered by either co-existing PEM or compromised protein-energy status that arises after 
brain ischemia. Ultimately, research in this area may aid in the design of targeted nutritional 
interventions that will prevent or reverse PEM and enhance stroke outcome.  
2.2 Pathophysiology of Ischemic Stroke  
2.2.1 Overview 
 The pathogenesis of ischemic stroke is intricate and involves various complex 
mechanisms. These processes that lead to brain injury act at different times and can develop over 
several hours or even days following brain ischemia. The severity of each mechanism is 
dependent on the extent of cessation of cerebral blood flow and where in the brain it is occurring. 
Although reperfusion is necessary to restore blood flow, it also induces secondary injury caused 
by an influx in inflammatory cells, ROS, excitatory amino acids and intracellular calcium (Tang 
et al., 2007).  
Blood flow interruption results in the depletion of energy supply, which is the primary 
event that leads to cell necrosis (Astrup et al., 1977). Various pathways are disrupted in response 
to energy depletion, resulting in unfavorable outcomes that include glutamate excitotoxicity, 
calcium overload, and oxidative stress. Rapid depletion in adenosine triphosphate (ATP) that 
occurs at the time of ischemia has detrimental effects on a neuron by interfering with energy-
dependent ionic pumps, such as the sodium-potassium ATPase pump (Hansen, 1985). This 
critical active transporter is responsible for maintaining a high cellular concentration of 
potassium and low cellular levels of sodium. During ischemia this system is disrupted, resulting 
in the accumulation of sodium ions within a cell. The influx of cations causes membrane 
depolarization, which if significant enough, will result in the generation of an action potential. 
Glutamate, an excitatory amino acid found at high concentrations in normal neurons, is released 
by the pre-synaptic neuron during an action potential and rapidly binds to its ionotropic receptor 
on the post-synaptic neuron. Binding of glutamate opens voltage-gated calcium channels on the 
post-synaptic terminal, thereby facilitating calcium entry into the cell (Tang et al., 2007). 
Ultimately, over-firing of neurons during the post-ischemic period can cause intracellular 
calcium concentrations to rise by 1000-fold (Tang et al., 2007).  
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Given that calcium is a regulator of several enzyme systems, excess levels of calcium can 
result in over-activation of various pathways leading to detrimental outcomes. For example, 
calcium activation of proteases, such as calpain 1, leads to degradation of vital structural 
proteins, and calcium-activated endonucleases cause DNA cleavage (Choi, 1990). Production of 
toxic free radicals, such as nitric oxide, is also an unfavorable consequence of calcium influx and 
is the result of activation of nitric oxide synthase (Iadecola, 1997). Oxidative stress is another 
detrimental outcome of brain ischemia. At the time of reperfusion, oxygenated blood is supplied 
to deprived brain regions resulting in the generation of ROS. The brain has minimal antioxidant 
capacity, making this biological system very susceptible to oxidative stress (Chan, 2001). 
Therefore, extensive generation of ROS following ischemia overpowers the antioxidant defense 
system, and in turn the imbalance in the production and manifestation of ROS generates 
oxidative stress. Consequently, ROS can trigger the degradation of proteins, lipids and DNA, 
causing irreparable damage (Chan, 2001). Ultimately, marked levels of glutamate, calcium, and 
ROS following brain ischemia can cause significant cellular stress and lead to cell death. 
Neuronal death following brain ischemia is primarily the result of necrosis or apoptosis. 
Necrosis is the premature death of cells, and is characterized by cellular swelling and rupturing 
of the plasma membrane. As a result, the cellular contents, including toxic products of cell death, 
are released into the surrounding tissue and trigger an inflammatory response. Apoptosis, or 
programmed cell death, is an energy-dependent pathway that involves chromatin condensation, 
nuclear blebbing, DNA fragmentation and cell shrinkage. Apoptosis is considerably less 
destructive to the surrounding tissue, given that dying cells are broken up into apoptotic bodies 
and quickly degraded by phagocytic cells (Colbourne & Auer, 2010). Given that necrosis and 
apoptosis each have unique morphological features, it is possible to distinguish the mode of cell 
death by examining for cellular swelling, chromatin condensation, and the presence of apoptotic 
bodies (Colbourne & Auer, 2010). Evidence from rodent models of brain ischemia suggests that 
neuronal death is mostly necrotic. The mode of cell death is to some extent dependent on the 
type of brain ischemia; however, most evidence suggests that the global brain ischemia model 
used in this thesis results in cells with necrotic morphology (Colbourne & Auer, 2010).  
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2.2.2 Inflammation  
2.2.2.1 Neuroinflammation 
 The inflammatory response is another key constituent of this complex cascade of 
secondary mechanisms involved in brain injury. The orchestrated inflammatory response 
following an ischemic insult can play both beneficial and detrimental roles (Kriz & Lalancette-
Hébert, 2009). The inflammatory response can trigger oxidative stress and cytokine production, 
ultimately damaging the brain. Conversely, inflammatory cells can be beneficial by removing 
cell debris, repairing tissue and preventing further neuronal damage. The exact role inflammation 
has on ischemic brain injury is heavily dependent upon the severity of inflammation and the time 
over which it occurs following insult. Numerous studies have identified specific inflammatory 
cytokines as either having neuroprotective or detrimental effects on the damaged brain. Whereas 
increased levels of transforming growth factor (TGF)- and interleukin (IL)-1 can exacerbate 
neuronal injury (Allan & Rothwell, 2001; Patel et al., 2003), TGF- and IL-10 can have 
neuroprotective effects on an ischemic brain (Allan & Rothwell, 2001; Froen et al., 2002; Grilli 
et al., 2000). Similarly, activated microglia can play differential roles following brain ischemia. 
Microglia are valuable in removing dead neurons, but can have damaging effects by releasing 
cytokines and ROS (Lai & Todd, 2006). Although there are advantageous outcomes of 
inflammation, most of the evidence suggests that the inflammatory response following brain 
ischemia is more detrimental than beneficial (Feuerstein, 2001).  
Under normal conditions, the brain is an immune-privileged organ, implying that the 
blood-brain barrier prevents the infiltration of systemic inflammatory cells. Damage to the 
blood-brain barrier following an ischemic episode makes the diseased brain susceptible to 
systemic inflammation (Danton & Dietrich, 2003). Leukocytes migrate to the damaged brain and 
are involved in the local inflammatory response mediated by activated microglia. Inflammatory 
cells follow a chemokine concentration gradient to the damaged region and gain access into the 
tissue through interactions between adhesion molecules. 
2.2.2.1.1 Neuroinflammatory Mediators  
Secretion of cytokines by glial cells precedes the infiltration of inflammatory cells, and 
thus plays a major role in initiating and maintaining the inflammatory response following brain 
ischemia. Marked increases in cytokine concentrations, in both the brain and systemic 
circulation, are evident within hours following stroke (Ahmad & Graham, 2010). The best-
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characterized cytokines that are up-regulated in response to ischemia include tumor necrosis 
factor (TNF) and members of the interleukin family (IL-1, IL-6, IL-8, IL-10, IL-12) (Ahmad & 
Graham, 2010). The two contradicting signals involved in the inflammatory response are the pro-
inflammatory and anti-inflammatory pathways. Pro-inflammatory cytokines (e.g. TNF-, IL-1) 
amplify the response, while anti-inflammatory cytokines (e.g. IL-4, IL-10, IL-13) are involved in 
turning off an immune reaction (Planas et al., 2006). The majority of these cytokines have dual 
functions in the ischemic brain; therefore, simply inhibiting the expression does not provide 
neuroprotection. For example, one report has shown that inhibition of TNF- in mice can reduce 
ischemic brain injury (Yang et al., 1998), while another mouse ischemic model illustrated that 
TNF- is involved in ischemic tolerance and mice deficient in TNF- receptors have greater 
infarcts (Gary et al., 1998). 
 Chemokines, which are a subclass of cytokines, are also pivotal mediators of the 
ischemic inflammatory response and are produced by several kinds of cells, including activated 
leukocytes and microglia. The primary role of a chemokine is as a chemoattractant, which 
involves creating a chemokine concentration gradient that recruits inflammatory cells to the 
inflamed region. Inflammatory cells that are attracted to these gradients express chemokine 
receptors, which are G-protein linked seven transmembrane domain receptors, and include 
leukocytes, neurons and glial cells (Kiguchi et al., 2011). There are four subfamilies of 
chemokines, named according to the arrangement of the first two cysteines located at the N-
terminal end: CC, CXC, XC, and CX3C. CC and CXC chemokine pathways are crucial in 
ischemic stroke. Whereas CXC chemokines (e.g., CXCL1, CXCL8, CXCL12) typically promote 
neutrophils to leave the bloodstream and enter the inflamed tissue (Mirabelli-Badenier et al., 
2011), CC chemokines (e.g., CCL2, CCL3, CCL7, CCL20) are involved in the recruitment of 
monocytes/macrophages (Mirabelli-Badenier et al., 2011). When inflammatory cells reach the 
damaged region they leave the bloodstream and infiltrate the tissue, which is a process facilitated 
by cell adhesion molecules.  
Cell adhesion molecules, a group of proteins located on the cell surface, play a pivotal 
role in the infiltration of inflammatory cells into the damaged tissue. Adhesion molecules 
facilitate the interaction between inflammatory cells and the vascular endothelium, which is 
necessary for tissue infiltration. Adhesion molecules are commonly classified into four main 
protein families: immunoglobulin superfamily, integrins, cadherins, and selectins. For example, 
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intracellular adhesion molecule-1 (ICAM-1), an immunoglobulin member, is expressed on 
endothelial cells and binds to integrins (CD11/CD18) present on the cell surface of leukocytes. 
Following the initial interaction between the inflammatory cell and interior surface of the blood 
vessel, selectins are commonly involved in mediating the rolling process along the endothelium 
(Tang et al., 2007). The process of rolling decelerates the inflammatory cell, allowing for a firm 
adhesion to be formed and transmigration into the tissue.   
2.2.2.1.2 Nuclear Factor Kappa B    
A central regulator of the inflammatory response following brain ischemia is the 
transcription factor, NFB. NFB regulates the transcription of a wide variety of genes, which 
can be grouped into three main pathways: (1) inflammation (e.g., cytokines, adhesion molecules, 
chemokines, matrix metalloproteinase); (2) regulation of apoptosis (e.g., Bcl2 family); and (3) 
inhibitory component kappa B (IB) inhibitors, which provides a feedback loop for the NFB 
pathway (Harari & Liao, 2010). Overall, most evidence suggests that NFB activation is 
neurodegenerative by participating in blood-brain barrier disruption, augmentation of the 
inflammatory response and contributing to neuronal death (Feuerstein, 2001; Harari & Liao, 
2010; Ridder & Schwaninger, 2009). However, there are controversial reports suggesting that 
NFB activation does not always result in neurodegeneration following brain ischemia. 
Previously it has been demonstrated that the activation of NFB could be a pre-conditioning 
stimulus. Brief periods of ischemia, below the cell death threshold, can trigger NFB activation 
in neurons and promote neuroprotection (Blondeau et al., 2001). Nevertheless, it has been well 
established that NFB activation can have detrimental effects following brain ischemia 
(Feuerstein, 2001; Harari & Liao, 2010; Ridder & Schwaninger, 2009). NFB signaling is the 
highest within damaged neurons (Clemens et al., 1997; Schneider et al., 1999; Stephenson et al., 
2000); however, activation also takes place in endothelial cells, astrocytes, and microglia 
(Gabriel et al., 1999; Howard et al., 1998; Terai et al., 1996). There are numerous inducers of 
NFB signaling, including various inflammatory mediators (e.g., TNF, IL-1, and IL-2), growth 
factors (e.g., TGF-1), bacterial mediators (e.g., lipopolysaccharide [LPS]), and oxidants (e.g., 
hydrogen peroxide) (Harari & Liao, 2010). Therefore, certain target genes of NFB are also 
predominant activators of this transcription factor, resulting in an ongoing cycle that creates an 
elevated response to stress.  
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 NFB is constitutively expressed in latent cells and is activated via post-translational 
modification. There are multiple variations of the NFB complex, both homodimeric and 
heterodimeric in nature, composed of two members of the Rel protein family (e.g. p50, p65 
[RelA], c-Rel, p52, RelB). However, the most common NFB form is a p50/p65 heterodimer. In 
quiescent cells, NFB is located in the cytoplasm and is bound to an IB inhibitor, preventing 
translocation into the nucleus (Figure 2.1). Liberation of NFB occurs when the IB inhibitor is 
phosphorylated by an upstream activated IB kinase (IKK). Activation of IKK can be triggered 
by various stroke related factors, including ROS, inflammatory cytokines and excessive levels of 
intracellular calcium. Removal of IB allows NFB to translocate into the nucleus and bind to 
specific domains, known as B sites, within the promoter region of multiple NFB target genes 
(Figure 2.1). Thereby, NFB bound to the DNA sequence promotes the recruitment of an RNA 
polymerase and initializes transcription. The remaining IB in the cytoplasm is ubiquitinated and 
degraded by the 26S proteasome (Grisham et al., 1999).  
      
Figure 2.1. Diagram illustrating NFB signaling in brain ischemia. (From: Ridder DA, et al. 
Neuroscience. 2009; 158: 995-1006. Copyright © 2009, Elsevier).  
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2.2.2.1.3 Glial Cells   
2.2.2.1.3.1 Introduction  
The inflammatory response in the ischemic brain involves three main groups of 
inflammatory cells and the role of each subclass is greatly dependent on the nature of injury. The 
predominant responders to ischemic injury are glial cells and in some incidences they are the 
sole source of inflammatory cells. In response to severe and extensive tissue injury, leukocytes 
from systemic circulation migrate across the damaged blood-brain barrier and aid in the 
inflammatory response. Perivascular cells, the third subclass of inflammatory cells involved in 
the ischemic brain, are constitutive macrophage-like cells located in the vascular wall (Kaur & 
Ling, 2008). Leukocytes and perivascular cells are not major responders to the type of ischemic 
brain injury modeled in this thesis, and thus these inflammatory cells have not been reviewed in 
detail.     
2.2.2.1.3.2 Microglial Cells   
 Microglia are ubiquitously distributed throughout a healthy brain and act as the primary 
immune defense in the central nervous system. The microglia cell pool makes up approximately 
10% of the total number of cells in the mouse brain (Lawson et al., 1990), and is rarely 
replenished by hematogenous cells due to their stable nature (Lawson et al., 1992). In the 
presence of abnormal substances, such as LPS and cell necrosis factors, microglia become 
immediately activated (Liu et al., 2011). Microglia migrate along the chemotaxis gradient to the 
invaded/injured area and once activated become diversely involved in the inflammatory response 
by releasing various mediators including cytokines, ROS, proteases, and glutamate (Dheen et al., 
2007). Fully activated microglia transform into phagocytes and engulf offending material or 
cellular debris (Giulian, 1987). Furthermore, microglia secrete growth factors that facilitate 
tissue repair (Kreutzberg, 1996).  
The exact role that a microglial cell plays in the inflammatory response following brain 
ischemia is completely dependent on the stage of activation. There are three different stages of 
activation with the first being classified as resting microglia, followed by activated microglia, 
and lastly phagocytic microglia (Kato, 2001). Microglia activation occurs in a stepwise manner, 
with each stage having a characteristic cell morphology. Resting microglia are ramified cells, 
which allow them to constantly survey the area with their long branching processes. In response 
to various factors, such as pro-inflammatory cytokines, cell necrosis factors and altered 
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potassium levels, microglia convert from their ramified morphology to an activated form. At this 
early activated stage the cell body becomes enlarged and the long processes contract, resulting in 
a rod like appearance. Microglia at this stage are not phagocytic, but instead undergo extensive 
proliferation to expand the population of microglia. The last stage of activation is comprised of 
phagocytic microglia, which have the strongest immune response. The characteristic morphology 
at this final stage of activation is large amoeboid shaped cells, which allows engulfing of foreign 
material and at the same time production of key inflammatory mediators (Kato, 2001).  
2.2.2.1.3.3 Macroglial Cells 
 Macroglia are another group of glia in the central nervous system. Astrocytes are the 
most abundant type of macroglia and make up more than 50% of cells in the central nervous 
system. Astrocytes have a unique star-like structure with long processes extending from a central 
cell body, which form connections with various cell types including neurons, microglia and other 
astrocytes. Astrocytes are involved in stabilizing chores, such as maintaining extracellular ion 
balance and regulating neurotransmitter concentrations (Verkhratsky & Steinhauser, 2000). 
However, these roles weaken following injury in order for astrocytes to participate in tissue 
repair, which includes releasing neurotrophic factors, undergoing proliferation and forming glial 
scars (Liu et al., 2011). The beneficial action of the glial scar is that it suppresses further physical 
damage to the area; however, it also prevents full recovery by hindering axon regeneration.  
Activation of microglia and macroglia happen at different stages of the inflammatory 
process and involves intricate cross talk between cell types (Liu et al., 2011). Under most 
pathological conditions, microglia are activated first and release pro-inflammatory cytokines, 
such as IL-1, to facilitate the activation of astrocytes. In turn, activated astrocytes play a 
fundamental role in regulating microglia activities by either enhancing or inhibiting the response. 
Following ischemia, distant microglia become activated by astrocytes via calcium waves (Liu et 
al., 2011). Conversely, activated astrocytes can have an inhibitory effect on microglia by 
diminishing the cellular levels of nitric oxide, ROS and pro-inflammatory mediators (Liu et al., 
2011). Therefore, astrocytes play a central role in both tissue repair and the regulation of the 
inflammatory process following brain ischemia.   
2.2.2.1.3.4 Assessment of Glial Response  
 Immunocytochemistry is commonly performed in animal studies to evaluate the presence 
of glial cells following brain ischemia. To identify astrocytes using immunocytochemistry, 
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GFAP is frequently targeted and stained. GFAP, an intermediate filament protein that is most 
commonly expressed by astrocytes, provides mechanical strength for the cell, assists in cellular 
communication, and aids in the functioning of the blood-brain barrier (Fuchs & Weber, 1994). 
The positive expression of GFAP is considered one of the universal indicators of central nervous 
system damage following traumatic injuries. Identification of microglia is commonly by Iba-1, 
ED-1, and OX-42 immuno-staining, although there are other useful antibodies. Iba-1, expressed 
by microglia in the brain, is a calcium binding adapter molecule that is upregulated during 
microglia activation. ED-1, which is also used to mark microglia activation, stains the lysosomal 
membrane protein CD68 present on phagocytosing activated microglia (Damoiseaux et al., 
1994). OX-42 is an antibody that recognizes an antigen (CD11b) associated with the complement 
receptor 3 protein, which is expressed on amoeboid microglia and is thought to play a role in 
endocytosis (Ling et al., 1990).  
2.2.2.2 Systemic Inflammation   
 In addition to the neuroinflammatory response to brain ischemia, evidence from clinical 
studies suggests that systemic inflammation can also be triggered by stroke (Dziedzic, 2008). 
More specifically, the disruption in homeostasis following cerebral stroke can elicit a systemic 
reaction, referred to as an acute-phase response (Dziedzic, 2008; Idicula et al., 2009; Smith et al., 
2006). The acute-phase response includes a subset of proteins for which plasma concentration 
changes by a factor of several fold in response to acute and chronic inflammation. Exposure to 
inflammatory conditions can result in elevated circulating concentrations of various positive 
acute-phase proteins (e.g. C-reactive protein, A2M, AGP, and haptoglobin), while at the same 
time causing depleted levels of negative acute-phase proteins (e.g. albumin, transferrin). Positive 
acute-phase proteins serve various physiological functions, including the role of chemotactic 
agents, coagulation factors, transport proteins, and regulators of the inflammatory response. The 
acute-phase response is stimulated and modulated by the release of pro-inflammatory cytokines, 
including IL-6, IL-1 and TNF- (Andus et al., 1988). Therefore, concentrations of acute-phase 
proteins and pro-inflammatory cytokines are commonly measured in stroke patients to assess the 
extent of systemic inflammation (Dziedzic, 2008).  
Numerous clinical studies have assessed the acute-phase response in ischemic stroke and 
correlated this response to patient outcome. Several factors contribute to the varying degree of 
acute-phase response observed in stroke patients, which include the severity of stroke, sample 
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timing, presence of infection, genetic variation, and drug therapy (Smith et al., 2006). Although 
the acute-phase response after ischemic stroke is variable, increased C-reactive protein levels 
have been reported in 94% of patients within the first week following stroke onset (Smith et al., 
2006). C-reactive protein concentrations begin to rise within hours of a stroke, peak within days, 
but can remain heightened for months (Dziedzic, 2008). Early serum levels of C-reactive protein, 
collected within the first 24 hours after stroke onset in patients with no considerable difference in 
lesion size, showed a significant correlation with 6 month functional outcome (Ryu et al., 2009). 
Furthermore, C-reactive protein is a predictor of long-term mortality, even when adjusted for 
age, sex, and stroke severity (Idicula et al., 2009). Similar correlations have been made with 
other acute-phase markers, including IL-6, IL-1, and fibrinogen (Dziedzic, 2008). Although 
acute-phase proteins are independent predictors of survival after stroke, it is unknown whether 
they are active players in tissue destruction or solely reflect the degree of injury.  
2.2.2.3 Temperature Regulation and Inflammation  
 Inflammation is highly temperature sensitive. Post-ischemic hypothermia mitigates 
damage by, among other mechanisms, directly altering various pathways involved in the 
inflammatory response. A drop in brain temperature can result in the suppression of neutrophil 
infiltration, along with a decrease in microglia proliferation and activation (Ishikawa et al., 1999; 
Silasi & Colbourne, 2011; Wang et al., 2002). Furthermore, mild hypothermia can elicit reduced 
nuclear NFB translocation and activation (Webster et al., 2009). Conversely, post-ischemic 
hyperthermia can significantly aggravate injury, although the mechanisms associated with 
elevated brain temperatures are less established (Wang et al., 2009). However, there is evidence 
of an elevated inflammatory response in stroke victims with hyperthermia, as represented by 
increased plasma levels of IL-6, TNF-, and ICAM-1 (Leira et al., 2006). These findings have 
strong clinical relevance, since approximately 50% of patients develop fever during the acute 
period following a stroke (Wrotek et al., 2011). This common complication of stroke has a 
severe impact on outcome, with clinical evidence indicating that a fever occurring within 24 
hours following an ischemic episode doubles the odds of mortality (Prasad & Krishnan, 2010).  
2.2.3 Neuroplasticity  
2.2.3.1 Overview  
Neuroplasticity refers to the structural and functional changes that can occur within the 
central nervous system in response to a stimulus (e.g., injury, learning, hormones). Many patients 
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experience spontaneous recovery following a stroke, with the extent of this response being 
highly dependent on severity of insult (Jorgensen et al., 1999). Spontaneous recovery during the 
acute period following stroke often occurs because of resolution of harmful factors (e.g., edema, 
cell death, raised intracranial pressure, inflammation). Neuroplasticity mechanisms are also 
involved in spontaneous recovery, and include cell remodeling and neuron production. Surviving 
neurons undergo extensive repair in an attempt to make new synaptic connections with other 
functional neurons. Remodeling of synaptic connections, termed synaptic plasticity, involves 
various growth-related processes including dendritic growth, axonal sprouting, and 
synaptogenesis (Murphy & Corbett, 2009). In addition to the remodeling of surviving neurons, 
new neurons are also generated in the ischemic brain through the process of neurogenesis. Cells 
are typically generated in the dentate gyrus or lateral ventricles and migrate to the damaged 
region, in an attempt to replenish the neuronal population (Ekdahl et al., 2009). The 
neuroplasticity mechanisms triggered by brain ischemia are very similar to the processes 
involved during normal brain development. During brain development, neuronal growth is 
regulated through the release of particular growth factors, neurotrophins, hormones, and 
neurotransmitters (Murphy & Corbett, 2009). Expression of these positive factors typically 
decrease with aging; however, brain ischemia, as well as other forms of trauma, can induce the 
expression of these proteins with an attempt to return synaptic activity to pre-stroke levels 
(Murphy & Corbett, 2009).  
2.2.3.2 Post-Ischemic Synaptic Plasticity  
 The mechanisms of neuroplasticity can remain activated for months following brain 
ischemia and promote restoration of functional ability (Kriz & Lalancette-Hébert, 2009). 
Spontaneous recovery in the brain involves various growth-related events, including axonal, 
dendritic and synaptic changes. Within hours following brain ischemia, affected neurons undergo 
extensive modifications, including a loss in the number and the length of dendritic spines (Kriz 
& Lalancette-Hébert, 2009). More pronounced changes to the neuronal circuitry occur when 
neurons die, causing a significant depletion of axons and dendrites, and thus a loss of 
connections. In an attempt to retain synaptic activity, surviving neurons undergo axonal and 
dendritic sprouting allowing for the formation of new synapses, and as a result rewiring of the 
circuitry. Positive factors, including GAP-43 and brain-derived neurotrophic factor (BDNF), are 
involved in promoting these growth-related-processes (Murphy & Corbett, 2009). 
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 A key player in synaptic plasticity is the intracellular growth associated protein, GAP-43. 
GAP-43 has been associated with the formation of filopedia, the finger-like projections that 
develop into neuronal branches (Denny, 2006). GAP-43 is also involved in neurotransmitter 
release, synaptic vesicle endocytosis, and vesicle recycling. This growth-associated protein is 
synthesized on free ribosomes, travels by vesicle transport down the axon, and binds to either the 
growth cone plasma membrane or presynaptic membrane (Denny, 2006). Under steady-state 
conditions, GAP-43 is found at the highest concentration around the axonal plasma membrane 
with concentrations estimated at 50-100 M (He et al., 1997). GAP-43 is vital for brain 
development, as shown in a mouse model where deletion of GAP-43 resulted in death during the 
early postnatal period (Strittmatter et al., 1995). Expression of GAP-43 is reduced following 
development, but retained at low levels throughout most regions of the mature brain (Schmidt-
Kastner et al., 1997). However, an exception is within the limbic system, where GAP-43 is 
expressed at relatively high levels throughout life (Denny, 2006). The most concentrated levels 
of GAP-43 in the adult rat hippocampus are detected within the cornu ammonis 3 (CA3) region, 
with these neurons typically having extensive arborization of terminals (Denny, 2006). 
Continuous GAP-43 expression in the hippocampus may contribute to information storage and 
more specifically the formation of spatial learning and memory. Following brain ischemia, as 
well as other forms of trauma, synthesis of GAP-43 is significantly increased within the 
hippocampus and is associated with the formation of neuronal branches and new synaptic 
connections. GAP-43-dependent neuronal branching is commonly triggered by neurotrophins, 
including BDNF, nerve growth factor (NGF) and neurotrophin-3 (NT-3) (Goldberg, 2003).  
2.2.3.3 Post-Ischemic Neurogenesis  
 Neurogenesis, or birth of new neurons, is another component of neuroplasticity that is 
influenced by brain ischemia. The two regions in the adult brain where neurogenesis occurs are 
the subgranule zone of the dentate gyrus and the subventricular zone of the lateral ventricles 
(Gonzalez-Perez, 2012). Progenitor cells generated through the process of neurogenesis undergo 
neuronal differentiation and are integrated into existing circuits. It has been theorized that adult 
neurogenesis is required for learning, memory and mood regulation (Ekdahl et al., 2009). Under 
pathological conditions, including brain ischemia, it is possible for damaged regions to be 
repopulated with newly born neurons (Ekdahl et al., 2009). Given that the hippocampus is 
particularly vulnerable to ischemia, neurogenesis has been widely studied in this region. Several 
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studies have reported spontaneous regeneration within the hippocampal CA1 region following 
brain ischemia, with evidence suggesting that these newborn neurons originate from both the 
lateral ventricles and dentate gyrus (Bendel et al., 2005; Salazar-Colocho et al., 2008; Schmidt & 
Reymann, 2002). It is important to note that newborn neurons may potentially have aberrant 
function, as the result of abnormal dendritic processes (Langdon et al., 2008). However, there are 
contradictory findings regarding spontaneous repopulation, with some studies reporting an 
absence of CA1 neuronal regeneration even when the same brain ischemia models and time-
points are used (Colbourne & Corbett, 1995; Silasi & Colbourne, 2011). Another important 
consideration is that increased cell proliferation in the dentate gyrus does not necessary lead to 
neuronal regeneration, given that newly generated cells can differentiate into other cell types, 
such as microglial cells (Silasi & Colbourne, 2011). Newborn cells generated in the dentate 
gyrus can also migrate to the granule cell layer of the dentate gyrus or to the dentate hilus, where 
they differentiate into astrocytes (Sharp et al., 2002).  
The relationship between neurogenesis and functional recovery following brain ischemia 
has been examined. Wang et al. (2005) reported a significant reduction in the synaptic field 
response within the dentate gyrus at 10 days following brain ischemia, with activity recovering at 
day 35. Within this time period, there was a significant increase in the number of cells generated 
in the dentate gyrus. Thus, these findings suggest that hippocampal functional recovery 
following brain ischemia is associated with new cell production in the dentate gyrus. Although it 
has been theorized that neurogenesis improves recovery after brain ischemia, definite proof of 
causation has not been convincingly demonstrated. The extent to which neurogenesis improves 
recovery is most likely dependent on the degree of cell survival. Surprisingly, up to 80% of new 
neurons generated after stroke die within two weeks of formation (Arvidsson et al., 2002). Cell 
survival is strongly dependent on the environment, with a major influencing factor being 
inflammation. The inflammatory response can have either a detrimental or beneficial effect on 
neurogenesis, depending on if the brain is intact or injured (Ekdahl et al., 2009).   
2.2.3.4 The Interaction Between Inflammation and Neuroplasticity  
Inflammation strongly influences neuroplasticity and its effects can be both supportive 
and detrimental. Both pro- and anti-inflammatory cytokines have been highlighted as important 
regulators of synaptic plasticity; however, the particular role of each cytokine is strongly 
dependent on their synaptic concentration. Whereas basal levels of inflammatory cytokines are 
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essential for the maintenance of plasticity (Di Filippo et al., 2008; Vilcek & Feldmann, 2004), 
over-expression of the same cytokines can deter this response (Bellinger et al., 1995; Katsuki et 
al., 1990). There is strong evidence that inflammatory cytokines regulate hippocampal long-term 
potentiation (LTP), which is the prolonged increase in signal transmission that occurs between 
two neurons. Under physiological conditions, pro-inflammatory cytokines including IL-1, IL-6, 
and IL-18, are required for hippocampal LTP; however, overexpression of these cytokines 
impairs synaptic plasticity by inhibiting hippocampal LTP (Di Filippo et al., 2008). 
Overexpression of these cytokines may result in the blocking of N-methyl-D-aspartate receptor 
(NMDAR), the glutamate receptor controlling synaptic plasticity (Di Filippo et al., 2008). In 
addition to the role that cytokines play in signal transmission, there is evidence suggesting that 
the number of synapses is altered by inflammatory cytokines. Although the results are 
preliminary, increased neuroinflammation has been associated with synaptic loss, as 
demonstrated by a decrease in synaptic proteins including synaptophysin and drebrin (Rao et al., 
2012). Ultimately, abnormal synaptic signaling that can occur under inflammatory states has 
been associated with cognitive impairment (Di Filippo et al., 2008).  
In addition to the role that neuroinflammation has on synaptic plasticity, neurogenesis is 
also strongly impacted by inflammatory molecules, including pro-inflammatory cytokines, 
chemokines, and microglia (Ekdahl et al., 2009). The involvement of each of these molecules is 
complex and greatly dependent on the extent and timing of the inflammatory response. For 
example, evidence suggests that TNF- has an inhibitory effect on progenitor proliferation when 
expressed during the acute period following brain ischemia; however, the role of TNF- appears 
to be reversed at later time-points (Ekdahl et al., 2009). Similar to the inhibitory effects reported 
with early expression of TNF-, overexpression of IL-1 and IL-6 can also significantly 
suppress neurogenesis under various pathological states (Ekdahl et al., 2009). Chemokines also 
play a central role in neurogenesis through their involvement in recruiting newborn neurons to 
the site of injury. Stromal cell-derived factor-1, a chemokine expressed by microglia after brain 
ischemia, enhances progenitor proliferation and promotes migration of newborn neurons to the 
affected region (Imitola et al., 2004). Inflammatory cells, particularly microglia, typically 
interfere with neurogenesis under pathological conditions. A strong microglia reaction, such as 
the one triggered by LPS, prevents neuronal differentiation and is detrimental to the survival of 
newborn neurons (Ekdahl et al., 2009). Activated microglia appear to have a similar response 
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following stroke. Blocking microglia activation in the ischemic brain increases the number of 
new neurons generated within the dentate gyrus (Liu et al., 2007). It is important to note that the 
effects of microglia on neurogenesis are strongly dependent on the stage of activation. Unlike the 
detrimental effects caused by activated microglia, ramified microglia are thought to have a 
supportive role. Following brain ischemia, chronic accumulation of non-activated microglia 
within the lateral ventricles is thought to promote progenitor proliferation and differentiation 
(Ekdahl et al., 2009).        
In summary, although neuroinflammation supports various aspects of neuroplasticity 
under normal conditions, the response is greatly different in the pathological brain. In general, 
the strong neuroinflammatory response triggered by brain ischemia is unfavorable to both 
synaptic plasticity and neurogenesis, and as a result may possibly hinder brain recovery.  
2.3 Current Advances in Stroke Treatment  
Despite years of pre-clinical research focusing on the pathophysiology of ischemic brain 
injury, there have been challenges in translating much of this work into effective treatments for 
human stroke victims (Hossmann, 2009). Currently, t-PA, which restores blood flow by 
dissolving blood clots, is the only validated and approved stroke therapy included in the 
Canadian Best Practice Recommendations for Stroke Care (Lindsay et al., 2010). T-PA is a 
serine protease that catalyzes the conversion of plasminogen to plasmin, resulting in the 
breakdown of blood clots. Administration of this enzyme can be very effective in treating both 
embolic and thrombotic strokes. However, the 4.5 hour therapeutic time window for drug 
administration is a major setback for this treatment (Hacke et al., 2008). Consequently, less than 
2% of Canadian stroke victims receive this type of intervention (Yip & Demaerschalk, 2007). 
Given that the current thrombolytic treatment is only administered to a small subset of stroke 
patients, it is critical to find improved approaches that will allow more rapid reperfusion with an 
extended therapeutic time window. A second approach of stroke therapies involves administering 
neuroprotective agents, which target and impede specific aspects of the cellular cascade of 
ischemic injury. Despite the success of neuroprotectants tested in animal models, this has yet to 
be translated into effective clinical treatment. Currently, there are no neuroprotective drugs used 
for the treatment of stroke (Cook & Tymianski, 2011; Fisher et al., 2009).  
Various limitations have prevented the successful translation of animal research into 
clinical stroke treatments. A major setback has been that the majority of studies have targeted 
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only one part of the ischemic cascade. STAIR has recently highlighted this as a limitation and 
has recommended that novel neuroprotective therapies target multiple pathways (Albers et al., 
2011). Another major limitation is that most research groups do not factor in the effects of 
common stroke co-morbidity factors, such as malnutrition, hypertension, and hyperglycemia. 
Given that most human stroke patients are elderly and suffer from underlying diseases, it is 
crucial to understand what effects these co-morbidity factors have on the ischemic cellular 
events. Therefore, the major aim of the research described in this thesis was to delve further into 
the mechanisms by which stroke outcome is impaired by the common co-morbidity factor, 
malnutrition. Another key reason for this failure of translating animal research into beneficial 
treatments is that the focus has mostly been on targeting very early events in the cascade of brain 
injury. Treatments targeting early cellular events, such as radical formation, accumulation of 
Na
+
/Ca
2+
 ions, and excitotoxic mediator release, would have to be administered within the first 
few hours following stroke, which in most cases is unachievable in a medical facility. Since 
more than half of patients do not seek help within the first 3 hours following stroke (Evenson et 
al., 2009), targeting cellular events that occur several hours after an ischemic attack will allow 
for a larger population of stroke patients to receive the pharmacological agent. The inflammatory 
cascade is a good molecular target since the acute reaction is initiated within hours following 
brain ischemia and can last for several days, weeks or even months. In addition, brain ischemia 
triggers a robust neuroplasticity response that remains heightened for at least a month after insult 
(Krakauer et al., 2012). Therefore, the possibility exists that by targeting the underlying 
mechanisms of spontaneous recovery, such as through neurorehabilitation, stroke outcome can 
be improved (Krakauer et al., 2012).  
In summary, significant emphasis needs to be placed on expanding our understanding of 
the cellular cascade of events, examining how these pathways are altered by co-morbidity 
factors, and ultimately developing new therapies which target long lasting mechanisms including 
inflammation and neuroplasticity. 
2.4 Rodent Models of Cerebral Ischemia  
Animal models of stroke are crucial in enhancing our understanding of the 
pathophysiological changes that occur following ischemia resulting in brain injury. These models 
have been developed to closely mimic the biochemical changes in brain that occur both during 
and after human stroke. Currently, there are a wide variety of animal models used to study 
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cerebral ischemia, with variations such as the species utilized, type of ischemia induced (global 
or focal) and techniques used to generate insult. There are several criteria that should be satisfied 
when using an animal model of brain ischemia and they include: (a) the pathophysiological 
changes replicate that of human ischemic stroke, (b) the ischemic lesion and extent of neuronal 
damage is reproducible, (c) the surgical procedure is as noninvasive as possible and 
physiological determinants of ischemic brain injury are maintained within normal ranges, and (d) 
both histological and functional assessment is performed to evaluate the extent of brain damage 
(Traystman, 2003).  
 A wide variety of animals are used to study cerebral ischemia including higher species 
(e.g., cats, rabbits, dogs, monkeys, pigs) and rodents (e.g., rats, mice, gerbils) (Traystman, 2003). 
However, the most common animal used in stroke studies is the male rat. The rat is a good 
candidate for stroke research because of homogeneity within strains, ability to easily monitor 
physiologic parameters, and the low cost of animal care and availability. The majority of 
researchers exclusively use male rats to avoid variability caused by female hormones. Previous 
research has indicated that gender can directly affect ischemic stroke outcome, with female rats 
presenting with smaller infarctions following brain ischemia (Alkayed et al., 1998; Li et al., 
1996). Interestingly, results from multiple studies performed in both female and male rats have 
shown that estrogen administration has neuroprotective properties (Alkayed et al., 1998; Fukuda 
et al., 2000; Zhang et al., 1998). Consequently, our understanding of stroke in females is very 
limited. Another limitation is that the majority of studies are performed on young, growing rats. 
Ideally, aged rats would be used to better model human stroke victims; however, various surgical 
complications can arise when using older rats. Furthermore, researchers tend to avoid using aged 
rats due to the considerable costs of housing animals for extended periods of time. These 
limitations apply to the research described in this thesis.  
Models of ischemic brain injury are classified based on the location of occlusion (focal or 
global) and the extent of blood blockage (transient or permanent). In human stroke cases, 
occlusion is commonly seen in the middle cerebral artery or one of its branches (del Zoppo et al., 
1992). Therefore, the majority of focal models have been developed to mimic this by inducing 
ischemia in the middle cerebral artery territory. Alternatively, global ischemia occurs when the 
cerebral blood flow is drastically reduced throughout most or all of the brain for a brief period of 
time, followed by reperfusion. Although this model of ischemia replicates the consequences of 
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cardiac arrest and resuscitation in humans, its use is relevant for the study of focal ischemia 
(stroke) since it induces many of the same pathophysiological mechanisms (Harukuni & 
Bhardwaj, 2006; Traystman, 2003). The other type of classification is dependent on whether 
there is reperfusion (transient model) or no-reflow (permanent model) following occlusion. 
Transient models of ischemia have two phases of reperfusion, with an initial period of increased 
blood flow (post-ischemic hyperemia) followed by an extended phase of reduced blood flow 
(post-ischemic hypoperfusion). Permanent models of ischemia, in which the vessels remain 
occluded, involve incomplete restoration of blood flow to the damaged tissue resulting in 
decreased neuronal survival (Iadecola, 1999). In summary, there are numerous animal models of 
cerebral ischemia that are currently being utilized in the stroke field to investigate ischemic 
mechanisms, prevention and treatment. Each of these models has potential advantages and 
disadvantages, which should be considered when designing a pre-clinical experiment.  
2.4.1 Focal Ischemia Models 
Induction of focal ischemia usually involves the occlusion of one major blood vessel 
resulting in transient or permanent reduction of blood flow to a specific brain region. Variations 
in focal models do exist with diverse techniques being commonly utilized to induce focal 
cerebral ischemia. Some of the current major animal models of focal ischemia include proximal 
or distal middle cerebral artery occlusion, intraluminal suture, middle cerebral artery embolism, 
endothelin 1 vasoconstriction, and photothrombosis (Murphy & Corbett, 2009). In brief, for the 
proximal/distal middle cerebral artery occlusion model, the middle cerebral artery is temporarily 
occluded using microvascular clips or permanently blocked by cauterization. The intraluminal 
suture model consists of interruption of blood flow for 30-120 minutes by placing a suture at the 
carotid artery and middle cerebral artery junction. Longer occlusion periods with this model can 
cause large infarcts in both hemispheres. Smaller infarct sizes, similar to human ischemic stroke, 
can be produced using the middle cerebral artery embolism model, in which a blood clot is 
introduced to occlude the middle cerebral artery. The endothelin 1 vasoconstriction model uses a 
strong vasoconstrictor, endothelin 1, to occlude various blood vessels. Lastly, photothrombosis 
involves a vascular injection of a photoactive dye combined with irradiation of a specific area of 
cortex with a light beam at a given wavelength. Irradiation of the circulating dye, such as rose 
bengal, produces free radicals and results in platelet aggregation and thrombus formation 
(Watson et al., 1985). An advantage of this model is the ability to produce a small infarct in a 
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specific cortical area by selectively illuminating the targeted brain tissue (Tatlisumak et al., 
2007). Although these focal models are routinely used in experimental study, there are also 
disadvantages to using these surgical techniques, as outlined in section 2.4.2.1, which led to the 
selection of a global ischemia model for the thesis research.   
2.4.2 Global Ischemia Models 
2.4.2.1 Overview   
 Global cerebral ischemia models, in which the entire brain is transiently deprived of 
blood flow, have been designed to mimic cardiac arrest in humans. However, these models are 
also commonly employed in stroke research, as is the case in this thesis, to provide insight on the 
regional and cell specific vulnerability to ischemia. Furthermore, global brain ischemia has been 
shown to induce many of the same pathophysiological mechanisms of focal ischemia, making it 
a relevant model for studying cerebral ischemia (Harukuni & Bhardwaj, 2006). The advantages 
of utilizing global cerebral ischemia models are that, in general, they provide more defined and 
consistent injury, require a lower level of surgical expertise, and have fewer variables that need 
to be controlled compared to focal ischemia models (Traystman, 2003). In addition, focal 
ischemia models generally require extensive and invasive surgery (Tatlisumak et al., 2007; 
Traystman, 2003). Focal ischemia models requiring craniotomy, such as middle cerebral artery 
occlusion models, are considered especially traumatic. Major invasive surgeries can have 
pronounced effects on nutritional status, and thus are potentially problematic for the nutritional 
studies undertaken in this thesis. For these reasons, a global brain ischemia model was 
considered the most appropriate stroke paradigm for the thesis research. It is important to note, 
however, that the level of inflammation, and more specifically leukocyte infiltration, differs 
between global and focal ischemia models. Unlike focal ischemia, in which there is a high level 
of leukocyte infiltration, global ischemia does not damage the blood-brain barrier and therefore 
glial cells are the sole source of inflammatory cells (Kato, 2001).  
The premise of most global cerebral models is to obstruct blood flow to the entire brain 
for a short duration (e.g., 5-15 minutes), causing damage to vulnerable neurons and avoiding 
overt brain infarction. The same subset of vulnerable neurons are injured in response to various 
experimental models of global ischemia. Reduction of blood flow to the brain results in forebrain 
structures virtually undergoing complete ischemia, with a rank order of vulnerability throughout 
the forebrain. Vulnerable brain regions include the hippocampus (CA1, CA2, and hilar neurons), 
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thalamus, and striatum (Pulsinelli et al., 1982). The most extensive and reliable damage is 
predominantly in the CA1 region of the hippocampus, becoming apparent within 2-4 days 
following global ischemia (Kirino et al., 1984). Some regions of the hippocampus, including 
CA3 pyramidal cells and granule cells of the dentate gyrus, are highly resistant to ischemia. 
However, damage can occur in these hippocampal areas following global ischemia if the injury 
is extensive. Therefore, in general, the hippocampus is the main region of interest when 
assessing damage elicited by global brain ischemia. 
2.4.2.2 The Hippocampus  
2.4.2.2.1 Overview  
 The hippocampus belongs to the limbic system and is a paired structure composed of 
mirror-image halves in both hemispheres of the brain. The elongated c-shaped structure extends 
from the basal forebrain into the temporal lobe of the rat brain. The hippocampal formation is 
composed of three distinct regions that include the dentate gyrus, the hippocampus proper (CA1, 
CA2, and CA3) and the subiculum. These cortical structures all share a similar three-layered 
appearance with the cellular connectivity mostly being uni-directional (Witter & Amaral, 2004).   
2.4.2.2.2 Hippocampus Proper  
Characterization of hippocampal neurons is based on cellular morphology and 
connectivity, with the hippocampus proper being divided into three subfields known as the CA1, 
CA2 and CA3 regions. All three regions contain a compact layer of excitatory pyramidal neurons 
(stratum pyramidale) that transmit glutamate; however, the size and arrangement of these 
neurons differ between subfields. The CA3 region lies proximal to the dentate gyrus and is 
composed of a layer of relatively large pyramidal cells. Alternatively, the CA1 region lies distal 
to the dentate gyrus and contains smaller pyramidal neurons that have a more compact 
arrangement than CA3 neurons. The CA2 region lies between CA3 and CA1 and contains many 
large pyramidal neurons similar in size to those in CA3, but with a more compact arrangement. 
The CA2/CA3 border can be hard to discriminate; however, another distinguishing characteristic 
is that mossy fibers originating from the dentate gyrus only extend to the CA3 neurons and not to 
CA2 neurons (Witter & Amaral, 2004).  
The laminar organization of the hippocampus proper can be categorized into three main 
layers known as the stratum oriens (SO), stratum pyramidale (SP) and the stratum radiatum (SR) 
(Figure 2.2). The principal layer of the hippocampus proper is the stratum pyramidale, which is 
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several cells thick and mostly composed of excitatory pyramidal neurons. Stratum oriens is a 
narrow, relatively cell-free region superior to the stratum pyramidale. This stratum is mostly 
composed of the basal dendrites of pyramidal neurons, but also contains scattered basket cells 
and polymorphic neurons. Inferior to the pyramidal layer is the stratum radiatum, which contains 
projections from pyramidal neurons, basket cells and other interneurons. In addition to the three 
main layers, there are smaller defined hippocampal strata that include stratum lucidum (SL) and 
stratum lacunosum-moleculare (SLM) (Figure 2.2). Stratum lucidum is only found in the CA3 
subfield and is occupied by the mossy fiber axons from the granule cell layer of the dentate 
gyrus. Stratum lacunosum-moleculare is the deepest stratum of the hippocampus and consists of 
perforant path fibers that originate from the superficial layers of the entorhinal cortex (Witter & 
Amaral, 2004).  
 
         
Figure 2.2. Diagram illustrating laminar organization of the hippocampus proper in the rat (SP, 
stratum pyramidale; SO, stratum oriens; SL, stratum lucidum; SR, stratum radiatum; SLM, 
stratum lacunosum-moleculare; DG, dentate gyrus). (From: Nishimura-Akiyoshi et al. PNAS. 
2007; 104: 14801-14806. © 2013 by The National Academy of Sciences of the USA).  
 
SP 
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2.4.2.2.3 Hippocampal Circuitry   
The hippocampal circuitry is complex and Figure 2.3 highlights only the major pathways 
involved in the uni-directional flow of hippocampal information that originates and terminates in 
the entorhinal cortex (Witter & Amaral, 2004).  
 The perforant pathway, which is glutamatergic and arises from the entorhinal cortex, is 
the major input to the hippocampus. The axons of the perforant pathway terminate in all 
subregions of the hippocampus; however, the dentate gyrus is the predominant target of this 
pathway. Within the dentate gyrus, the majority of axons synapse on dendritic spines of granule 
cells. The signal is transferred from the dentate gyrus to the CA3 hippocampal region via the 
mossy fiber pathway, with glutamate being the primary neurotransmitter released. In particular, 
axons of dentate gyrus granule cells extend to the CA3 region and synapse on pyramidal 
neurons. The majority of these synapses occur within the stratum lucidum, the inner region of the 
CA3 bend. On average, a single mossy fiber has 14 synaptic connections within the stratum 
lucidum, thus influencing multiple CA3 pyramidal neurons (Witter & Amaral, 2004). CA3 
neurons extend their axons to CA1 pyramidal neurons via the Shaffer Collateral pathway. 
Typically, Shaffer Collateral fibers extend through the CA3 stratum oriens and synapse on 
dendritic spines of CA1 neurons located within the stratum radiatum. CA3 neurons from the 
contralateral hippocampus also make connections with CA1 pyramidal neurons, and are termed 
commissural fibers. In addition, the CA3 region can be innervated by CA3 neurons, by means of 
CA3-to-CA3 associational connections (Witter & Amaral, 2004). The major output from the 
hippocampus is the pathway from the CA1 region to the subiculum and back to the entorhinal 
cortex. CA1 neurons extend their axons through the stratum oriens and synapse on subicular 
pyramidal neurons. Subsequently, projections from the subiculum terminate on the pyramidal 
neurons in the entorhinal cortex.  
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Figure 2.3. The rat hippocampal network. The hippocampus forms a principally uni-directional 
network, with input from the entorhinal cortex that forms connections with the dentate gyrus 
(DG) and CA3 pyramidal neurons via the Perforant Pathway (PP – split into lateral and medial). 
CA3 neurons also receive input from the DG via the Mossy Fibers (MF). They send axons to 
CA1 pyramidal cells via the Schaffer Collateral Pathway (SC), as well as to CA1 cells in the 
contralateral hippocampus via the Associational Commisural (AC) Pathway. CA1 neurons also 
receive inputs direct from the Perforant Path and send axons to the Subiculum (Sb). These 
neurons in turn send the main hippocampal output back to the entorhinal cortex, forming a loop. 
(From: Dr. Andrew Doherty; University of Bristol).  
  
2.4.2.3 Gerbil Bilateral Common Carotid Artery Occlusion Model  
The simplest surgical model of global brain ischemia is the bilateral common carotid 
artery occlusion in the gerbil. This was an excellent model due to the unique cerebrovascular 
anatomy of the Mongolian gerbil, in which the posterior communicating arteries were absent, 
thus forming an incomplete circle of Willis (Traystman, 2003). This surgically simple model 
involved a short occlusion period of approximately 5 minutes, which historically produced very 
consistent hippocampal CA1 injury (Colbourne & Corbett, 1995; Small & Buchan, 2000). 
However, over the last decade there has been an alarming increase in variability of ischemic 
damage (Ji et al., 2008; Laidley et al., 2005; McEwen & Paterson, 2010). To study this 
phenomenon, the cerebral vasculature of Mongolian gerbils from two suppliers were compared 
(Laidley et al., 2005). Approximately 61% of gerbils obtained from Charles River, the largest 
supplier in North America, had posterior communicating arteries forming either a complete 
(22.7%) or partial (38.6%) circle of Willis. Consequently, this subset of gerbils had significantly 
less CA1 neuronal damage following bilateral common carotid artery occlusion compared to 
gerbils with no posterior communicating arteries. The mechanisms leading to the variation in the 
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circle of Willis are currently unknown, but are most likely due to a genetic component. 
Consequently, most researchers have abandoned the bilateral common carotid artery occlusion 
model due to the large portion of gerbils possessing the complete circle of Willis.     
2.4.2.4 Rat Global Ischemia Models  
Rats are also considered a good candidate for stroke research, given that their relatively 
large blood volume allows for continuous sampling throughout the surgical period to monitor 
physiological variables known to influence ischemic injury. Induction of global brain ischemia in 
rats is commonly via 4-vessel occlusion (4-VO) or 2-VO. The 4-VO model was introduced in 
1979 and is a two-step surgical process consisting of permanent occlusion of the vertebral 
arteries on day one, followed by occlusion of the bilateral common carotid arteries on day two 
(Pulsinelli & Brierley, 1979). Major disadvantages of this method include the permanent 
occlusion of the arteries and high occurrence of seizures (up to 40%) following occlusion 
(McBean & Kelly, 1998). Furthermore, the level of surgical invasiveness with this procedure is 
problematic for the nutritional studies undertaken in this thesis. The 2-VO model is often used 
instead of the 4-VO model to reduce the surgical stress on the animal (Smith et al., 1984). The 
damage induced via the 2-VO model is similar in size and location to that produced with the 4-
VO model (McBean & Kelly, 1998). Therefore, the 2-VO model has been widely accepted as a 
relevant and important model used for identifying the physiological, biochemical and functional 
mechanisms of the human condition of stroke.   
2.4.2.4.1 Rat 2-Vessel Occlusion   
 The 2-VO model involves occlusion of both bilateral common carotid arteries combined 
with systemic hypotension, ultimately inducing a rapid onset of ischemia followed by quick 
reperfusion. Induction of systemic hypotension is necessary, since occlusion of the common 
carotid arteries alone does not sufficiently decrease the cerebral blood flow below the ischemic 
threshold (Eklof & Siesjo, 1973). The advantages of this model include a relatively straight-
forward surgery that has a lower experimental failure rate than other models, production of high-
grade forebrain ischemia, and acceptable consistency in insult severity. The extent of ischemic 
insult is dependent on successful blood pressure reduction (30-40 mmHg) and complete but 
temporary occlusion of the carotid arteries (8-10 minutes) (Smith et al., 1984). Depending on the 
size of rat, systemic hypotension can be induced by withdrawing blood from the jugular vein or 
tail artery. As well, the tail arterial site can be used to obtain blood samples for physiological 
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monitoring. Physiologic parameters, including blood gases and glucose, are attained several 
times throughout the surgery, allowing monitoring of acid-base balance and adjustment of 
oxygen levels as necessary to achieve appropriate tissue oxygenation.     
The severity and homogeneity of ischemic injury induced in rodent stroke models is 
dependent on several surgical variables, including duration of ischemia, blood pressure, 
temperature, blood glucose levels and blood gases. The 2-VO model is no exception. Extensive 
neuronal damage can be obtained with the 2-VO model by using a relatively short occlusion 
period of 8-10 minutes. The extent of ischemic injury was recently characterized after 8, 9 and 
10 minutes of occlusion using the 2-VO model. Histological analysis of tissue collected 7 days 
following ischemia revealed that all three occlusion periods resulted in extensive CA1 
hippocampal injury with no difference in the extent of damage among groups (Clark et al., 
2007). Variations in blood glucose levels can contribute to heterogeneity in the 2-VO model, 
with elevated blood glucose concentrations exacerbating brain injury (Dietrich et al., 1993; 
Siemkowicz & Hansen, 1978). To prevent potential variability in ischemic injury, animals are 
commonly fasted to achieve blood glucose levels within a consistent range. Arterial blood 
samples are generally collected several times throughout the surgical period to allow monitoring 
of pH, pO2 and pCO2. Global ischemia models are relatively insensitive to small changes in 
blood gases; however, extreme variation from the desired range can cause heterogeneity in 
ischemic injury (Nowak, 2007). For example, marked reductions in pH during brain ischemia 
exacerbates tissue damage by activating acid-sensing ion channels resulting in an influx of 
calcium (Huang & McNamara, 2004). Another surgical challenge is providing adequate oxygen 
to ensure 100% saturation of the blood (as assessed by arterial blood pO2), while preventing a 
surplus of oxygen that would enhance oxidative stress. Hematocrit is routinely monitored as a 
measure of the percentage of the total blood volume made up by red blood cells, and therefore is 
a good indicator of the oxygen-carrying capacity of the blood (Kiyohara et al., 1985).  
Full characterization of each surgical variable for the given model is necessary to 
establish the parameter threshold that needs to be obtained to produce consistent and extensive 
hippocampal CA1 neuronal death. Arvanitidis et al. (2009) recently modified the 2-VO 
methodology, which was based on that of Smith et al. (1984), providing descriptions of the 
desirable range for each surgical variable. Nonetheless, it is good practice to establish the 
desirable range of each variable to induce ischemia under the specific conditions of model usage. 
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A limitation of the 2-VO model is that some variability in neuronal damage can occur between 
animals. Unilateral damage is observed in a subset of animals following 2-VO ischemia, even 
with all surgical parameters being well controlled (Smith et al., 1984). Autoradiographic 
measurements of local cerebral blood flow have illustrated that in the occasional animal, flow 
rates are maintained on one side of the brain during carotid artery occlusion (Smith et al., 1984). 
This phenomenon has been difficult to explain and highlights the importance of histological 
assessment to confirm extensive ischemic injury.  
2.4.2.5 Regulation of Brain Temperature   
  Brain temperature should be assessed when using any brain ischemia model, given that 
neuronal damage is highly temperature-sensitive. The persistent lack of attention to temperature 
regulation is the most common error in experimental stroke research, causing increased 
variability in neuronal injury. The effects of temperature following global brain ischemia have 
been comprehensively reviewed, and it is evident that hypothermia has neuroprotective 
properties by enhancing CA1 survival (Colbourne & Corbett, 1995; MacLellan et al., 2009; van 
der Worp et al., 2007), while hyperthermia worsens outcome by increasing degeneration of CA1 
neurons (Minamisawa et al., 1990; Wang et al., 2009). Attention to intra- and post-ischemic 
temperature is necessary since hippocampal pathology is prolonged and remains temperature 
sensitive (Nowak, 2007). Thermocouple wires are commonly used during the 2-VO surgery to 
record skull or tympanic temperature as estimates of brain temperature. Temperature is 
maintained within a consistent range with the use of heat lamps and water blankets. Given that 
core body temperature and brain temperature are usually highly correlated after global ischemia 
induced by the 2-VO procedure (Clark et al., 2007), implanted core probes are often adequate for 
monitoring post-ischemic temperatures. Furthermore, a recent report suggests that spontaneous 
temperature changes do not occur in healthy Sprague-Dawley rats following 2-VO surgery, and 
thus heating sources are not necessary during the acute post-ischemic period (Clark et al., 2007). 
However, this response can vary depending on rat strain, surgical sterility, and method used to 
measure temperature (Clark et al., 2007).  
2.4.2.6 Assessment of Ischemic Injury 
2.4.2.6.1 Histological Assessment   
To accurately assess the extent of ischemic injury, it is necessary to have both 
histological and functional endpoints. There are various histological techniques that are 
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commonly used to accurately and objectively analyze the extent of neuronal death. Histological 
techniques used for global brain ischemia research include hematoxylin and eosin (H&E) 
staining, nitroblue tetrazolium and Nissl’s staining (cresyl violet) (Tatlisumak et al., 2007). 
Cresyl violet staining is a well established histological stain used for light microscopy (Burnett et 
al., 1987) to evaluate both early and delayed neuronal death following global ischemia that was 
used in this thesis research. Cresyl violet stains the nissl substance, known as the rough 
endoplasmic reticulum, found within the cytoplasm. Early histological endpoints can detect 
neuronal death within 2-4 days following global brain ischemia, with neurons appearing 
shrunken (Kirino, 1982; Kirino et al., 1984; Pulsinelli et al., 1982). Cresyl violet staining 
diminishes as neurons degenerate in the hippocampus. Long-term endpoints are necessary when 
studying a treatment effect since it might simply delay neuronal death, which if using an early 
time-point might deliver encouraging but false results (Corbett & Nurse, 1998). Similarly, long-
term endpoints are important for the research described in this thesis, given that a detrimental 
factor such as PEM might exacerbate the slow, long-term increase in CA1 neuronal death.   
2.4.2.6.2  Functional Assessment   
Functional recovery should be evaluated in combination with histological analysis, given 
that a neuron exposed to ischemia could appear viable but have aberrant function. Two of the 
most common techniques incorporated into experimental stroke studies to assess functionality 
are behavioural tests and electrophysiological assessment. The open field and T-maze test are the 
best-characterized behavioural tests to assess functional recovery following global ischemia in 
the gerbil (Babcock & Graham-Goodwin, 1997; Colbourne & Corbett, 1995; Farrell et al., 2001). 
More sensitive behavioural paradigms are necessary in measuring functional outcome in the rat 
2-VO model, given that the behavioural impairments seem to be milder than for the gerbil 
model. Recently, Langdon et al. (2008) assessed the sensitivity of three commonly used 
hippocampal-dependent tests; Morris water maze, radial arm maze, and T-maze. It was 
demonstrated that the radial arm maze, along with more difficult versions of the T-maze, had 
better sensitivity in detecting CA1 injury than the standard Morris water maze. However, the 
radial arm maze and T-maze are very time consuming and labour intensive. Increasing the 
difficulty of the Morris water maze can enhance the sensitivity level. More specifically, a 
reduction in the number of cues and trials increases the difficulty of the task and allows for 
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detection of modest functional impairments in rats exposed to global brain ischemia (Langdon et 
al., 2008).  
 Electrophysiology is a technique that allows direct observation and recording of the 
electrical activity of a cell. To analyze the extent of damage to a specific area of the brain, such 
as the hippocampus, the tissue is excised and analyzed with an electrode. A single-unit recording 
can be obtained by inserting a micro-electrode into a neuron, which will detect the action 
potential activity of a single cell (Henderson, 1993). If the neuron is undamaged from ischemia, 
the recorded resting membrane potential should be between -60 to -80 mV, and reaching +40 mV 
during an action potential. Another technique, referred to as extracellular field potentials, 
involves placing a larger electrode in the extracellular space to measure the collective activity of 
many neurons (Henderson, 1993). Therefore, unlike behavioural tests, which have limited 
sensitivity of detecting damage to a specific cell group, electrophysiology can effectively 
measure deficits in localized regions (Corbett & Nurse, 1998). However, the major disadvantage 
of electrophysiology is that tissue slices are required, and thus afferent inputs outside the plane of 
the cut are transected. Nevertheless, electrophysiology has been frequently employed to measure 
injury following global brain ischemia (Corbett & Nurse, 1998). Extracellular field potentials can 
be evoked in CA1 neurons between 0-48 hours following insult, but then are greatly reduced at 
later time-points (Jensen et al., 1991). These results illustrate that the morphological and 
functional changes to CA1 neurons during the acute period after global ischemia follow a similar 
time course.  
2.4.2.7  Synaptic Plasticity Triggered by Global Brain Ischemia  
 Post-ischemic synaptic plasticity in global ischemia models has not yet been fully 
characterized, due to limited studies and assessment only at early time-points. Procedures 
commonly used to assess synaptic plasticity include electrophysiology, Golgi-Cox staining, and 
immunocytochemical profiles of neuroplastic positive factors (e.g. BDNF, GAP-43) and synaptic 
vesicle proteins (e.g. synapsin, synaptophysin). Interestingly, increases in proteins involved in 
plasticity have mostly been detected within the mossy fiber terminals, which is the location 
where axons of the dentate gyrus synapse on CA3 pyramidal neurons. These findings suggest 
that global brain ischemia is affecting signaling in ischemia-resistant regions.  
Alterations in GAP-43, a molecular marker of neuronal plasticity, have been described in 
two models of global brain ischemia. Following 4-VO surgery in the rat, mRNA expression of 
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GAP-43 declined in the CA1 subfield, as the result of cell death, but increased in CA3 neurons 
and dentate gyrus granule cells (Schmidt-Kastner et al., 1997). GAP-43 protein 
immunoreactivity after global ischemia in the gerbil increased after 3 days within the dentate 
gyrus and dying CA1 neurons; however, the signal was lost by day 7 (Prosser-Loose et al., 
2010). Similar to the distribution of GAP-43, reports have shown an increase in BDNF 
expression within the CA3 and dentate gyrus regions following global ischemia (Kokaia et al., 
1996; Lee et al., 2002).  
Synaptophysin, SNAP-25 (synaptosomal-associated protein of 25 kDa) and Mint1 
(munc-18-interacting protein 1) are examples of presynaptic proteins measured to assess changes 
to synaptic terminals in the ischemic hippocampus. These proteins are found within synaptic 
vesicles, and thus an increase in concentration suggests enhanced neuronal signaling. Within 
mossy fiber terminals, protein levels of SNAP-25 are increased as early as 2 days after global 
ischemia (Marti et al., 1998). Similarly, Mint1 immunoreactivity is significantly increased within 
the mossy fiber region 3 days following global brain ischemia (Nishimura et al., 2000). Together, 
these results suggest that increases in synaptic proteins occur in the mossy fiber region near the 
time of delayed CA1 neuronal death. In the CA1 region, SNAP-25 and synaptophysin levels are 
significantly depleted by day 2 following global ischemia. However, around surviving CA1 
neurons, both of these proteins are considerably increased on days 7 and 14 (Ishimaru et al., 
2001). These studies were performed using either a gerbil or mouse model of transient global 
brain ischemia, and therefore characterization of these synaptic proteins in the rat 2-VO model is 
required. Nevertheless, the rat 2-VO model was recently used to evaluate whether post-ischemic 
hypothermia impedes plasticity (Silasi et al., 2012). Although synaptophysin levels were 
examined in this study, the absence of sham-operated animals prevented analysis of the ischemic 
effect. Interestingly though, the results suggest that prolonged hypothermia does not alter the 
neuroplasticity response to global brain ischemia in rats.    
2.4.2.8 Inflammatory Response after Global Brain Ischemia 
Global brain ischemia results in extensive CA1 neuronal damage within days of insult, 
which is accompanied by marked glial reactions that involve both microglia and macroglia. 
Unlike focal ischemia, global ischemia does not usually result in blood-brain barrier damage and 
therefore immune cells are not recruited from systemic circulation (Kato, 2001). Therefore, 
microglia are the sole responders since infiltration of leukocytes and activation of perivascular 
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cells does not occur following global brain ischemia (Kato, 2001). Furthermore, it is currently 
unknown whether global brain ischemia triggers an acute-phase response, thus highlighting a 
novel research area that will be assessed in this thesis.   
The vulnerability of the hippocampus to global brain ischemia makes it the primary site 
of inflammation. The initial activation of microglia, which is not confined to one area of the 
hippocampus but instead is present throughout the entire hippocampus, has been observed within 
minutes following reperfusion (Kato et al., 1995; Morioka et al., 1991). At day 2-4 following 
global ischemia, neuronal death becomes apparent which triggers another wave of microglial 
activation. A significant increase in microglial immunoreactivity occurs within 72 hours 
following global ischemia in the CA1 region of the hippocampus and between the blades of the 
dentate gyrus (Webster et al., 2009). Proliferation of microglia within the CA1 region continues 
until at least the third post-ischemic week, as demonstrated by increased numbers of 
bromodeoxyuridine (BrdU)/Iba-1 co-labeled cells (Silasi & Colbourne, 2011). The glial 
population within the CA1 region remains heightened for up to 9 months following global brain 
ischemia (Langdon et al., 2008). Chronic neuroinflammation suggests that there is continuing 
injury for months following global ischemia resulting in long-term cell death. In combination 
with these findings, it has been demonstrated that functional impairments are sustained for at 
least 9 months following global brain ischemia (Langdon et al., 2008).     
The master regulator of the inflammatory response, NFB, is activated within 12 hours 
following global brain ischemia (Murakami et al., 2005). NFB activation occurs at marked 
levels in the nucleus of degenerating CA1 hippocampal pyramidal neurons. Conversely, 
activation of NFB has not been demonstrated in brain regions that are not as vulnerable to 
global ischemia, such as the cerebral cortex, thalamus, and hypothalamus (Clemens et al., 1997). 
Activators of NFB, including TNF- and IL-I, are vastly increased within hours following 
global ischemia. Global brain ischemia in the mouse, induced via bilateral common carotid 
artery occlusion, results in elevated hippocampal TNF- mRNA expression 3 hours following 
insult with increased protein levels by 6 hours. Expression levels of TNF- mRNA remain 
heightened for 36 hours after global ischemia and return to basal levels by day 4 (Murakami et 
al., 2005). Furthermore, mRNA expression of the pro-inflammatory cytokine, IL-1, peaks 8 
hours following reperfusion in the hippocampus region (Sairanen et al., 1997). In the CA1 and 
CA2 regions of the hippocampus, IL-1 mRNA levels remain elevated for up to 24 hours, with 
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the major cellular source of the protein being from glial cells (Sairanen et al., 1997). Together 
these results suggest that pro-inflammatory cytokines are rapidly expressed during the acute 
period following global brain ischemia; however, the cytokine response at longer time-points has 
not yet been characterized. The inflammatory mechanisms triggered by global brain ischemia 
could potentially be influenced by various factors, including poor nutrition. The co-morbidity 
factor, co-existing PEM, could worsen brain ischemia outcome by escalating or prolonging the 
inflammatory response.  
2.5 Protein-Energy Malnutrition 
2.5.1 Overview 
 Mechanisms triggered by brain ischemia can be strongly influenced by a common type of 
malnutrition called PEM, which is characterized by inadequate protein and energy status. 
Primary PEM, which results from the consumption of an inadequate diet that is deficient in 
protein and other nutrients, is predominantly seen in developing countries due to factors such as 
poverty, famine, and unsanitary living conditions. Primary PEM is often seen among infants and 
children and is classified as either marasmus, a severe and gradual form of PEM, or kwashiorkor, 
an acute type of PEM that progresses more rapidly. PEM in the elderly also exists in developed 
countries and is likely to arise from the combination of suboptimal diet and secondary causes 
such as co-morbidities. Various underlying diseases or treatments can cause impairments in food 
digestion, absorption of nutrients, or swallowing, ultimately causing the manifestation of PEM 
(Torun, 2006). Given that variations of secondary PEM exist, it has been recently proposed that a 
valid etiology-based diagnosis construct be used in clinical settings to properly identify adult 
malnutrition (Jensen et al., 2010). One of the key classification criteria proposed for this 
diagnosis scheme is the presence or absence of a systemic inflammatory response. This has been 
highlighted as an important component of the diagnosis construct, since the presence of 
inflammation requires different medical therapy and nutritional intervention. It is imperative that 
PEM is diagnosed correctly, since it is systemic in nature and can have detrimental effects on 
almost every organ system in the body (Torun, 2006).  
2.5.2 PEM in the Elderly Population  
 Seniors living in industrialized countries are at high risk for developing PEM, with 
approximately 15% of community-dwelling and home-bound elderly, 23-62% of hospitalized 
patients, and up to 85% of individuals residing in nursing homes being categorized as protein-
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energy malnourished (Guigoz, 2006). Strong evidence from epidemiologic studies have 
highlighted PEM as an independent predictor of mortality, regardless of whether the individual is 
an independent living elderly or a patient in a hospital/nursing home (Campbell et al., 1990; 
Cederholm et al., 1995; Morley & Silver, 1995). Furthermore, mortality rates are even higher in 
the cases where PEM is a co-morbidity factor (Chapman, 2006). Given that the elderly 
population in Canada is on the increase (Turcotte & Schellenberg, 2006), these alarming findings 
emphasize the importance of research that aims to improve survival rates and quality of life in 
the malnourished. 
 The elderly are at increased risk of developing PEM due to social, psychological, and 
medical factors (Chapman, 2006). Poor eating habits, usually as a consequence of living alone, is 
the most common underlying cause of primary PEM in seniors. The inability to shop, prepare 
food, or cook meals are examples of challenges that can result in insufficient food intake. 
Furthermore, individuals that live alone commonly experience decreased appetite resulting in 
reductions in daily energy intake (Walker & Beauchene, 1991). Malnutrition in seniors can also 
be the result of poor dentition, causing difficulties in biting, chewing and swallowing of certain 
foods. Depression, dementia and alcoholism are examples of other factors that can directly affect 
eating habits (Chapman, 2006). Additionally, there is a greater likelihood for drug-nutrient 
interactions in elderly, due to the increased chance of an individual both being of poorer 
nutritional status and taking medications. Secondary PEM commonly manifests in patients 
suffering from serious medical conditions, such as cardiac failure, cancer, infection, and stroke, 
due to physical impairments and long-term treatments. Hence, the research reported in this thesis 
focused on the effects of both PEM as a co-morbidity factor at the time of stroke and PEM 
developing as a result of the stroke.  
2.5.3 Prevalence of PEM in Stroke Patients  
PEM is one of the most prevalent types of malnutrition in North America and is a co-
morbidity factor in approximately 16% of stroke cases (Davis et al., 2004; Martineau et al., 
2005; Yoo et al., 2008). In addition to the subset of patients with co-existing PEM at the time of 
stroke, the prevalence rates of PEM double within the first week following a stroke due to 
inadequate hospital care and physical impairments. Dysphagia, occurring in 24-53% of stroke 
patients (Foley et al., 2009), is the inability to control food in the mouth and swallow, and is a 
major precipitating factor of malnutrition. A systematic review demonstrated that there is a 
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significant relationship between dysphagia and malnutrition following stroke (Foley et al., 2009). 
In addition to dysphagia, other factors that can contribute to poor nutritional status following a 
stroke include depression, paralysis of the arm or face, and reduced level of consciousness 
(Bouziana & Tziomalos, 2011). Therefore, both co-existing PEM and post-ischemic PEM are 
clinically relevant health conditions. Given that PEM can have adverse effects on stroke 
outcome, it is crucial that it is correctly diagnosed and monitored during the acute period 
following stroke. There are numerous methods used to diagnosis PEM in patients, although there 
are many identified limitations with the current nutritional assessment techniques available.   
2.5.4 Diagnosis of PEM  
2.5.4.1 Overview  
Malnutrition has been associated with poorer survival and functional outcome following 
a stroke (Davis et al., 2004; Martineau et al., 2005; Yoo et al., 2008). Therefore, it is crucial for 
health professionals to thoroughly assess the nutritional status of stroke patients so that the 
appropriate support can be provided. Evaluation of the presence and severity of PEM will assist 
in determining the effectiveness of nutritional support, and also decrease the risk of 
complications associated with malnutrition. The traditional methods used in the diagnosis of 
PEM include dietary, anthropometric, biochemical and functional measurements (Torun, 2006). 
However, the extent of assessment is commonly dependent on the simplicity and expense of the 
procedure, time requirements, and availability of measurement instruments. Given that many of 
these assessment techniques are plagued by difficulties, it is common for PEM diagnosis to be 
based on a single parameter. Serum albumin is one of the most frequently used single 
biochemical indices for PEM assessment (Johnson, 1999). However, it has major limitations (see 
Section 2.5.4.3.2), and a multi-parameter protocol is recommended for a more adequate 
assessment.  
2.5.4.2 Anthropometric Measurements   
Weight loss is a common and pronounced symptom of PEM. A reduction in energy 
intake is commonly compensated by a decrease in energy expenditure. However, if the energy 
output is still greater than intake, the outcome is weight loss. As malnutrition progresses and 
energy deficits become more severe, muscle protein catabolism occurs which leads to muscular 
wasting (Torun, 2006). Anthropometric measurements are generally used to assess body 
composition, given that they are noninvasive, low in cost, quick and simple. Raw measurements 
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of weight, height, skinfolds (triceps and subscapular) and waist, hip and arm circumferences are 
easily attainable and can predict nutritional status. Furthermore, the body mass index, calculated 
as weight relative to height, is widely used in the assessment of PEM severity in adults. The 
classification protocol used for PEM assessment states that a body mass index of ≥18.5 kg/m2 is 
normal, 17.0-18.4 kg/m
2
 is mild PEM, 16.0-16.9 kg/m
2
 is moderate PEM, and < 16.0 kg/m
2
 is 
severe PEM (World Health Organization, 2006). Although a main clinical characteristic of PEM 
is weight loss, various nutritional deficits can have similar effects and therefore anthropometric 
measurements are not sensitive enough to detect specific nutrient deficiencies. Similarly, there 
are various non-nutritional factors, such as medical conditions and medications, which can affect 
anthropometric measurements, thus reducing testing sensitivity and specificity. For that reason, 
relying on only the body mass index assessment is not considered adequate to confirm the 
diagnosis of PEM, and additional parameters should be measured.  
2.5.4.3 Biochemical Measurements  
2.5.4.3.1 Overview  
 PEM can drastically impact protein anabolism and catabolism. PEM most commonly 
results in a reduction in protein synthesis, and as a result the half-lives of proteins are increased 
(Torun, 2006). Due to limited amino acid availability, serum concentrations of various proteins, 
such as albumin and transferrin, are commonly decreased in individuals with moderate to severe 
PEM and are used as biochemical indices of PEM. As well, suboptimal protein status can cause a 
decline in urinary excretion of urea nitrogen, creatinine, and hydroxyproline. Measuring total 
iron binding capacity, white blood cell counts and calculating the ratio of non-essential to 
essential amino acids in plasma are also examples of laboratory tests that can be included in the 
screening protocol for PEM (Gibson, 2005; Torun, 2006). Although these biochemical tests can 
be effective in diagnosing PEM, they are nonspecific in that underlying diseases can alter many 
of these measured parameters. Therefore, given that these biochemical determinants are non-
specific to PEM, they should be included in the full nutritional assessment along with other 
parameters.  
2.5.4.3.2 Serum Albumin  
 Serum albumin is a valuable indicator of protein production, given that approximately 
40% of the total protein produced by the liver and released into circulation is albumin (Charlton, 
1996). Depending on the severity of PEM, a shift of albumin from the extravascular system to 
 41 
the intravascular pool can prevent substantial diminishment in circulating albumin levels. 
However, with severe PEM the decrease in protein synthesis is too extreme and the adaptive 
mechanisms are unable to prevent significant depletion of albumin (Torun, 2006). Although 
serum albumin is one of the most universally used clinical markers of PEM, it is important to 
highlight that it is not only influenced by dietary amino acid availability but also by the acute-
phase reaction (Don & Kaysen, 2004). The effect of protein depletion and inflammation on 
serum albumin levels can be similar in degree (Qu et al., 1996).  
2.5.4.4 Functional Measurements  
 In many hospitals, functional tests are regularly employed and used in a full nutritional 
assessment of PEM. Weakening in muscle strength, poor wound healing, fatigue, depression, and 
disruptions in thermoregulation are all examples of parameters included in full nutritional 
assessments of PEM to establish the severity of functional impairment (Gibson, 2005). A hand-
grip strength test is one of the most frequently used functional assessments of PEM and is a 
promising indicator of nutritional status (Gibson, 2005). Although most of these assessment tools 
are simple and inexpensive, one of the major limitations is that they are not yet well 
standardized. Furthermore, similar to the limitations with anthropometry and biochemical 
measurements, functionality can be influenced by other nutritional deficits and medical 
conditions, including stroke. Functional impairment resulting from some types of stroke could 
impact hand-grip strength, therefore making it difficult to differentiate a post-stroke deficit from 
a nutritional effect.  
2.6 Rat Models of PEM 
Minimal information is known about the particular mechanisms altered by PEM in 
human stroke patients, due to various practical and ethical research challenges. Therefore, animal 
models of PEM are a valuable approach that can justly mimic clinical PEM and aid in 
establishing which mechanisms are altered by malnutrition and the impact that this may have on 
stroke recovery. There is no standard methodological approach used to reproduce PEM in rats, 
given the differences in nutrient requirements at different ages and the various types of PEM that 
investigators may wish to mimic. However, there is a vast amount of literature available for the 
weanling and adolescent rat. Determination of protein-energy status is commonly based on the 
degree of reduction in food intake, body weight, and serum albumin concentration, as well as the 
extent of increase in liver lipid levels (Heard et al., 1977; Qu et al., 1996).  
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PEM is normally achieved by reducing the amount of casein in the diet and feeding 
animals ad libitum (Woodward, 1998). If the protein content is sufficiently low, animals 
commonly voluntarily reduce their total food intake (Heard et al., 1977; Rozwadowski et al., 
1995; Taylor et al., 1992). Consequently, a decrease in food intake causes daily energy intakes to 
diminish, inducing a condition referred to as mixed PEM. The voluntary reduction of food intake 
is dependent on many factors including species, age of rat, and severity of the protein restriction. 
Therefore, in cases where animals do not voluntarily reduce their food intake, researchers may 
choose to induce mixed PEM by feeding a restricted amount of the low protein diet. Dietary 
carbohydrate, commonly in the form of cornstarch, is substituted for protein to maintain the 
protein deficient diet isocaloric relative to the control diet. Although it is important to have the 
equivalent energy density between diets, the major disadvantage of substituting with 
carbohydrates is that the ratio of carbohydrates to protein is augmented, which can exert its own 
effects on the experimental outcome. There is no standard protein-deficient diet that is 
universally used to model PEM in rats, given that the diet formulation should be specialized to 
the age of animal and desired duration and severity of PEM.  
It is crucial for researchers to verify that the animal nutritional paradigm is correctly 
mimicking similar features to that of PEM in the clinical population of interest. For example, my 
laboratory thoroughly characterized a gerbil model of chronic moderate PEM for use in 
mimicking human stroke patients, in which adult gerbils developed mixed PEM after a 4 week 
feeding period on a 2% protein diet. Reported findings from studies using this model 
demonstrated a reduction in food intake (15%) (Bobyn et al., 2005), body weight (17%) (Bobyn 
et al., 2005), liver reduced-glutathione (49%) (Bobyn et al., 2005), and serum albumin (18%) 
(Prosser-Loose et al., 2007), and an increase in liver lipids (~65%) (Bobyn et al., 2005).  
Since rats fed a low protein diet commonly voluntarily reduce their food intake, 
collecting data on daily food intake is essential for characterizing models of PEM. A similar 
phenomenon is commonly seen in clinical PEM in which individuals with kwashiorkor 
consistently present with symptoms of anorexia (Castiglia, 1996). The mechanisms involved in 
the suppression of food intake are largely unknown, although it has been suggested that the 
phenomenon is dependent on the ratio of non-essential to essential amino acids (de Angelis et al., 
1978). Evidence indicates an inverse correlation between this ratio and food intake, such that an 
increase in the ratio results in a decrease in appetite (de Angelis et al., 1978). Further evidence 
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suggests that anorexia could be regulated by the indispensable amino acid, histidine. Protein 
malnourished rats commonly experience a systemic increase in histidine, which has shown to be 
strongly correlated with a depression in food intake. Furthermore, healthy rats exposed to 
increased levels of histidine produce more hypothalamic histamine and temporarily decrease 
their food intake (Mercer et al., 1989). Given that histidine is a precursor of the neurotransmitter 
histamine, it is likely that food depression is neuroregulated. Furthermore, a reduction in body 
weight is another common indicator of PEM that manifests during the early stages of protein 
depletion (Balmagiya & Rozovski, 1983; Ling et al., 2004; Lyoumi et al., 1998; Rothwell & 
Stock, 1987). Measuring body weight is essential in nutritional studies, given that weight loss 
occurs when protein requirement is not met.  
Despite its many limitations (discussed above), serum albumin is the most commonly 
measured biochemical indicator of PEM (Johnson, 1999), given that its circulating concentration 
is markedly decreased in response to limited amino acid availability. However, since non-
nutritional factors can influence serum albumin levels, it should not be used as a single indicator 
of malnutrition in patients or rat models of PEM. Although serum albumin is considered a more 
specific indicator of PEM in animal studies, since health status and environment can be closely 
regulated, the caveat holds that a decline in serum albumin can also reflect an inflammatory state 
(reviewed above in Section 2.5.4.3.2).  
Elevated liver lipid concentration is another common indicator of PEM. Protein 
malnourished rats develop fatty livers that have significantly higher levels of triglycerides, 
monoglycerides, and cholesterol esters (Taylor & Ziboh, 1972). The liver plays a central role in 
lipid metabolism by synthesizing various compounds such as cholesterol, triglycerides, and 
lipoproteins. Under normal conditions, cholesterol and triglycerides are distributed throughout 
the circulatory system within lipoproteins. It has been proposed that PEM causes decreased 
synthesis of transport proteins, such as lipoproteins, which would ultimately cause a buildup of 
lipids in the liver. It has been demonstrated that feeding rats a low protein diet does affect lipid 
storage, as shown by decreased lipoprotein lipase activity and reduced serum levels of very-low-
density lipoproteins (VLDL) (Boualga et al., 2000). Fatty liver is also a common characteristic of 
certain clinical forms of PEM, with excess fat frequently reported in the liver of patients with 
kwashiorkor but absent in those with marasmus (Agbedana et al., 1979).   
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2.7 PEM and Cerebral Ischemia  
2.7.1 Overview  
Recovery from cerebral ischemia can be strongly influenced by malnutrition. Numerous 
clinical studies have demonstrated that PEM is a common co-morbidity factor of cerebral 
ischemia and is present in 7-19% of stroke patients upon admission to the hospital (Davis et al., 
2004; Martineau et al., 2005; Nip et al., 2011; Yoo et al., 2008). The problem often worsens as a 
result of post-stroke hospital care to reach prevalence rates as high as 20-35% at one week 
(Brynningsen et al., 2007; Yoo et al., 2008), and 35-49% by the time of admission to a 
rehabilitation unit (Finestone et al., 1995; Poels et al., 2006). Clinical evidence, with noted 
methodological limitations (see below), has demonstrated a correlation between PEM and 
increased morbidity and mortality following stroke (Davis et al., 2004; FOOD Trial 
Collaboration, 2003; Martineau et al., 2005; Yoo et al., 2008). A cause-and-effect relationship 
has been identified with the use of a rodent model of global brain ischemia demonstrating that 
PEM impairs outcome on both a cellular and functional level (Bobyn et al., 2005; Ji et al., 2008; 
Prosser-Loose et al., 2010). The objective of the thesis research was to delve further into the 
mechanisms by which stroke outcome is impaired by either co-existing PEM or compromised 
protein-energy status that arises after the stroke. 
2.7.2 The Clinical and Experimental Evidence that PEM Impairs Stroke Outcome  
A strong correlation has been shown to exist between nutritional status and health 
outcome following stroke. Numerous studies over the last three decades have provided strong 
evidence that protein-energy malnourished stroke patients have increased risk of morbidity and 
mortality (Axelsson et al., 1988; Davalos et al., 1996; Gariballa et al., 1998; Pandian et al., 
2011). One of the more recent studies highlighting this relationship was performed on 141 stroke 
patients, with results strongly concluding that malnutrition is an independent predictor of poor 
outcome (Yoo et al., 2008). Nutritional assessment was performed at the time of admission and 
one week post-stroke by evaluating several objective nutritional parameters, such as weight loss, 
body mass index, and serum albumin, transferrin, and prealbumin levels. Undernutrition was 
diagnosed in 12% of stroke patients at admission and in 20% of patients one week later. 
Furthermore, assessment at three months post-stroke demonstrated that undernutrition was a 
significant predictor of poor outcome. Malnourished stroke patients were not able to recover as 
well from the insult and experienced more post-stroke complications (Yoo et al., 2008). 
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To determine if nutritional status is a predictor of long-term stroke survival, a large 
epidemiological study was performed on a Danish cohort of 21,884 stroke patients that were 
monitored for five years (Olsen et al., 2008). Body mass index was recorded at the time of 
admission and patients were assigned to one of five categories. Although mortality following a 
stroke was inversely related to body mass index, the analysis did not establish the latter as an 
independent predictor. Survival during the five-year follow-up period was the lowest among the 
underweight patients. Underweight patients had the highest mortality rate at 46%, compared to 
25% in normal weight patients and 18% in overweight individuals. These results highlight body 
mass index as a risk factor marker and demonstrate that poor nutrition significantly increases the 
risk of mortality within five years following stroke (Olsen et al., 2008).   
Evidence that nutritional status adversely affects stroke outcome has been repeatedly 
demonstrated over the last three decades (Davis et al., 2004; Martineau et al., 2005; Yoo et al., 
2008). However, a major limitation of most of these studies is that data were collected from a 
single tertiary hospital, thus limiting the generalization of these results to other communities. 
Other limitations of these studies include small sample size, the use of nutritional assessment 
tools that are limited in sensitivity and specificity, and that some studies were designed to 
establish correlations but not a cause-and-effect relationship. Therefore, a large multicenter 
randomized trial was designed, referred to as the FOOD (Feed or Ordinary Food) Collaboration 
Trial, that had the potential of establishing a causal relationship between nutritional status and 
functional outcome following stroke (Dennis et al., 2005a; Dennis et al., 2005b). A preliminary 
analysis was performed on the first 3,012 stroke patients randomized in the FOOD Trial between 
1996-2001 using data on nutritional status collected at trial entry and at six months following 
stroke to assess functional and survival status. Preliminary results showed evidence that patients 
who were undernourished had reduced functional ability and survival at six months following 
stroke (FOOD Trial Collaboration, 2003). More specifically, results demonstrated a survival rate 
of 63% in the undernourished group, whereas a higher survival rate of 80% was reported in the 
group of well-nourished stroke victims. Malnourished stroke victims were also more likely to 
have functional impairments and increased risk of developing serious health conditions such as 
pneumonia and gastrointestinal bleeding (FOOD Trial Collaboration, 2003). Although these 
results were promising, the completed trial failed to provide a definitive answer on the link 
between nutritional status and post-stroke recovery due to experimental design flaws, including 
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the absence of standardized nutritional assessment and poor choice of sampling times (Prosser-
Loose & Paterson, 2006). Furthermore, there was inconsistent access to specialized equipment 
resulting in informal nutritional assessment relying on ‘eyeball’ estimates of body size and fat 
distribution. Therefore, due to these major methodological limitations, the FOOD Collaboration 
Trial failed to address this important question of whether there is a causal relationship between 
PEM and stroke outcome (Prosser-Loose & Paterson, 2006).   
Collective results from various clinical studies strongly imply that PEM predicts a poor 
stroke outcome, but there are no clinical studies at this time that provide substantive proof of 
causation. Therefore, my laboratory utilized an animal model of global brain ischemia to 
determine if a causal relationship exists between co-existing PEM and both functional and 
histological outcome (Bobyn et al., 2005). Gerbils were randomized to control diet or a low 
protein diet for 28 days before being subjected to global ischemia or sham surgery. Functional 
outcome was assessed using an open field test at 3, 7 and 10 days following insult. The open 
field behavioural test detects deficits in spatial memory, as indicated by an animal’s ability to 
adapt in a novel environment, and therefore provides information about the severity of 
hippocampal damage (Colbourne & Corbett, 1995; Wang & Corbett, 1990). Results from the 
open field test demonstrated that protein-energy malnourished gerbils did not habituate 
appreciably by 10 days after brain ischemia whereas, by day 7, gerbils fed a control diet 
habituated at a level comparable to the sham controls (Bobyn et al., 2005). However, the 
impaired function observed in malnourished gerbils occurred without an increase in CA1 
hippocampal neuronal death, suggesting that either CA1 neurons remain viable but with aberrant 
function or that there was injury occurring elsewhere. Given that a relatively short post-ischemic 
sampling time (10 days) was used for this study and cell death can continue for months 
(Colbourne & Corbett, 1995), it is possible that long-term cell death could have been increased 
in the malnourished animals due to elevated inflammation. The latter was suggested by an 
increase in reactive gliosis in a subset of malnourished gerbils at 10 days after brain ischemia. In 
summary, the results obtained from this well-controlled animal trial provide support for the 
relationship found from the preliminary FOOD Trial data (FOOD Trial Collaboration, 2003). As 
well, this study is the first to conclusively demonstrate the existence of a causal relationship 
between PEM and poor functional outcome after brain ischemia. Reliance on an animal model of 
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brain ischemia has the added advantage of being able to examine mechanisms in the brain by 
which PEM could directly influence ischemic cell death and/or brain remodeling.  
2.7.3 Mechanisms By Which PEM Could Alter Ischemic Brain Injury and Brain 
Remodeling 
2.7.3.1 Overview  
Although there is considerable evidence that PEM is associated with increased morbidity 
and mortality following brain ischemia, the exact mechanisms that are altered by PEM are 
largely unknown. Most likely, co-existing PEM alters various components of the cascade of 
secondary events responsible for brain injury. It has been suggested that one of the key 
mechanisms influenced by PEM is the inflammatory response. This notion is based on both the 
indirect findings that co-existing PEM exacerbates brain inflammation following global ischemia 
(Bobyn et al., 2005; Ji et al., 2008) and from the evidence that dietary protein depletion can 
independently stimulate a systemic inflammatory response (Ling et al., 2004; Lyoumi et al., 
1998). Additionally, PEM is likely to affect mechanisms involved in brain remodeling following 
cerebral ischemia, given the previous data demonstrating that various plasticity-associated 
proteins are altered by co-existing PEM (Prosser-Loose et al., 2010). The aim of this thesis was 
to more directly address whether PEM exerts some of its deleterious effects on functional 
outcome by altering post-ischemic inflammation and neuroplasticity. The following sub-sections 
provide rationale for the mechanisms that were examined in this thesis. 
2.7.3.2 Effects of PEM on Inflammation 
The relationship between PEM and the immune response has not yet been studied in 
stroke patients. However, given that both clinical and animal studies have strongly demonstrated 
that protein malnutrition can have considerable impact on immune system functioning (Torun, 
2006), it is speculated that the inflammatory response to stroke is altered by PEM. The effects of 
PEM on the immune response are broad and when a malnourished individual is confronted with 
a serious infection or trauma, the inflammatory response could either be inappropriately high or 
low (Bistrian, 2007). Cell-mediated immunity, phagocyte function, secretory antibody response, 
acute-phase response, antibody affinity and cytokine production are all examples of mechanisms 
that can be disrupted by PEM (Amati et al., 2003; Johnson, 1999). Therefore, malnutrition can 
have varying adverse effects on outcome depending on the particular infection or nature of 
trauma. While most studies have addressed whether PEM blunts the ability to mount a controlled 
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inflammatory response to tissue injury or infection, there are data suggesting that dietary protein 
depletion can be an independent stimulus of low-grade inflammation and an acute-phase 
response (Dulger et al., 2002; Ling et al., 2004; Lyoumi et al., 1998). A limitation is that the 
majority of research investigating the effects of PEM on the immune response has been executed 
in young animals and children. While the effect of PEM on immunity can be strongly influenced 
by factors such as the age of onset, and the type and severity of PEM (Woodward, 1998), 
minimal information is known about how PEM influences the immune response in the elderly.  
Cytokine production is a major component of the inflammatory response that can be 
influenced by PEM. Protein deficiency has been shown to trigger atypical expression of various 
inflammatory cytokines, ultimately hindering immune responsiveness to a stimulus. For 
example, protein-energy malnourished mice stimulated with LPS had significantly higher 
circulating levels of IL-10, when compared to control animals (Fock et al., 2008). IL-10 is an 
anti-inflammatory cytokine and overexpression of this cytokine is often associated with 
immunosuppression. Furthermore, macrophages from protein-energy malnourished mice have 
decreased synthesis of pro-inflammatory cytokines, such as TNF-, in response to LPS 
stimulation (Fock et al., 2010). Activation of the pro-inflammatory transcription factor, NFB, 
can also be altered by PEM. Macrophage NFB activation after LPS stimulus is significantly 
lower in protein energy-malnourished mice (Fock et al., 2010), which presumably accounts for 
the decreased expression of pro-inflammatory cytokines. Together these results demonstrate that 
the abnormal immune response in malnourished animals following infection is likely the result 
of elevated levels of anti-inflammatory cytokines, in combination with decreased concentrations 
of pro-inflammatory cytokines. However, these studies have solely focused on assessing the 
effects of PEM on the cytokine response stimulated by infection. Therefore, this response may be 
different in malnourished individuals that are faced with a trauma, such as stroke.   
Malnutrition-mediated changes to inflammatory cytokine concentrations can result in an 
attenuated acute-phase reaction in response to a stimulus. Typically in response to acute 
inflammation, increased concentrations of various inflammatory cytokines, such as IL-6, IL-1, 
and TNF-, triggers the production of positive acute-phase proteins (e.g., C-reactive protein, 
A2M, haptoglobin). Interestingly, clinical evidence suggests that malnourished individuals are 
unable to mount a proper acute-phase response at the time of infection. Reid et al. (2002) 
examined plasma levels of positive acute-phase proteins in protein-energy malnourished children 
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that were fighting infection. Although positive acute-phase proteins were elevated in all children 
at the time of infection, plasma levels of haptoglobin and 1-antitrypsin were the lowest in 
severely protein-energy malnourished children. These results demonstrate that severely 
malnourished children are able to mount an acute-phase response to an infection; however, the 
magnitude of the response is smaller. Similarly, animal models have been used to demonstrate 
attenuation of the acute-phase reaction in protein malnourished rats in response to an 
inflammatory stimulus. Jennings et al. (1996) verified that the inflammatory response elicited by 
turpentine results in an increase in circulating A2M. Interestingly, this response was markedly 
reduced in protein-deficient rats compared to well-nourished controls. It is possible, then, that 
malnourished patients might mount an incomplete acute-phase reaction in response to stroke. 
However, this relationship is likely to be more complex, given emerging evidence that PEM can 
serve as an independent stimulus of the acute-phase response. 
Although there is substantial evidence that protein deficiency impairs the immune 
response to infection or trauma, certain data suggest that under normal conditions protein 
malnutrition can be an independent stimulus of systemic inflammation and an acute-phase 
response. Ling et al. (2004) demonstrated that under basal conditions, serum levels of key 
inflammatory cytokines, including TNF-, IL-1, and IL-6, were appreciably increased in rats 
maintained on a low protein diet for two weeks. Furthermore, serum levels of the positive acute-
phase protein, AGP, were also significantly higher in protein-energy malnourished rats than in 
healthy controls. Similarly, Lyoumi et al. (1998) detected A2M in the serum of severely protein-
malnourished rats but not in control animals, inferring higher levels of this acute-phase protein in 
the malnourished. As well, IL-6 mRNA expression was only detectable in peripheral blood 
mononuclear cells and the intestine of protein malnourished rats and not in controls.  
In addition to the results obtained from animal studies, there is clinical evidence 
highlighting PEM as an independent stimulus of inflammation. However, it is more challenging 
to detect the independent effects of malnutrition on systemic inflammation in humans, given that 
patients with PEM frequently present with concomitant infections. Sauerwein et al. (1997) 
reported elevated plasma concentrations of IL-6, C-reactive protein, and TNF-receptors in 
severely malnourished patients. Although patients with obvious signs of serious infections were 
excluded, subjects presenting with minor infections remained in the study. Therefore, a separate 
analysis was performed on only those patients presenting with no signs of infections. 
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Independent of the presence of minor infections, severely malnourished patients showed 
considerably higher plasma concentrations of TNF-receptors and IL-6. A similar study was 
performed by Dulger et al. (2002), which compared the inflammatory response in children with 
either kwashiorkor (primarily caused by protein deficiency) or marasmus (primarily caused by 
energy deficiency). It is important to note that this study did not evaluate the presence of 
underlying infections. Children with kwashiorkor had significantly lower serum albumin levels, 
as compared to the marasmus and control groups. In addition, serum IL-6 concentrations were 
considerably increased in both the kwashiorkor and marasmus groups, as compared to healthy 
patients. Collectively, results from both clinical and animal studies strengthen the notion that 
PEM can independently stimulate a systemic inflammatory response.  
As the relationship between PEM and the acute-phase response appears to be complex, 
one cannot predict the relationship following brain ischemia. An animal model of PEM was thus 
used in this thesis to confirm the previous findings showing that PEM is an independent stimulus 
of an acute-phase response. A subsequent objective of the thesis research was to determine 
whether post-ischemic PEM blunts the ability to mount a controlled acute-phase response to 
global brain ischemia.  
2.7.3.3 Effects of PEM on the Neuroinflammatory Response to Global Brain Ischemia 
Previous studies from my laboratory have inferred that the previously reported adverse 
effects of malnutrition on outcome following brain ischemia are in part due to increased 
neuroinflammation. A major finding from these studies has been that co-existing PEM increased 
activation of NFB in the hippocampus of gerbils exposed to global ischemia (Ji et al., 2008). In 
addition, results from electrophoretic mobility shift assays (EMSA) showed that the effect of 
PEM was independent of brain ischemia. That is, increased activation of this transcription factor 
was also present in the hippocampus of sham-operated and non-operated malnourished gerbils. 
Therefore, given that pro-inflammatory mediators are predominantly regulated at the level of 
transcription by NFB, these results suggest that PEM can independently induce hippocampal 
inflammation (Ji et al., 2008). However, there is yet no direct evidence that PEM enhances the 
expression of NFB pro-inflammatory target genes following brain ischemia in experimental 
stroke models or stroke patients.  
Other evidence supporting the hypothesis that PEM increases the inflammatory response 
after global ischemia came from the observation that a subset of malnourished gerbils subjected 
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to global ischemia experienced marked reactive gliosis (Bobyn et al., 2005). The latter was 
evident on routine histological staining in one-third of malnourished gerbils following global 
brain ischemia. Interestingly, these animals also presented with the most severe functional 
impairment (thigmotaxis in the open field test), and greater than average hippocampal CA1 
neuron death. A limitation of this study, however, was that the glial cell type was not 
characterized by immunocytochemical analysis. Another perplexing finding was that the 
pronounced reactive gliosis, while never apparent after global ischemia in control diet fed 
gerbils, was evident in only a subset of malnourished animals. A possible contributor to the 
variability in reactive gliosis is reduced reliability in the hippocampal injury due to the 
previously reviewed developing problem of altered brain vasculature in the gerbil. 
Accompanying the exacerbated glial response in malnourished gerbils was an increase in the 
oxidative stress response following global ischemia. Protein thiols, which are susceptible to 
oxidation and therefore used as a marker of oxidative stress, were significantly decreased by 
PEM. Similarly, the data suggested that PEM could alter components of anti-oxidant defense, as 
shown by a trend for glutathione reductase activity to be decreased following brain ischemia. 
Given that oxidative stress is a strong activator of NFB in ischemic stroke (Harari & Liao, 
2010), a likely outcome of PEM-induced oxidative stress is an exacerbated inflammatory 
response. Nevertheless, a major limitation of this study, possibly contributing to variability in 
reactive gliosis and the extent of ischemic injury, is that post-ischemic temperature was not 
monitored (although intra-ischemic tympanic temperature was strictly controlled). Given that 
spontaneous variation in post-ischemic temperature is known to occur in the gerbil (Colbourne & 
Corbett, 1994), the occurrence of either hypothermia or hyperthermia cannot be ruled out.  
In summary, my laboratory has provided indirect evidence of an altered glial and 
inflammatory response following global ischemia in protein-energy malnourished rodents. This 
research was done using a co-existing PEM model, which mirrors those patients who are already 
malnourished at the time of brain ischemia. A major objective of this thesis was to obtain direct 
evidence that PEM exacerbates or prolongs the inflammatory response to global brain ischemia. 
To date, the additional clinical problem of PEM developing after and because of the stroke (post-
ischemic PEM) has not been modeled experimentally. Thus, this thesis work examined the 
effects of both co-existing and post-ischemic PEM on the inflammatory response to brain 
ischemia.  
 52 
2.7.3.4 Effects of PEM on Neuroplasticity    
In addition to malnutrition-mediated alterations to inflammation, there is evidence 
suggesting that PEM also induces neuroplastic deficits. PEM-induced changes to these two 
processes may be related, given that inflammatory mediators are involved in regulating 
neuroplastic mechanisms (Kriz & Lalancette-Hébert, 2009). It is well established that 
malnutrition during brain development can result in structural and functional deficits (Alamy & 
Bengelloun, 2012). More specifically, malnutrition during brain maturation affects neurogenesis, 
cell migration and differentiation, and synaptogenesis (Alamy & Bengelloun, 2012). 
Consequently, changes to the organization of the brain can cause functional deficits, such as 
impaired learning and retention (Alamy & Bengelloun, 2012). Although there is sound evidence 
that protein malnutrition is detrimental to the developing brain, the effects of malnutrition started 
during adulthood are not as clear.  
The majority of studies assessing the effect of protein deprivation during adulthood have 
characterized changes to the hippocampus, given that this region of the brain is one of the most 
affected by low dietary protein (Andrade et al., 1996). Within the CA3 mossy fiber region of the 
hippocampus, adult protein deprivation causes a 30% decrease in the number of synapses 
(Andrade et al., 1991; Andrade et al., 1995; Lukoyanov & Andrade, 2000). These synaptic 
deficits were present in adult rats after lengthy periods on a low protein diet lasting between 6-18 
months. A decrease in the number of mossy fiber synapses is most likely the combined result of 
changes to neuronal structure and the number of viable neurons, both of which have shown to be 
affected by protein deprivation. Rats started on a low protein diet during adulthood and 
continued for 6 months had reduced numbers of dendritic branches within the CA3 and dentate 
gyrus hippocampal subfields (Andrade et al., 1996); however, the changes to dendritic branches 
are not uniform throughout the hippocampus (Andrade et al., 1996). Protein deprivation during 
adulthood also affects hippocampal cell number, with considerable loss of granule cells and CA1 
and CA3 pyramidal neurons reported after prolonged periods on a low protein diet (Lukoyanov 
& Andrade, 2000; Paula-Barbosa et al., 1989). Progressive cell loss may potentially be caused by 
changes to neurotrophin levels. Levels of BDNF, and its receptor tropomyosin-related kinase B 
(trkB), were notably reduced within the granular layer of adult rats submitted to protein 
deprivation for 6 months (Mesquita et al., 2002). Ultimately, synaptic and neuronal loss within 
the hippocampus is associated with behavioural impairments. Rats that were protein deprived 
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during adulthood exhibited impaired habituation in the open field test, suggesting deficits in 
hippocampal functioning (Lukoyanov & Andrade, 2000).  
In summary, malnutrition during development has severe and wide-spread effects on the 
brain; however, protein deprivation during adulthood can also cause marked structural 
alterations, which have mostly been characterized within the hippocampus (Alamy & 
Bengelloun, 2012). It is important to note that these studies have highlighted the effects of 
chronic protein deprivation on neuroplastic mechanisms. A major limitation of these studies is 
that nutritional status of the animal was poorly characterized and several of these reports lacked 
evidence of malnutrition. Therefore, the immediate effect of adult PEM (e.g. a few weeks on low 
protein diet), as used in this thesis, upon the structure of the hippocampus is mostly unknown. In 
addition, the effects of PEM on the neuroplasticity response triggered by brain injury, such as 
stroke, have not yet been well characterized. Therefore, a previous study performed by my 
research group examined whether the neuroplasticity response to global brain ischemia is altered 
by co-existing PEM.  
2.7.3.5 Effects of PEM on the Neuroplasticity Response to Global Brain Ischemia 
Promising findings from my laboratory have demonstrated that co-existing PEM alters 
plasticity mechanisms important to brain recovery (Prosser-Loose et al., 2010). A gerbil model 
of global brain ischemia was employed to examine the effects of co-existing PEM on post-
ischemic expression of various plasticity-associated proteins that included BDNF, its receptor 
trkB, and GAP-43 (Prosser-Loose et al., 2010). In contrast to the underlying hypothesis that 
PEM would reduce plasticity in the hippocampus following global ischemia, the most striking 
finding was a more robust GAP-43 response with PEM. Co-existing PEM enhanced and 
prolonged GAP-43 expression within the CA1 hippocampal region following brain ischemia. 
Additionally, PEM exacerbated GAP-43 expression within the CA3 and hilar regions at 3 days 
post-ischemia. Protein expression of trkB within the CA1 hippocampal region was also 
exacerbated by co-existing PEM at 7 days post-ischemia. Unlike trkB and GAP-43, BDNF was 
unaltered by PEM, although these results were not considered definitive due to a number of 
methodological limitations. Elevated GAP-43 protein levels in malnourished gerbils could 
possibly be explained by an augmented inflammatory response, given that expression of this 
gene can be directly induced by inflammation (Hossain-Ibrahim et al., 2006). Although enhanced 
expression of GAP-43 is generally associated with a protective neuroplastic response, it was 
 54 
proposed that excessive GAP-43 signal could instigate excessive sprouting resulting in hyper-
excitability. However, electrophysiological recordings to assess whether PEM altered the 
electrical activity of the surviving neurons were not obtained to support this hypothesis. While 
the influence of PEM on post-ischemic brain plasticity was expanded upon in this thesis, a 
different research question was addressed. It was investigated whether PEM developing in the 
first few days after global brain ischemia would exert effects on plasticity.   
2.7.3.6 Effects of PEM on Thermoregulation  
PEM may exert some of its effects on outcome after brain ischemia by altering key 
physiological determinants of ischemic brain injury. Brain temperature is a major influencing 
factor on brain ischemia outcome, given that hypothermia can drastically reduce brain injury 
(MacLellan et al., 2009; van der Worp et al., 2007), while hyperthermia can aggravate injury 
(Wang et al., 2009). More specifically, an increase in brain temperature can directly exacerbate 
both the glial and inflammatory responses following global ischemia (Ceulemans et al., 2010). 
Therefore, it is imperative to understand the effects of PEM on thermoregulation so that the 
correct measures can be made during post-stroke hospital care. It is difficult to predict the effects 
on the basis of experimental studies, since there are considerable discrepancies in the literature, 
with both cooling (Duran et al., 2008) and warming (Balmagiya & Rozovski, 1983; Castanon-
Cervantes & Cintra, 2002) responses reported in rodents experiencing varying states of protein 
and/or energy deficiencies.  
Although clinical studies addressing the effects of malnutrition on body temperature are 
scarce, and data do not exist for malnourished stroke patients, most of the literature suggests that 
poor nutrition impairs thermoregulatory function and results in mild hypothermia. Allison et al. 
(2000) reported a relationship between undernutrition and impaired thermoregulation, with 
malnourished elderly patients experiencing lower core temperatures than well-nourished 
individuals. Brooke et al. (1972) also reported mild hypothermia in a group of malnourished 
Jamaican children. Rectal temperatures were measured every four hours during the first week of 
hospital treatment in 137 malnourished children. Mild hypothermia (<35°C) was evident in 20% 
of malnourished children, with the highest prevalence in patients with marasmus and marasmic 
kwashiorkor. Similar statistics were reported by Devi et al. (1980), in which 26% of children 
with PEM experienced mild hypothermia during their hospital stay. Although the results from 
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clinical studies are thus generally in agreement, a major drawback is that the majority of data in 
this area of research has come from young patients and not from the elderly.  
Minimal information is known about how PEM alters thermoregulation in the elderly, 
and reports on how malnourished elderly patients respond to the stress of stroke are nonexistent. 
Given that the majority of clinical data suggests that PEM causes hypothermia, it could be 
speculated that this in turn is protective at the time of stroke. However, this is contradictory to 
the reports cited above that malnourished stroke patients have impaired outcome. A potential 
explanation is that the absolute changes in temperature are too small to directly influence 
ischemic brain injury. Similarly, if the drop in temperature is small, PEM, acting through other 
mechanisms, could induce adverse effects even in the presence of mild hypothermia. However, a 
more likely explanation is that the effect of PEM on temperature regulation is different in the 
presence of stroke. This notion is supported by numerous studies that have consistently 
demonstrated that malnourished humans and rodents experience disruptions in thermoregulatory 
homoeostasis when confronted with a challenge (Balmagiya & Rozovski, 1983; Fellows et al., 
1985). Given that a common complication of stroke is fever, which occurs in approximately 50% 
of cases (Wrotek et al., 2011), it can be postulated that malnourished stroke victims are among 
this subset of patients due to their inability to finely regulate body temperature. Consequently, 
elevated temperatures experienced by malnourished stroke patients could cause an exacerbated 
inflammatory response leading to impaired outcome. However, to establish whether this 
mechanism contributes to PEM-induced increases in morbidity and mortality following brain 
ischemia, a more detailed evaluation of thermoregulatory function is necessary. 
Since the effects of PEM on temperature are unclear, there is a demand for more 
comprehensive assessment of thermoregulatory function in the malnourished. Chronic and 
frequent temperature measurements obtained using implantable temperature probes are useful in 
exemplifying the daily rhythmicity of the temperature diurnal cycle. More specifically, chronic 
temperature readings make it possible to assess specific parameters commonly utilized to 
characterize the pattern of a rhythm. These include the mean, fluctuation/amplitude, period, 
acrophase, and robustness (Refinetti, 2006). To measure the central tendency of a daily rhythm, 
the most frequent method is by calculating the arithmetic mean. Fluctuation and amplitude are 
the two most common terms to express the daily range of oscillation. Whereas daily temperature 
fluctuation is the full range of oscillation over a 24 hour cycle, amplitude refers to half the range 
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of oscillation (Refinetti, 2006). However, in most cases the real data is noisy and is filtered prior 
to amplitude computation. As a result, the amplitude of a fitted curve is typically considerably 
smaller than half the range of oscillation. The term period refers to the time it takes to complete a 
daily cycle, which under normal conditions is 24 hours (Refinetti, 2006). Furthermore, acrophase 
is the time at which the daily rhythm peaks. Another parameter used to describe diurnal cycles is 
robustness, which refers to the strength of the rhythm. If the robustness is low, then the cycle is 
rather variable, while a stronger robustness refers to a more consistent cycle (Refinetti, 2006). 
These parameters were used in this thesis to characterize the diurnal rhythm of temperature in 
malnourished rats. Ultimately, the research conducted in this thesis investigated how PEM 
affects temperature and its relationship to the inflammatory response to brain ischemia.  
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CHAPTER 3: 
PROTEIN-ENERGY MALNUTRITION ALTERS THERMOREGULATORY 
HOMEOSTASIS AND THE RESPONSE TO BRAIN ISCHEMIA 
 
This chapter has been published as follows:  
Smith SE, Prosser-Loose EJ, Colbourne F, Paterson PG. Protein-energy malnutrition alters 
thermoregulatory homeostasis and the response to brain ischemia. Current Neurovascular 
Research 2011; 8: 64-74.   
Publisher and Copyright Holder: Bentham Science Publishers Ltd.  
 
3.1 Abstract  
Co-existing protein-energy malnutrition (PEM), characterized by deficits in both protein 
and energy status, impairs functional outcome following global ischemia and has been associated 
with increased reactive gliosis. Since temperature is a key determinant of brain damage 
following an ischemic insult, the objective was to investigate whether alterations in post-
ischemic temperature regulation contribute to PEM-induced reactive gliosis following ischemia. 
Male Sprague-Dawley rats (190-280g) were assigned to either control diet (18% protein) or PEM 
induced by feeding a low protein diet (2% protein) for 7 days prior to either global ischemia or 
sham surgery. There was a rapid disruption in thermoregulatory function in rats fed the low 
protein diet as assessed by continuous recording of core temperature with bio-electrical sensor 
transmitters. Both daily temperature fluctuation and mean temperature increased within the first 
24 hours, and these remained significantly elevated throughout the 7 day pre-ischemic period (p 
< 0.027). In the immediate post-surgical period, PEM decreased body temperature to a greater 
extent than that in well-nourished controls (p = 0.003). The increase in daily temperature 
fluctuation caused by PEM persisted throughout the 7 day post-surgical period (p < 0.001), and 
this interacted with the effects of global ischemia on days 8 (p = 0.018) and 11 (p = 0.021).  The
astrocytic and microglial responses induced at 7 days after global ischemia were not influenced 
by PEM, but this preliminary analysis needs to be confirmed with a more reliable global 
ischemia model. In conclusion, exposure to a low protein diet rapidly impairs the ability to 
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maintain thermoregulatory homeostasis, and the resultant PEM also diminishes the ability to 
thermoregulate in response to a challenge. Since temperature regulation is a key determinant of 
brain injury following ischemia, these findings suggest that the pathophysiology of brain injury 
could be altered in stroke victims with co-existing PEM. 
3.2 Introduction  
Despite years of animal research focused on understanding the pathophysiology of 
ischemic brain injury, there have been challenges in translating much of this work into effective 
neuroprotective treatments for human stroke victims (Hossmann, 2009). Our laboratory has 
instead focused on investigating the implications of compromised nutritional status as a possible 
stroke co-morbidity factor. Since a significant proportion of stroke patients have poor nutritional 
status at the time of insult (Crary et al., 2006; Davis et al., 2004; Martineau et al., 2005; Yoo et 
al., 2008), it is crucial to understand what impact this may have on the outcome. Thus, 
differences in the intracellular events following stroke caused by malnutrition need to be 
identified as the basis for designing targeted nutritional interventions.  
The extent of neuronal damage following an ischemic insult can be strongly influenced 
by poor nutritional status. PEM, characterized by deficits in both protein and energy status, is 
present in 12-19% of stroke patients upon admission to the hospital (Davis et al., 2004; 
Martineau et al., 2005; Yoo et al., 2008). The problem often worsens as a result of post-stroke 
hospital care to reach prevalence rates as high as 20-35% at one week (Brynningsen et al., 2007; 
Yoo et al., 2008), and 35-49% by the time of admission to a rehabilitation unit (Finestone et al., 
1995; Poels et al., 2006). Clinical evidence, with noted methodological limitations, has 
demonstrated a correlation between PEM and increased morbidity and mortality following stroke 
(Davis et al., 2004; FOOD Trial Collaboration, 2003; Martineau et al., 2005; Yoo et al., 2008). A 
cause-and-effect relationship has been identified with the use of a rodent model of global brain 
ischemia demonstrating that PEM affects outcome on both a cellular and functional level (Bobyn 
et al., 2005; Ji et al., 2008; Prosser-Loose et al., 2010).  
The extent of neuronal injury following global ischemia is highly temperature-sensitive. 
Post-ischemic hypothermia can drastically reduce ischemic brain injury (MacLellan et al., 2009; 
van der Worp et al., 2007), whereas hyperthermia can aggravate injury (Wang et al., 2009). 
Chronic malnutrition has been reported to impair the ability to maintain constant 
thermoregulatory homeostasis (Balmagiya & Rozovski, 1983; Castanon-Cervantes & Cintra, 
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2002; Conradi et al., 1988), especially when animals are confronted with thermoregulatory 
challenges (Balmagiya & Rozovski, 1983). Therefore, an altered thermoregulatory response 
induced by PEM could explain some of the changes in neuronal and glial response following 
global ischemia previously reported by our laboratory (Bobyn et al., 2005; Ji et al., 2008). 
Neuronal damage progresses during the acute period following ischemia by activation of 
several interrelated secondary mechanisms. Reactive gliosis and inflammation are among two of 
these processes within a complex cascade of intracellular and extracellular events (Ceulemans et 
al., 2010; Lai & Todd, 2006). These two processes are also strongly interrelated, since pro-
inflammatory mechanisms modulate the activation of glial cells, which in turn produce more 
inflammatory cytokines (Ceulemans et al., 2010; Lai & Todd, 2006). Inflammation is an 
orchestrated response following an ischemic insult that can contribute both to neuronal death and 
modulation of repair processes (Kriz & Lalancette-Hébert, 2009). Since the post-ischemic 
inflammatory response is only partly understood, there has been much debate about its overall 
effect on outcome. That immunodeficient mice present with less stroke injury (Hurn et al., 2007) 
suggests that inflammation is more detrimental than beneficial. Temperature regulation can 
directly alter both the glial and inflammatory responses following global ischemia (Ceulemans et 
al., 2010). One mechanism by which hypothermia attenuates neuronal damage after global 
ischemia is by reducing microglial activation and NFB activation (Webster et al., 2009). The 
mechanisms associated with hyperthermia are less established (Wang et al., 2009); however, 
stroke victims with hyperthermia have increased plasma levels of pro-inflammatory mediators 
when compared to normothermic patients (Leira et al., 2006). 
We have previously obtained indirect evidence of an altered glial and inflammatory 
response following global ischemia in protein-energy malnourished rodents (Bobyn et al., 2005; 
Ji et al., 2008) that appeared to be related to impaired functional outcome as assessed by the open 
field test (Bobyn et al., 2005). Since this impaired function occurred without an increase in 
hippocampal CA1 neuronal death, it suggests either that the CA1 neurons remained viable but 
with aberrant function or that there was injury occurring elsewhere. Given that a short post-
ischemic sampling time (10 days) was used for this study and cell death can continue for months 
(Colbourne & Corbett, 1995), it is possible that long-term cell death would have been increased 
in the malnourished animals due to elevated inflammation. Unusually dramatic reactive gliosis 
was evident on routine histological staining in one-third of the malnourished gerbils (Bobyn et 
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al., 2005). These animals were also the ones with both the most severe functional impairment 
(thigmotaxis) and greater than average hippocampal CA1 neuron death, leading to the hypothesis 
that PEM enhanced the inflammatory response. A limitation, however, was that the glial cell 
type was not characterized by immunohistochemical analysis. Another perplexing finding was 
that the pronounced reactive gliosis, while never apparent after global ischemia in control diet 
fed gerbils, was evident in only a subset of malnourished animals (Bobyn et al., 2005). While 
intra-ischemic tympanic temperature was strictly controlled in this study, a possible contributor 
to variability in reactive gliosis and the extent of ischemic injury is post-ischemic temperature 
regulation. Since spontaneous variation in post-ischemic temperature occurs in the gerbil 
bilateral carotid artery model of global ischemia (Colbourne & Corbett, 1994), we cannot rule 
out the occurrence of either hypothermia or hyperthermia.  
Other evidence supporting the hypothesis that PEM increases the inflammatory response 
came from the observation that malnourished gerbils have increased activation of the 
transcription factor NFB in the hippocampus (Ji et al., 2008). Pro-inflammatory molecules are 
predominantly regulated at the level of transcription by the critical intracellular mediator, NFB, 
which also plays a role in glial cell function (Mattson, 2005). NFB activation rapidly occurs 
following ischemic stroke, ultimately escalating inflammation by altering pro-inflammatory gene 
expression (Harari & Liao, 2010; Ridder & Schwaninger, 2009). Although there is yet no direct 
evidence that PEM enhances the expression of NFB pro-inflammatory target genes following 
brain ischemia in experimental stroke models or stroke patients, it appears that PEM itself causes 
a low-grade inflammatory response (Ling & Bistrian, 2009; Ling et al., 2004).  
In the current study, we extend our previous findings to the influence of PEM on global 
ischemia modeled by 2-VO in the rat. The first objective was to investigate if the astrocytic 
(GFAP) and microglial (ED-1 and OX-42) responses after global ischemia were altered by PEM.  
Second, we assessed whether PEM modifies pre- and post-ischemic temperature regulation with 
the intent of clarifying whether such alterations contribute to PEM-induced reactive gliosis 
following ischemia. 
3.3 Materials and Methods 
3.3.1 Animals 
 Forty-three male Sprague-Dawley rats (30-32 day old) (Charles River Canada, QC, 
Canada) were acclimatized on rat chow for 2 days and then placed on a purified control diet (see 
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below for composition) for 5-6 days. The rats were caged in groups of 2-4 and had food and 
water available ad libitum. Animals were housed in a temperature and humidity controlled room 
with a 12-hour light/dark cycle. All animal procedures were in compliance with guidelines of the 
Canadian Council on Animal Care and were approved by the University of Saskatchewan 
Committee on Animal Care and Supply.  
3.3.2 Core Temperature Bio-electrical Sensor Transmitter Implantation  
After acclimation, calibrated bio-electrical sensor transmitters encapsulated in 
biocompatible silicone (SubCue
TM
 Dataloggers), pre-programmed to record core body 
temperature every 30 minutes, were implanted aseptically into the abdominal cavity. Rats were 
anaesthetized with isoflurane (4% induction, 2% maintenance with 1 L/min oxygen) and placed 
on a heated water blanket. A 2-3 centimeter mid-abdominal incision through the skin and linea-
alba was made, allowing insertion of the sterilized, calibrated temperature sensor into the 
peritoneal cavity. Following suturing of the incision site, a single subcutaneous injection of 
Ketaprofen (5mg/kg) was given. Temperature sensors remained in situ until the end of the 
experiment.  
3.3.3 Diet Assignment  
At 5-7 days following temperature sensor implantation, the rats (190-280g) were 
randomly assigned to either a protein adequate control diet (CON, 18% protein) or a protein-
deficient diet (PEM, 2% protein) (Dyets, Inc., PA, USA) (Prosser-Loose et al., 2011) (see Table 
4.1 for diet composition) and remained on the respective diet regimen until euthanasia. Rats of 
this age fed a 2% protein diet voluntarily reduce food intake, resulting in mixed PEM (Prosser-
Loose et al., 2011). Diets were modified from the American Institute of Nutrition-93G diet 
(Reeves et al., 1993) to not contain the antioxidant, tertiary-butylhydroquinone. Food intake was 
recorded daily and body weight recorded weekly. The day of assignment to diet was considered 
experimental day 0, and the experimental timeline is shown in Figure 3.1.  
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Figure 3.1. Experimental design and timeline. Baseline core temperature readings were collected 
for a 3 day period with all animals on control diet prior to placement on experimental diet. On 
experimental day 0, rats were randomly assigned to either PEM or a CON diet. Following 
surgery on experimental day 7, four experimental groups were present (CON-SHAM, CON-ISC, 
PEM-SHAM, PEM-ISC). 
 
3.3.4 Global Forebrain Ischemia   
 On experimental day 7-8, rats were subjected to either global forebrain ischemia via the 
2-VO model of bilateral common carotid artery occlusion combined with hypotension (ISC) or 
sham surgery (SHAM), as previously modified (Arvanitidis et al., 2009) from Smith et al. 
(1984). All surgical procedures were performed using aseptic technique. Prior to surgery, 
animals were fasted (16-20 hours) to achieve blood glucose levels within a consistent range. 
Animals were anaesthetized with isoflurane (~2% maintenance in 70% N2O and 30% O2) and 
placed on a heated water blanket. During surgery, brain temperature was estimated using a 
tympanic probe (IT-18 flexible probe; Physitemp Instruments Inc., NJ, USA) and maintained 
near 37.5°C with an overhead heating lamp outfitted with an infrared bulb (250W). The heating 
lamp was controlled by an automated feedback temperature controller (CN9500; Omega 
Engineering Inc., CT, USA) attached to the tympanic probe. Both common carotid arteries were 
isolated via a 2 centimeter ventral midline incision. The jugular vein was cannulated for blood 
withdrawal and infusion to induce hypotension during the ischemic period. The tail artery was 
cannulated for insertion of a blood pressure sensor (PressureMAT PDKTP4-PCS; PendoTech, 
NJ, USA) for measurement of mean arterial blood pressure (MABP). Arterial blood samples 
(100 µL) were obtained from the tail artery for measurement of blood gases, hematocrit, and 
glucose concentration. For induction of ischemia, once blood pressure had reached 35 mmHg, 
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micro-aneurysm clips (S&T Vascular Clamps HD-S; Fine Science Tools, BC, Canada) were 
applied to both carotid arteries for 10 minutes. During this period, blood was withdrawn into a 
heparinized syringe warmed by the heating lamp or infused as necessary to sustain MABP at 35-
40 mmHg. Clips were removed following the 10 minute occlusion, carotid artery reperfusion 
was visually verified, and blood was slowly re-infused via the jugular vein. All incisions were 
sutured, and a bupivacaine dose (2mg/kg) was divided equally among the 3 incision sites and 
subcutaneously injected. Sham rats were treated identically except that carotid arteries were not 
occluded and hypotension was not induced. Thus, the four experimental groups generated at this 
time were: CON-SHAM (n=10), CON-ISC (n=10), PEM-SHAM (n=12), and PEM-ISC (n=11).  
3.3.5 Immunohistochemistry       
 On experimental day 14 (7 days following surgery), rats were anaesthetized under 
isoflurane and perfused transcardially with 0.9% heparinized saline followed by 4% 
paraformaldehyde. Intact heads were stored at 4°C overnight in paraformaldehyde. Brains were 
removed and refrigerated for an additional 24 hours in paraformaldehyde. Extracted brains were 
submerged into a 20% sucrose solution for 3-5 days. Fixed brains were stored at -20°C until 
sectioning. Coronal sections (14 µm) were taken from the anterior hippocampus and 
immunolabeled for GFAP, ED-1 and OX-42. To ensure accurate assessment of relative 
immunohistochemical changes among experimental groups, one section from each of the 
experimental groups was mounted on the same slide. Thus, each slide contained 4 sections, and 
all experimental groups were processed under identical conditions.  
The protocol used for each of the glial markers was identical, except that the sections for 
OX-42 staining underwent citrate antigen retrieval. Sections were washed in phosphate-buffered 
saline (PBS) and exposed to 1.0% H2O2. Sections were blocked with normal goat serum (5%; 
Invitrogen, CA, USA), followed by an overnight incubation at 4°C with either polyclonal rabbit 
anti-GFAP (1:1000, Z0334; DakoCytomation, ON, Canada), monoclonal mouse anti-rat CD68 
(ED-1, 1:1000, MCA341R; Serotec, NC, USA), or monoclonal mouse anti-rat CD11b (OX-42, 
1:500, MCA275G; Serotec). Slides were washed in PBS and incubated in goat anti-mouse 
biotinylated secondary antibodies (GFAP, 1:500; ED-1, 1:1000; OX-42, 1:1000; Vector 
Laboratories, CA, USA). Sections were treated with extravidin (10 µg/ml; Sigma –Aldrich, ON, 
Canada) and reacted with diaminobenzidine (Vector Laboratories). Quantification was 
performed by measuring the integrated density value (IDV=sum of pixel values in the region of 
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interest) (AlphaEaseFC Imaging Software, Alpha Innotech) of photographs taken under identical 
conditions at 400x magnification. The IDV for OX-42 and ED-1 was determined for an isolated 
region of the hippocampal CA1 pyramidal cell layer (pixel area of 59,985) for both the right and 
left hemispheres and averaged. The same method was used to obtain the IDV for GFAP, except 
the stratum oriens and stratum radiatum areas were included with the hippocampal CA1 
pyramidal cell layer (pixel area of 367,845). The staining in the CA1 region was normalized 
against background staining measured as an IDV for the corpus callosum by calculating the ratio, 
IDV of CA1/IDV of corpus callosum.   
3.3.6 Core Temperature Analysis  
 At the time of euthanasia, the temperature sensors were retrieved and logged temperature 
data were obtained using the SubCue™ analyzer software. Alterations in thermoregulatory 
function resulting from experimental diet and surgical assignment were assessed by examining 
differences in: a) daily mean temperature, b) daily temperature fluctuation calculated by 
deducting the lowest core temperature from the highest temperature measured over a 24 hour 
diurnal cycle, and c) lowest core temperature observed within 8 hours of anaesthetic induction 
for the surgery. 
3.3.7 Statistical Analysis  
 Statistical analyses were conducted using SPSS 17.0 for Windows. All data are presented 
as mean ± SEM. Pre-surgical temperature data were analyzed using an independent t-test. Two 
groups were analyzed during the baseline period when all rats were on control diet to 
demonstrate that there were no initial differences in the groups randomly selected to receive 
different experimental diets. All post-surgical temperature and immunohistochemical data were 
analyzed by two-factor ANOVA, and LSD post-hoc tests were performed where indicated. 
Correlations between hippocampal CA1 injury and the lowest core temperature observed within 
8 hours of anaesthetic induction were analyzed by Pearson’s correlation coefficient for data 
obtained for all rats exposed to ischemia (PEM-ISC + CON-ISC combined) as well as for 
individual ischemic groups. A probability value of ≤ 0.05 was considered to be statistically 
significant.  
3.4 Results 
Three rats (2 PEM-SHAM, 1 PEM-ISC) were excluded from the study due to surgical 
complications involving arterial cannulation and maintenance of anaesthesia. Data collected 
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from these experimental rats to assess protein-energy status (food intake, body weight, and 
serum albumin), intra-ischemic tympanic temperature and blood pressure, the physiological 
response during surgery (blood gases, blood glucose, and hematocrit), hippocampal CA1 neuron 
loss, expression of microtubule-associated protein-2, and serum corticosterone concentration are 
presented in a separate publication (Prosser-Loose et al., 2011). These results formed part of the 
thesis of another graduate student in the laboratory.  
3.4.1 Thermoregulation 
Figure 3.2 shows diurnal rhythm for core temperature as influenced by both PEM and 
exposure to global ischemia.  
          
Figure 3.2. Diurnal rhythm of core temperature as influenced by both PEM and global ischemia. 
Values are mean core temperature readings taken at 30 minute intervals (n=10). Baseline data 
were collected for 3 days before assignment to experimental diet (day 0). The pre-surgical 
fasting occurred on days 6-7, and surgery occurred on day 7.  
 66 
3.4.1.1 Pre-Surgical Period 
There were no significant differences in baseline mean daily core temperature (p=0.063) 
and daily temperature fluctuation (p=0.37) when all animals were still on the CON diet (Figure 
3.3). After commencement of the diet regimen, mean daily core temperature significantly 
increased in the group assigned to PEM within the first 24 hours (p=0.006), and remained 
significant for each of the following days during the pre-surgical period (Figure 3.3A) 
(p<0.024). PEM also significantly increased the daily core temperature fluctuation within 24 
hours (p=0.027), which remained elevated until surgery day (Figure 3.3B) (p<0.027). The 
malnourished rats were warmer than the CON rats during the 12-hour dark period of each day 
and cooler during the 12-hours of light (Figure 3.2).  
 
 
 
Figure 3.3. Mean (±SEM) daily core temperature (A) and daily core temperature fluctuation (B) 
for CON and PEM rats during the pre-surgical period calculated for each 24-hr diurnal cycle 
(n=20). Baseline data were collected for 3 days before assignment to experimental diet (day 0). 
Day 6 represents the beginning of the fasting period (~6 PM). *Indicates a significant effect of 
diet based on an independent t-test (p<0.05). 
 
3.4.1.1 Immediate Pre- and Post-Surgical Periods 
 The mean core temperatures for PEM and CON animals during 12 hours (8 PM-8 AM) of 
the 16-20 hour fasting period before surgery are shown in Table 3.1. The fasted protein-energy 
malnourished rats were significantly warmer prior to surgery (p= 0.002). Although tympanic 
 67 
temperature was maintained at ~37.5°C throughout the surgical period for all 4 treatment groups, 
core temperature was altered by dietary treatment in the immediate post-surgical period. Table 
3.1 shows that, irrespective of surgical treatment, PEM independently caused a decrease in the 
mean lowest core temperature measured within 8 hours following anaesthetic induction 
(p=0.003). There was no effect of ischemia (p=0.75) nor was there an interaction between diet 
and ischemia (p=0.24).  
 
Table 3.1. Core temperature measurements in the immediate pre- and post-surgical periods 
 
Data are mean (±SEM). n=20 for pre-surgical data, and n=10 for post-surgical groups. *Indicates 
a significant difference from CON group by independent t-test (p=0.002). α Indicates a 
significant independent effect of diet (p=0.003) by 2-factor ANOVA. 
 
3.4.1.2 Post-Surgical Period 
 The only significant difference in mean daily temperature in the post-surgical period was 
an independent decrease on day 7 (p=0.004) and an increase on day 9 caused by ischemia 
(p=0.02) (Figure 3.4A). There were no effects of PEM nor an interaction on any experimental 
day (p>0.05). The daily temperature fluctuation remained significantly increased by PEM 
throughout the 7 day post-surgical period (Figure 3.4B). This was an independent effect of PEM 
(p<0.001), with the exception of an interaction on days 8 (p=0.018) and 11 (p=0.021). On day 8, 
the PEM-SHAM animals had a significantly greater temperature fluctuation compared to the 
other three experimental groups (p<0.001).  On day 11, ischemia increased the temperature 
fluctuation only when the rats were malnourished (p<0.015). There was also an independent 
decrease caused by ischemia on day 9 (p=0.002).  
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Figure 3.4. Post-surgical mean (± SEM) core temperature (A) and daily core temperature 
fluctuation (B) for CON-SHAM, CON-ISC, PEM-SHAM, and PEM-ISC (n=10). Experimental 
day 7 is 0-24 hours after surgery. For mean daily core temperature, an independent effect of 
ischemia occurred on days 7 and 9 (§). For daily temperature fluctuation, there was an 
independent effect of PEM (*), with the exception of an interaction on days 8 and 11 (£) and an 
independent effect of ischemia on day 9 (§). 
 
Figure 3.5A shows representative data to illustrate the influence of the extent of 
hippocampal injury on the diurnal rhythm of core temperature during the post-ischemic period in 
well-nourished rats. In general, CON-ISC rats presenting with unilateral hippocampal damage 
tended to have diurnal cycles similar to those of CON-SHAM rats (Figure 3.5A). With extensive 
bilateral hippocampal CA1 injury, there was a disruption in the diurnal cycle of CON-ISC rats 
(Figure 3.5B). The disruption lasted for 1-2 days, at which time the cycle returned to a normal 
pattern. This pattern of disruption in relation to extent of injury was observed in some of the 
PEM-ISC group, but the observation was not as consistent. 
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Figure 3.5. Post-ischemic diurnal pattern for core temperature as influenced by extent of 
hippocampal injury in rats exposed to control diet and global ischemia. Representative patterns 
are shown for a CON-ISC rat with unilateral hippocampal damage (A) and a CON-ISC rat with 
extensive bilateral damage (B).   
 
3.4.2 Immunohistochemistry 
 A separate report describes hippocampal CA1 cell counts from the animals in this study 
(Prosser-Loose et al., 2011). Extensive bilateral hippocampal CA1 injury after 2-VO surgery was 
evident in 7 CON-ISC animals, with 3 rats demonstrating unilateral hippocampal injury. 
Surprisingly, only 5 rats in the PEM-ISC group had bilateral hippocampal CA1 injury, while 1 
rat demonstrated unilateral CA1 damage and 4 rats sustained no CA1 injury (Prosser-Loose et 
al., 2011). 
There were no differences in background staining in the corpus callosum caused by 
surgical treatment (p>0.05) or diet assignment (p>0.05) for any of the three glial markers 
(GFAP, ED-1, OX-42). 
Due to the unexpected variability in the CA1 neuronal damage, only rats with bilateral 
hippocampal damage were included in analysis to provide a preliminary assessment of the effect 
of PEM. Figure 3.6 shows images of the CA1 region immunostained for GFAP, ED-1 and OX-
42 on experimental day 14 for all four experimental groups. The images for the CON-ISC and 
PEM-ISC groups are representative of sections from rats sustaining bilateral CA1 injury in 
which CA1 cell counts are similar. Semi-quantification analyses revealed that global ischemia 
significantly increased GFAP (p<0.001; n=10 CON-SHAM, n=7 CON-ISC, n=10 PEM-SHAM, 
n=5 PEM-ISC), ED-1 (p<0.001; n=10 CON-SHAM, n=7 CON-ISC, n=10 PEM-SHAM, n=5 
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PEM-ISC) and OX-42 (p<0.001; n=7 CON-SHAM, n=5 CON-ISC, n=7 PEM-SHAM, n=3 
PEM-ISC) staining, but were unaffected by dietary treatment (GFAP p=0.61; ED-1 p=0.20; OX-
42 p=0.17), nor was there an interaction (GFAP p=0.056; ED-1 p=0.15; OX-42 p=0.13).  
 
 
Figure 3.6. Representative images from brains with bilateral hippocampal damage to highlight 
the immunohistochemical characterization of the glial response in the CA1 region of CON-
SHAM (A,E,I), CON-ISC (B,F,J), PEM-SHAM (C,G,K) and PEM-ISC (D,H,L) rats. There 
was a significant independent increase (p<0.001) in integrated density values (IDV) for ED-1 (A-
D), OX-42 (E-H) and GFAP (I-L) caused by global ischemia with no effect of dietary treatment. 
Scale bar = 50 m.  
 
3.4.3 Correlations 
Correlation analysis was performed to determine if the inconsistency in CA1 
hippocampal injury was related to a post-ischemic drop in core temperature. The lowest core 
temperature within 8 hours of anaesthetic induction was correlated with total CA1 cell counts 
reported in (Prosser-Loose et al., 2011) for: 1) CON-ISC and PEM-ISC groups combined, and 2) 
CON-ISC and PEM-ISC groups separately as shown in Table 3.2. Results from correlation 
 71 
analysis detected a significant negative correlation between hippocampal injury and the drop in 
temperature when only CON-ISC animals were included in the analysis (r
 
=-0.897, p<0.001). 
Thus, the decrease in neuronal damage was limited to the CON-ISC animals that experienced a 
drop in core temperature. 
 
Table 3.2. Correlation of post-ischemic hippocampal CA1 total cell counts with post-surgical 
decline in core temperature* 
    
*Detected by Pearson’s Correlation Coefficient. Lowest core temperature observed within 8 
hours following surgical anaesthetic induction. 
 
3.5 Discussion 
 The major finding from this study was the rapid effect of a change in experimental diet 
on thermoregulation. Both daily temperature fluctuation and daily mean temperature were 
increased consistently within the first 24 hours after assignment to the low protein diet. As 
malnutrition developed, both parameters remained significantly higher than those of control diet-
fed rats throughout the pre-ischemic period. During this period, the greatest differences between 
the two experimental groups were 0.90ºC for temperature fluctuation on experimental day 3 and 
0.35ºC for mean temperature on day 1.  
This disruption in thermoregulatory response is in agreement with previous reports. 
However, the extent of the response and the trend in temperature patterns vary, with both 
warming (Balmagiya & Rozovski, 1983; Castanon-Cervantes & Cintra, 2002) and cooling 
(Allison et al., 2000; Brooke, 1973; Duran et al., 2008) responses reported. These discrepancies 
are likely due to differences in species, method used to measure temperature, age, severity of 
malnutrition, extent to which protein and/or energy were limiting, and stage of adaptation to the 
nutrient deficiency. Most studies in malnourished rodents have been well-controlled, although 
findings cannot be specifically attributed to protein-energy status in those studies in which the 
control and deficiency diets are not matched for all other nutrients (Duran et al., 2008). The 
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technique by which temperature data are obtained is a key factor, since most studies rely on 
single periodic measurements that fail to highlight changes in diurnal cycles. Furthermore, when 
conclusions have been drawn from acute rectal monitoring in rodents, this type of measurement 
can yield artificial temperature data by triggering stress-induced hyperthermia (Clark et al., 
2003). An advantage of implantable temperature transmitters, as used by us and others 
(Castanon-Cervantes & Cintra, 2002; Duran et al., 2008), is that accurate chronic readings 
highlighting diurnal cycles can be obtained in unanaesthetized animals without inducing a stress 
response.  
Our core temperature results are comparable to the findings from Castañón-Cervantes et 
al. (2002), who observed chronic occipital-cortex temperature regulation in rats exposed to 
protein malnutrition during brain development and into adulthood. Analogous to our core 
temperature findings, malnourished Sprague-Dawley rats presented with an altered circadian 
rhythm characterized by higher-amplitude daily cortical temperature rhythms. Mean daily 
cortical temperatures were also higher in young malnourished rats. However, this altered 
thermoregulatory response was not significant in malnourished old rats, demonstrating that age is 
another variable that may explain discrepancies among studies.   
 We found a prominent difference between the effects of the low protein diet on the daily 
temperature fluctuation and mean temperature during the pre-ischemic period. During the first 
three days after exposure to a low protein diet, rats increased both their daily temperature 
fluctuation and mean temperature. Following this initial period, the increase in temperature 
fluctuation remained constant and appeared to be permanent, whereas the increase in mean 
temperature began to decline after the second day. During the initial three day period, 
malnourished animals were warmer than control animals while awake, but had similar core 
temperatures while asleep. As time advanced, malnourished rats became cooler during the sleep 
period, resulting in more normalized mean core temperatures. This suggests that malnourished 
rats were able to adapt to the initial warming period by adjusting their temperature fluctuation. 
The increase in amplitude of daily temperature fluctuation was sustained throughout the post-
surgical period. In contrast, the malnutrition-induced increase in mean daily temperature did not 
re-establish after surgery, suggesting that it was an acute response. Due to the short post-surgical 
period, we cannot rule out the possibility that a change in mean core temperature would re-
establish with chronic PEM. Although the long-lasting effects of PEM on thermoregulation are 
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rarely studied, one previous study revealed a persistent effect of chronic protein malnutrition on 
circadian rhythm for 28 days (Castanon-Cervantes & Cintra, 2002). 
Our study did not address the mechanisms responsible for the temperature changes 
observed in the protein-energy malnourished rat. Body temperature is tightly regulated, with 
afferent thermal sensing receptor input sent from the skin surface, deep abdominal and thoracic 
tissues, spinal cord, and brain to the major thermoregulatory regulator, the hypothalamus (Kurz, 
2008). Temperatures exceeding the warm- or cold-response thresholds activate the 
thermoregulatory defense (efferent) responses of sweating, vasodilation or vasoconstriction, non-
shivering thermogenesis, and shivering. Behavioural responses, such as altering locomotion, are 
another form of defense. We propose that the effects of PEM on thermoregulatory defense are 
complex, involving heat production and loss, and are dependent upon the characteristics of the 
deficiency as discussed above. 
The immediate temperature effects of the low protein diet may reflect a behavioral stress 
response similar to what has been described with rat handling (Briese, 1998). We hypothesized 
that the immediate increase in mean core temperature is contributed to by an acute stress-induced 
rise in locomotor activity reflecting increased foraging caused by exposure to suboptimal diet. 
The data indirectly support this, since during the initial period of exposure to low protein diet, 
the largest temperature change in malnourished rats was during the awake cycle. Simultaneous 
measurements of the activity and temperature circadian rhythms would address this hypothesis. 
The sustained increase in amplitude of the diurnal temperature cycle, however, suggests that 
alterations in thermoregulatory defense are also related to the adaptive metabolic and behavioral 
adjustments that occur as malnutrition develops (Torun, 2006). 
PEM may exert direct effects on central regulation of temperature by altering specific 
hypothalamic nuclei that sense nutrient level and alter feeding and metabolic rate (Tabarean et 
al., 2010). In addition, the altered thermoregulatory amplitude suggests that the low protein diet 
could be interacting with the hypothalamic suprachiasmatic nucleus (SCN). The latter regulates 
the circadian rhythms for many processes including sleep-wake cycles, feeding, body 
temperature, and locomotor activity; an alteration in one cycle can influence that of another 
(Weinert, 2005). Increases in rapid eye movement (REM) sleep, which attenuates 
thermoregulatory responsiveness (Horne, 2009), have been reported with chronic malnutrition 
(Durán et al., 1999). The latter can also modify the phase relation of core temperature to the 
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motor activity oscillation (Castanon-Cervantes & Cintra, 2002). It has even been suggested that a 
low protein diet can modify the cellular composition of the SCN, resulting in a weaker coupling 
force among oscillators (Aguilar-Roblero et al., 1997). However, unlike our investigation, all of 
these studies initiated protein deficiency during brain development.  Nonetheless, influences 
could also be indirectly exerted through modifications in neuroactive peptides and hormones. 
PEM induces a host of endocrine changes that regulate heat production and basal metabolic rate, 
including increased glucocorticoids (Torun, 2006). Although we did not detect elevated 
corticosterone levels in these malnourished rats (Prosser-Loose et al., 2011), the 
unphysiologically high values measured are likely indicative of sampling stress, which can mask 
an increase caused by malnutrition (Shipp & Woodward, 1998).  
Protein-energy malnourished rats also showed a greater decrease in core temperature 
immediately following anaesthesia, and this was independent of the type of surgery. These data 
demonstrate that extra precautions need to be taken when studying PEM coupled with any 
surgical model. Rodents are highly susceptible to hypothermia induced by anaesthesia (Taylor, 
2007). Despite the use of a circulating water blanket and heat lamp in the present study, all four 
experimental groups experienced a decrease in core temperature either during or immediately 
after anaesthesia. The greater tendency in the malnourished group may have been related to 
decreased heat conservation resulting from reduced thermal insulation from adipose tissue. None 
of the rats were able to seek a warmer environment (that is, huddle with cage-mates) due to 
single-housing during the recovery period. This finding is in agreement with others’ reports on 
the inability of malnourished rats to cope with environmental temperature stressors. Sprague-
Dawley rats fed a protein-restricted diet for 6 weeks were not able to respond to the same level as 
control animals when subjected to a mild cold challenge. Following a 90-minute exposure period 
to an 18-19ºC environment, the malnourished animals were on average 2.5ºC cooler and took 
approximately twice the length of time to recover from the stressor (Balmagiya & Rozovski, 
1983). A similar trend has been reported in malnourished elderly patients (Allison et al., 2000). 
 Unlike a previous report (Clark et al., 2007), exposure to global ischemia induced by 2-
VO also affected temperature regulation during the post-surgical period. Following the 
immediate cooling period, there was a distinct recovery phase, which differed depending on 
experimental group and the extent of neuronal damage. Independent of diet, SHAM animals 
returned to regular diurnal oscillations immediately following the anaesthetic induced cooling 
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period. CON-ISC animals with extensive hippocampal damage tended to present with distorted 
diurnal rhythms that lasted approximately 48 hours whereas CON-ISC rats with unilateral 
hippocampal damage regulated temperature similarly to SHAM animals during the recovery 
phase. This relationship between disrupted diurnal cycle and extent of hippocampal injury was 
more ambiguous in the PEM-ISC rats, presumably because of the independent effects of PEM on 
thermoregulation.  
An unfortunate and unexpected finding of the current study reported in detail elsewhere 
(Prosser-Loose et al., 2011) is that co-existing PEM increased the inconsistency of the 2-VO 
model of global ischemia. This may be a consequence of PEM altering multiple physiological 
variables, since there was no one clear contributor (Prosser-Loose et al., 2011). The decline in 
core temperature in the immediate post-anaesthetic period presented here also does not offer an 
explanation. The mean lowest core temperature in PEM-ISC rats during the 8 hours following 
anaesthetic induction was 0.8ºC lower than the corresponding mean of CON-ISC animals. 
However, a negative correlation between temperature and the number of surviving CA1 neurons, 
while detected for the CON-ISC animals, was not evident in the malnourished rats exposed to 
ischemia. Thus, the decrease in CA1 neuronal damage was not explained by a drop in core 
temperature. Multiple variables can affect the efficacy of post-ischemic hypothermia for 
neuroprotection, including the duration, rate and severity of temperature drop, as well as the type 
of stroke (MacLellan et al., 2009). The majority of protein-energy malnourished rats experienced 
a brief post-ischemic drop in temperature, and it is unlikely that the temperatures were low 
enough to provide significant neuroprotection. Greater and more prolonged drops in temperature 
are needed to significantly mitigate injury (MacLellan et al., 2009).  
This failure to achieve a consistent model of global ischemia (Prosser-Loose et al., 2011) 
has confounded the assessment of glial response and prevents us from drawing conclusions on 
whether PEM exacerbates reactive gliosis after global ischemia through alterations in 
temperature regulation. A preliminary assessment was conducted exclusively on rats presenting 
with extensive bilateral hippocampal damage. The extent of gliosis appeared to mirror the degree 
of neuronal injury, but the striking increase in reactive gliosis previously observed in protein-
energy malnourished gerbils after global ischemia (Bobyn et al., 2005) was not observed. While 
the glial response significantly differed between SHAM and ISC groups, PEM had no effect on 
GFAP, ED-1 and OX-42 expression. Since the model of brain ischemia was confounded and 
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evaluating only those rats with bilateral hippocampal injury can introduce bias, our preliminary 
analysis of the effects of malnutrition on the glial response is inconclusive and should be re-
addressed in future with a reliable ischemia model.  
Exposure to a low protein diet rapidly impairs the ability to maintain constant 
thermoregulatory homeostasis. Furthermore, when confronted with the thermoregulatory 
challenge associated with anaesthesia, protein-energy malnourished rats were less able to adapt 
than well-nourished animals and thus presented with a greater transient drop in core temperature. 
Since temperature regulation is a key determinant of brain injury following ischemia, these 
findings suggest that the pathophysiology of brain injury in malnourished stroke victims could be 
altered and that these patients might require distinct treatment. Although our preliminary analysis 
of the influence of PEM on the glial response to global ischemia is inconclusive, this question 
should be re-addressed in a different model of brain ischemia since other evidence suggests that 
PEM lowers the setpoint for inflammation. 
3.6 Experimental Progression of Thesis  
The overarching objective of this thesis was to investigate the effects of PEM on the 
inflammatory response to brain ischemia. Given that there is a strong relationship between 
inflammation and temperature, it was imperative to follow-up on the temperature findings 
obtained in this first study. Although it is well known that food availability influences body 
temperature, this is the first report to highlight the immediate changes in body temperature in 
response to a protein-deficient diet. However, the long-term independent effects of PEM on 
temperature were not clear from this study, and therefore a comprehensive assessment of core 
temperature in chronically malnourished rats was performed in the second study. It was 
hypothesized that the immediate elevation in core temperature following placement on the 
suboptimal diet was an acute stress response characterized by hyperactivity. Thus, this 
relationship was examined in the second study by measuring the motor activity levels of rats on 
initial exposure to a low protein diet. Lastly, the findings from this study suggested that the 
clinical problem of co-existing PEM could not be reliably assessed using the rat 2-VO model. 
Therefore, this research question was abandoned. Instead, the third study in this thesis examined 
the consequences of the equally clinically relevant situation of PEM developing after brain 
ischemia.
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CHAPTER 4: 
PROTEIN-ENERGY MALNUTRITION INDUCES AN ABERRANT ACUTE-PHASE 
RESPONSE AND MODIFIES THE CIRCADIAN RHYTHM OF CORE 
TEMPERATURE 
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4.1 Abstract 
Protein-energy malnutrition (PEM), present in 12-19% of stroke patients upon hospital 
admission, appears to be a detrimental comorbidity factor that impairs functional outcome, but 
the mechanisms are not fully elucidated. Since ischemic brain injury is highly temperature-
sensitive, the objectives of this study were to investigate whether PEM causes sustained changes 
in temperature that are associated with an inflammatory response. Activity levels were recorded 
as a possible explanation for the immediate elevation in temperature upon introduction to a low 
protein diet. Male, Sprague-Dawley rats (7 wk old) were fed control diet (18% protein) or a low 
protein diet (PEM, 2% protein) for either 7 or 28d. Continuous core temperature recordings from 
bio-electrical sensor transmitters demonstrated a rapid increase in temperature amplitude, 
sustained over 28d, in response to a low protein diet. Daily mean temperature rose transiently by 
d2 (p=0.01), falling to normal by d4 (p=0.08), after which mean temperature continually 
declined as malnutrition progressed. There were no alterations in activity mean (p=0.3) or 
amplitude (p=0.2) that were associated with the early rise in mean temperature. Increased serum 
alpha-2-macroglobulin (p<0.001) and decreased serum albumin (p≤0.005) combined with a 
decrease in serum alpha-1-acid glycoprotein (p<0.001) suggest an atypical acute-phase response. 
In contrast, a low protein diet had no effect on the signaling pathway of the pro-inflammatory 
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transcription factor, NFB, in the hippocampus. In conclusion, PEM induces an aberrant and 
sustained acute-phase response coupled with long-lasting effects on body temperature.  
4.2 Introduction  
PEM, characterized by deficits in protein and energy status, is frequently associated with 
critical illnesses and chronic disease states, ultimately contributing to increased morbidity and 
mortality (Omran & Morley, 2000). We have been investigating the implications of PEM to 
stroke outcome, since 12-19% of stroke patients are protein-energy malnourished at the time of 
hospital admission (Davis et al., 2004; Martineau et al., 2005; Yoo et al., 2008), and this 
proportion rises to 35% by the time of admission to a rehabilitation unit (Brynningsen et al., 
2007; Poels et al., 2006). Numerous clinical studies, the largest being the multi-centre FOOD 
trial (FOOD Trial Collaboration, 2003), have associated suboptimal nutritional status with 
adverse clinical outcomes after stroke. However, since these studies had numerous 
methodological shortcomings that precluded establishing a causal relationship, we addressed this 
more directly in a rodent model of global brain ischemia in which the hippocampal CA1 region 
is most vulnerable. Co-existing PEM was found to impair functional outcome (Bobyn et al., 
2005) and alter mechanisms underlying both neuronal death (Bobyn et al., 2005; Ji et al., 2008) 
and brain repair (Prosser-Loose et al., 2010). Here, we seek to characterize other 
pathophysiological features of malnutrition that could explain PEM-mediated changes in brain 
function following cerebral ischemia.  
Co-existing PEM may exert some of its effects on post-stroke functional outcome by 
altering key physiological determinants of ischemic brain injury. Stroke pathophysiology is 
highly temperature-sensitive (MacLellan et al., 2009; van der Worp et al., 2007; Wang et al., 
2009), and we recently employed bio-electrical sensor transmitters to observe a rapid 
perturbation in the circadian rhythm of core temperature in rats exposed to a low protein diet 
(Smith et al., 2011). Within the first day, daily temperature amplitude (half of the range of daily 
temperature oscillation over the 24hr diurnal cycle) increased markedly, and there was a small 
but clearly defined increase in mean temperature. Unfortunately, the long-term independent 
effects on mean temperature were not clear from this study, since the design exposed rats to the 
thermoregulatory stress of anaesthesia and surgery after only 7d on the low protein diet, which 
lowered core temperature. However, the increased amplitude was sustained over the two weeks 
of testing, during which the rats voluntarily reduced food intake and became protein-energy 
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malnourished (Prosser-Loose et al., 2011). There is considerable discrepancy in the related 
reports of others, with both cooling (Bastow et al., 1983; Brooke, 1973; Duran et al., 2008) and 
warming (Balmagiya & Rozovski, 1983; Castanon-Cervantes & Cintra, 2002) responses reported 
in humans and rodents experiencing varying states of protein and/or energy deficiencies. 
Reliance on single periodic rectal monitoring accounts for some of the inconsistencies in rodent 
studies, since this can trigger stress-induced hyperthermia (Clark et al., 2003), and changes in the 
diurnal cycle cannot be detected. Previous studies have not investigated the thermoregulatory 
response to PEM as it evolves over time.  
Since prolonged hyperthermia is associated with both an exacerbated inflammatory 
response and aggravated ischemic brain injury (Wang et al., 2009), it is clinically important to 
characterize the duration and severity of temperature changes that occur with the chronic PEM 
characteristic of patients admitted with stroke. The first objective of the current study was 
therefore to investigate whether the increase in daily temperature amplitude induced by exposure 
to a protein-deficient diet would be sustained over a 28d period. We further hypothesized that 
exposure to a low protein diet would cause an initial elevation in core temperature associated 
with increased foraging behavior, and that the higher temperature would persist due to the 
induction of inflammation (Ji et al., 2008; Ling et al., 2004; Lyoumi et al., 1998). Contradictory 
reports have described either an increase (Duran et al., 2008) or no change (Castanon-Cervantes 
& Cintra, 2002) in motor activity in rats exposed to low dietary protein since conception; 
however, these studies offer limited evidence of the protein-energy status under study.  
Since temperature alterations can modulate brain inflammatory pathways (Ceulemans et 
al., 2010; Wang et al., 2009; Webster et al., 2009), chronic PEM may trigger an exacerbated 
inflammatory reaction to brain ischemia through changes in thermoregulatory capacity. The 
hippocampal CA1 subregion of the brain is selectively vulnerable to global brain ischemia 
(Corbett & Nurse, 1998), and indirect evidence from our laboratory suggests that PEM could 
exacerbate the inflammatory response in this brain region (Bobyn et al., 2005; Ji et al., 2008). 
However, an additional intriguing finding was that PEM not only increased activation of the 
transcription factor, NFB, in the ischemic hippocampus, but also in the hippocampus of sham 
and non-surgically treated malnourished gerbils (Ji et al., 2008). As NFB directly regulates pro-
inflammatory gene expression (Hayden & Ghosh, 2011), this suggests that PEM can 
independently induce hippocampal inflammation. Therefore, in the current study, we aimed to 
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further characterize the influence of both acute and chronic PEM on the hippocampal NFB 
pathway. We hypothesized that PEM would increase mRNA expression of pro-inflammatory 
genes regulated by the NFB cascade.  
A final study objective was to investigate the degree to which a systemic inflammatory 
response is induced by PEM, as the extent of the acute-phase response predicts outcome in stroke 
patients (Dziedzic, 2008). While most studies have addressed whether PEM blunts the ability to 
mount a controlled inflammatory response to tissue injury or infection, there is also evidence that 
malnutrition can be an independent stimulus of inflammation and an acute-phase response. 
Serum albumin is a major negative acute-phase protein that decreases with inflammation (Qu et 
al., 1996). Positive acute-phase proteins produced at high levels with inflammation in the rat 
include alpha-1-acid glycoprotein (AGP) and alpha-2-macroglobulin (A2M); these are regulated 
by inflammatory cytokines such as IL-6, IL-1 and TNF- (Andus et al., 1988). Ling et al. 
(2004) reported a systemic inflammatory response to PEM on the basis of increased serum 
concentrations of TNF-, IL-1, IL-6 and AGP. Similarly, Lyoumi et al. (1998) demonstrated 
elevated serum A2M levels and IL-6 mRNA in peripheral blood mononuclear cells and intestine 
of severely protein-malnourished rats. In fact, increased inflammatory cytokines reported with 
PEM (Dulger et al., 2002; Ling et al., 2004) may constitute a mechanism for irregular 
thermoregulatory homeostasis, since the major endogenous pyrogens, including IL-6 and TNF-, 
migrate to the brain and increase the thermoregulatory set-point in the hypothalamus (Biddle, 
2006).   
We thus hypothesized that PEM elicits hippocampal and systemic inflammation that is 
associated with elevated core temperature. The first study was designed to investigate the effects 
of acute (7d) and chronic (28d) exposure to a low protein diet and the evolution of PEM on the 
hippocampal NFB signaling pathway and the systemic acute-phase response, as reflected by 
serum A2M, AGP and albumin concentrations. Chronic core temperature readings were obtained 
with bio-electrical sensor transmitters to characterize disruptions in body temperature induced by 
PEM as it evolved over 28d. In a second experiment, a cross-over design was used to study the 
short-term effects of exposure to low protein diet on the relationship between the daily rhythms 
of locomotor activity and body temperature.  
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4.3 Materials and Methods 
4.3.1 Animals  
Twenty-eight male Sprague-Dawley rats (Experiment 1, n=24; Experiment 2, n=4) 
obtained from Charles River Canada (QC, Canada), 30d in age, were acclimatized on rat chow 
for 2d before placement on a purified control diet (see below for composition). Rats were housed 
in groups of 2-4 (Carefresh bedding; Absorption Corp., Washington, USA) until temperature 
sensor implantation surgery and maintained on a 12hr light (07:00-19:00)/12hr dark (19:00-
07:00) cycle in a temperature controlled room (~22ºC) with free access to food and water. This 
work was approved by the University of Saskatchewan’s Animal Research Ethics Board, and 
adhered to the Canadian Council on Animal Care guidelines for humane animal use.  
4.3.2 Core Temperature Bio-Electrical Sensor Transmitter Implantation  
At 7d following arrival, calibrated bio-electrical sensor transmitters encapsulated in 
biocompatible silicone (SubCueDataloggers, AB, Canada) were aseptically implanted into the 
abdominal cavity. Sensor transmitters were pre-programmed to record core body temperature at 
set times as described under individual experiments. Rats were placed on a heated water blanket 
and anaesthetized with isoflurane (4% induction, 2% maintenance with 1 L/min oxygen). A 3- 
centimeter mid-abdominal incision was made, allowing intra-peritoneal implantation of the 
sterilized, calibrated temperature sensor. Following the suturing of the muscle wall and skin 
incisions, a subcutaneous injection of Ketoprofen (5mg/kg) was given. 
4.3.3 Experimental Diets  
A protein adequate control diet (CON, 18% protein) and a low protein diet (PEM, 2% 
protein) (Dyets, Inc., PA, USA) were used in both Experiments 1 and 2 (Table 4.1). Rats of this 
age fed a 2% protein diet voluntarily reduce food intake, resulting in mixed PEM (Prosser-Loose 
et al., 2011). The experimental diets were modified from the American Institute of Nutrition 
(AIN)-93G diet (Reeves et al., 1993) to not contain the antioxidant tertiary-butylhydroquinone.  
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Table 4.1. Composition of control and low protein diets
§
 
Component  Adequate Protein*(CON)  
g/kg 
Low Protein** (PEM)  
g/kg 
Vitamin Free Casein  200 22.4 
L-Cystine  3 0.29 
Sucrose 100 100 
Cornstarch 397.5 520.05 
Dextrinized Cornstarch 132 174 
Soybean Oil (without TBHQ
#
) 70 70 
Cellulose  50 50 
Mineral Mix 

 35 0 
Mineral Mix 

 0 35 
Calcium Phosphate, dibasic 0 12.4 
Calcium Carbonate 0 3.36 
Vitamin Mix 

 10 10 
Choline Bitartrate  2.5 2.5 
§ 
Experimental diets obtained from Dyets Inc. (PA, USA). *Protein adequate control diet was 
formulated to contain 18% protein. ** Low protein diet, used to induce PEM, was formulated to 
contain 2% protein. 
# 
Tertiary-butylhydroquinone.  AIN-93G mineral mix (Reeves et al., 1993). 
 AIN-93G modified mineral mix, without calcium and phosphorus, potassium citrate· H2O 
increased from 28 to 226.55 g/kg, sucrose increased from 209.806 to 618.256 g/kg mineral mix. 
 AIN-93G vitamin mix (Reeves et al., 1993). 
 
4.3.4 Experiment 1  
Experiment 1 assessed whether PEM induces an acute-phase response and evaluated the 
effects of PEM on circadian rhythm of core temperature and the hippocampal NFB signaling 
pathway. Two time-points were used to characterize both the acute (7d) and chronic (28d) 
response to a low protein diet.  
4.3.4.1 Diet Assignment  
Rats (47d old) were housed in groups of 3 and were randomly assigned to either continue 
on the CON diet (fed since d2 after arrival) or a low protein diet at 10d following temperature 
sensor implantation, which was sufficient time for full recovery from surgery and Ketoprofen 
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washout. Animals were fed their respective diets ad libitum for either 7 or 28d. Food intake was 
recorded daily and body weight recorded weekly. The four experimental groups generated in 
Experiment 1 were (n=6): CON-7d, PEM-7d, CON-28d, and PEM-28d.  
4.3.4.2 Tissue Collection  
Following either 7 or 28d on the assigned diet, rats were anaesthetized with isoflurane 
(100% O2), and blood samples were collected via cardiac puncture. Blood samples were allowed 
to clot for 30min at room temperature and then centrifuged at 1,500 x g for 10min. Serum was 
removed and stored at -80°C. Following transcardial perfusion with saline, liver was collected, 
immediately transferred to liquid nitrogen, and stored at -80°C. Intact hippocampus was excised 
from both hemispheres on an ice-cold dissection stage and stored at -80°C in RNAlater RNA 
Stabilization Reagent (Qiagen, CA, USA). Temperature sensors were retrieved from the 
peritoneal cavity. 
 4.3.4.3 Indices of PEM 
For analysis of liver lipid levels, liver was homogenized in 1 mL of 0.15 mol/L NaCl and 
added to 5 mL of chloroform:methanol (2:1). Samples were centrifuged at 3,200 x g for 10min, 
followed by dehydration of the isolated liver lipid pellet with anhydrous Na2SO4. The contents 
were filtered with chloroform, followed by evaporation of any remaining chloroform. To 
determine the liver lipid content of each sample, liver lipid weight was expressed as a percent of 
liver wet weight.  
4.3.4.4 Hippocampal NFB Signaling Pathway 
Hippocampal RNA was prepared using the Qiagen RNeasy Midi kit following the 
manufacturer’s protocol (Qiagen). Reverse transcription was carried out with the RT2 First-
Strand kit (SABiosciences, MD, USA) using 500 ng of RNA. The Rat NFB Signaling Pathway 
RT
2
 Profiler PCR Array (SABiosciences) was used to measure the transcript levels of 84 genes 
involved in NFB-mediated signal transduction and appropriate housekeeping controls (Rplp1, 
Hprt1, Rpl13a, Ldha, Actb). Gene detection and quantification was carried out using the AB1 
7300 Applied Biosystems Real-Time PCR Detection System. Data analysis was performed using 
the RT
2
 Profiler PCR Array Data Analysis program obtained from SABiosciences. Only the 
genes that had average delta cycle threshold (Ct) values differ by more than two cycles between 
treatment groups were included in the statistical analysis. 
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4.3.4.5 Serum AGP, A2M and Albumin  
To study the systemic inflammatory response resulting from exposure to a low protein 
diet, serum levels of positive acute-phase proteins were determined using the rat AGP ELISA kit 
and the rat A2M ELISA kit (Immunology Consultants Laboratory, Inc., OR, USA). Serum 
albumin concentration was determined by the bromocresol green method (Doumas et al., 1971). 
A volume of 25 L of sample serum or standard solution was added to 5.0 mL bromocresol 
green reagent (0.15 mmol/L bromocresol green, 0.075 mol/L succinate buffer, 30% Brij-35). 
After 30min, absorbance was measured spectrophotometrically at 628 nm (Biochrom Ultrospec 
3100 Pro). The albumin concentration of the sample was determined by linear regression. For all 
serum assays, samples were run in triplicate.  
4.3.4.6 Core Temperature Analysis  
Temperature probes were pre-programmed to record core body temperature every 15min. 
SubCue analyzer software (SubCueDataloggers, AB, Canada) was used to obtain logged 
temperature data. Alterations in body temperature resulting from exposure to a low protein diet 
were assessed by examining the mean temperature and temperature amplitude (half of the range 
of oscillation of a fitted curve) measured over each 24hr diurnal cycle. The software program 
COSINOR 2.3 was used to calculate daily temperature mean and amplitude (Refinetti et al., 
2007).   
4.3.4.7 Statistical Analysis  
Statistical analyses were conducted using SPSS 18.0 for Windows. All data are presented 
as mean ± SEM. Body weight, food intake, liver lipid percentage, serum protein concentrations 
and NFB PCR arrays were analyzed using an independent-sample Student’s t test. When 
multiple comparisons were made, the level of significance was adjusted using Bonferroni 
correction. Differences were considered significant at p ≤  0.05. Variability is presented as SEM; 
95% confidence intervals around the means were also calculated for food intake because of the 
small sample size (n=2 cages [3 animals/cage]). 
Analysis of daily mean temperature and amplitude was performed using a repeated 
measures ANOVA. To assess the immediate and longer-term effects of the low protein diet, data 
from the acute (d1-7) and chronic (d8-28) phases of malnutrition were analyzed separately for 
both temperature mean and amplitude. To allow for increased power with the sample size of n=6, 
a diet group X time ANOVA with repeated measures was performed using data from each day 
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during the acute phase (diet [2] X time [7]) and every other day during the chronic phase (diet [2] 
X time [10]). The Huynh-Feldt test was used to correct for violations of sphericity. For post-hoc 
comparisons, independent-sample Student’s t tests were performed among groups on d2, 3 and 4. 
Bonferroni correction was used when multiple comparisons were made to adjust the level of 
significance.  
4.3.5 Experiment 2  
To determine the extent to which low protein diet-induced changes in core body 
temperature were influenced by alterations in locomotor activity, 4 male, Sprague-Dawley rats 
were utilized in a cross-over design as described below.  
4.3.5.1 Locomotor Activity Monitoring  
At 7d following temperature sensor implantation, 4 cages with 1 rat per cage were placed 
in the Opto-M3 sensor cage system (Columbus Instruments, Ohio, USA). Detection of locomotor 
activity was based on disruptions of the 8 X 8 infrared beam grid. A count was accumulated 
every time a new beam was broken, so that stationary activity such as scratching, grooming and 
digging was excluded. Activity data were collected in 15min sampling intervals. Activity 
monitors were connected to a computer, and the CI Multi-Device Interface software (Columbus 
Instruments) was used to control the Opto-M3 device. Activity recording started at 4d after 
placement in the activity monitoring setup to allow for acclimatization to the new environment 
prior to recording.  
A cross-over design was utilized to study the relationship between daily rhythms of 
activity and body temperature under CON diet (18% protein) conditions versus low protein (2%) 
diet. For the first 7d of activity monitoring, rats remained on the purified CON diet provided at 
the time of arrival. Following 1 transition day, rats were given the low protein diet and locomotor 
activity was recorded for an additional 7d. To ensure that stress related to cage and animal 
handling did not alter activity readings, cage changes and body weight measurements were 
performed on the day before initiating activity monitoring on CON diet, the transition day 
between diets, and at the end of the low dietary protein period. That is, recording of activity was 
always initiated 24hr after manipulation.  
4.3.5.2 Temperature and Activity Analysis   
At the time of euthanasia, temperature sensors, pre-programmed to record temperature 
every 30min, were retrieved from the abdominal cavity. Logged temperature data were obtained 
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using the SubCue analyzer software. Parameters measured for both temperature and activity 
rhythms included: daily mean, amplitude and robustness (strength of the rhythm). In addition, we 
examined the effect of a low protein diet upon the acrophase, the time at which the peak of a 
rhythm occurs. Acrophase and robustness were calculated for the combined 7d while on each 
experimental diet. Acrophase difference (APH-D) was calculated by subtracting the acrophase of 
temperature from the acrophase of activity for each animal. Since the daily rhythms of activity 
and temperature are known to be closely associated (Refinetti, 1997), calculating the APH-D can 
identify any differences in the rhythmic pattern between the low protein and CON diet periods. 
Computation of all parameters was by means of the software program COSINOR 2.3 (Refinetti 
et al., 2007).   
4.3.5.3 Statistical Analysis  
 Statistical analyses were conducted using SPSS 18.0 for Windows. All data are presented 
as mean ± SEM. To assess the effects of a low protein diet on locomotor activity, both daily 
activity mean and amplitude were compared for each respective day on experimental diet (e.g. 
CON d1 versus low protein diet d1) using repeated measures ANOVA with two within-subject 
factors (diet [2] and time [7]). This approach was used to best examine the effects from the cross-
over design. The Huynh-Feldt test was used to correct for violations of sphericity, and the 
significance set at p ≤ 0.05. Statistical analyses of rhythm robustness and acrophase for both 
temperature and activity were conducted using paired-sample Student’s t tests.  
4.4 Results  
4.4.1 Experiment 1 
4.4.1.1 Indices of PEM 
There were no significant differences in initial body weight between CON-28d and PEM-
28d rats before commencement of the diet regimen (p > 0.4) (Figure 4.1A). A marked reduction 
in body weight compared to control rats was observed after 7d on the low protein diet (p < 
0.001); body weight remained significantly decreased throughout the 28d period (p < 0.001). 
Whereas rats fed the CON diet gained 72% of their initial body weight after 28d of feeding, 
malnourished rats lost 5% of their initial body weight. As shown in Figure 4.1B, food intake 
decreased by wk 2 in the low dietary protein-fed group compared to control rats (p=0.02). Food 
consumption remained significantly lower in malnourished rats for each of the subsequent weeks 
(p=0.01). The 95% confidence interval around the mean food intake for each week is as follows: 
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Wk 1 – CON: 475.3 to 555.7, PEM: 412.3 to 543.9; Wk2 - CON: 508.1 to 585.9, PEM: 341.9 to 
395.4; Wk3 – CON: 484.5 to 592.9, PEM: 244.9 to 305.3; Wk4 – CON: 521.6 to 604.0, PEM: 
201.7 to 307.3. Body weight and food intake results were similar for the 7d of data collected in 
CON-7d and PEM-7d rats (n=6, data not shown). Liver lipid percentage was significantly 
elevated in protein-energy malnourished rats on d28 (p < 0.001) but not by d7 (p = 1.00) (Figure 
4.1C).  
 
Figure 4.1. Effects of feeding a low protein diet for 28d on body weight (A), food intake (B) and 
liver lipid levels (C). Data are shown as mean ± SEM (some SEM bars are not visible due to 
small variability). Sample size for body weight and liver lipid is n=6. Food intake is based on 
cage data (n=2 cages [3 animals/cage]) and is presented as total food intake for each 
experimental week. *Indicates a significant difference between groups as detected by 
independent t test (p < 0.05). 
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4.4.1.2 Effects of a Low Protein Diet on the Acute-Phase Response  
Serum albumin concentration was significantly decreased in malnourished rats at d7 
(p=0.005) and remained significantly lower than CON rats on d28 (p<0.001) (Figure 4.2A). 
Conversely, serum A2M levels were significantly heightened by the low protein diet at both the 
7 and 28d time-points (p<0.001) (Figure 4.2B). The low protein diet did not alter serum AGP 
concentration after 7d (p=0.9), but serum AGP concentration was decreased 3.5-fold in protein-
energy malnourished rats by d28 (p<0.001) (Figure 4.2C).  
                          
Figure 4.2. Decreased serum albumin (A) and increased serum A2M (B) concentrations are 
evident by d7 on a low protein diet, whereas serum concentrations of AGP are decreased by d28 
(C). Data are shown as mean ± SEM, n=6. Rats received either CON or a low protein diet for 7 
or 28d. *Indicates a significant difference from control group at the given time-point as detected 
by independent t test (p < 0.05). 
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4.4.1.3 Effects of a Low Protein Diet on the Hippocampal NFB Signaling Pathway  
The complete list of the 84 genes examined by PCR arrays is provided in Table A.1. 
Gene expression of NFB signaling molecules was compared between diet groups at both time-
points (7d, n=5; 28d, n=6). Out of the 84 genes examined, only 3 genes at 7d (Atf1, Smad3, and 
TNF) and 2 genes at 28d (Ifna1 and Nalp12) met the defined cutoff value of greater than a 2-
cycle difference in average delta Ct between experimental groups and were included in the 
statistical analysis. Independent t tests demonstrated that neither acute nor chronic exposure to a 
low protein diet significantly altered the expression levels of these NFB signaling genes.  
4.4.1.4 Effects of a Low Protein Diet on Circadian Rhythm of Core Temperature  
 Figure 4.3 shows daily mean temperature and temperature amplitude as influenced by 
PEM over a 28d period. The acute (d1-7) and chronic (d8-28) phases of low protein diet were 
analyzed separately for CON-28d and PEM-28d rats. During the acute period, there was a 
significant interaction between diet and time for both daily mean temperature (p=0.001) and 
daily temperature amplitude (p=0.001). The small increase in daily mean temperature was 
transient, becoming significant by d2 on low protein diet (p=0.01), and normal temperatures 
were again observed by d4 on the diet regimen (p=0.08). Temperature amplitude for the group 
fed the low protein diet first became significantly greater than that of CON rats on d3 (p=0.002). 
These data were similar in the CON-7d and PEM-7d rats (n=6, data not shown). 
As malnutrition progressed during the chronic phase (d8-28), the interaction between diet 
and time remained significant for both daily mean temperature (p < 0.001) and daily temperature 
amplitude (p=0.05). As shown in Figure 4.3A, after the initial increase in daily mean 
temperature during the acute phase of malnutrition, there was a continual decline in mean 
temperature throughout the chronic phase of PEM which eventually reached a plateau. In 
contrast, the increase in temperature amplitude appeared to be relatively constant in the 
malnourished rats throughout the 28d test period (Figure 4.3B).  
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Figure 4.3. Daily mean temperature (A) and daily temperature amplitude (B) as influenced by 
chronic feeding of a low protein diet. Data are shown as mean ± SEM, n=6. Rats received either 
a CON or low protein diet for 28d. Results from repeated measures ANOVA demonstrated a 
significant interaction between diet and time for both the acute (1-7d) and chronic (8-28d) phases 
of malnutrition for daily mean temperature and daily temperature amplitude (p ≤ 0.05). 
Independent-sample Student’s t tests with Bonferroni correction were used for post-hoc 
comparisons on d2, 3, and 4. Rats on a low protein diet had a significantly higher daily mean 
temperature by d2 (p=0.01) to d4 (p=0.08); after this spike, mean temperature declined and 
eventually reached a plateau. Significantly greater daily temperature amplitude in the low 
protein-fed group developed by d3 (p=0.002).   
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4.4.2 Experiment 2  
4.4.2.1 Body Weight  
 During the 7d recording period on CON diet, rats on average (± SEM) gained 96 ± 12 
grams (35% body weight increase). The subsequent 7d on low protein diet resulted in stunting of 
growth (0.4% body weight decrease).  
4.4.2.2 Activity and Temperature Response to Low Protein Diet  
 Activity and temperature rhythms are shown for both dietary intervals for 1 rat in Figure 
4.4, which is representative of the pattern observed in all rats. Analogous to our findings from 
Experiment 1 (reported in Figure 4.3), there was an immediate increase in mean and amplitude 
of daily temperature after placement on low protein diet. The two-factor ANOVA with repeated 
measures demonstrated that there were no differences in daily mean activity (p=0.3) (Figure 
4.5A) or daily activity amplitude (p=0.2) (Figure 4.5B) between the two diet regimens when 
assessed throughout the 7d feeding intervals.  
 
 
 
Figure 4.4. Representative patterns are shown for 1 rat during periods of CON diet (d0-7) and 
low protein diet (d8-15). Circadian rhythms of temperature (A) and activity (B) are displayed to 
highlight the immediate effect of a low protein diet on temperature that is not accompanied by an 
alteration in activity level. Core temperature readings were taken at 30 min intervals and activity 
at 15 min intervals. The dashed lines illustrate the transition day between experimental 
treatments. 
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Figure 4.5. Exposure to a low protein diet for 7d had no effect on daily mean activity (A) and 
daily activity amplitude (B). Data are shown as mean ± SEM, n=4. Rats received CON diet for 
7d and then, after a transition day, were transferred to a low protein diet (PEM) for the 
subsequent 7d. No effect of diet was detected by repeated measures ANOVA (p > 0.05).  
 
4.4.2.3 Effect of PEM on Internal Synchronization 
 Acrophase and robustness were computed for the combined 7d on CON diet and 
compared to the 7d on low protein diet to determine whether acute malnutrition affects the 
internal synchronization of daily temperature and activity rhythms. As shown in Table 4.2, 
exposure to a low protein diet increased the robustness of both the rhythms of body temperature 
(p=0.001) and activity (p=0.02). Acrophase analysis, which calculates the peak time of the daily 
rhythm, showed that exposure to low protein diet significantly alters the acrophase of the activity 
rhythm (p=0.02) but not the temperature rhythm (p=0.1). More specifically, rats on low protein 
diet experienced an acrophase-advancement of the activity oscillation such that the peak of the 
daily cycle occurred approximately 1hr earlier. Although this resulted in a trend for activity and 
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temperature rhythms to be more superimposed, as identified by computing the APH-D 
(calculated time between the peak of the activity cycle and the peak of the temperature cycle), 
this was not statistically significant (p=0.06).  
 
Table 4.2. Acrophase, robustness and acrophase difference of temperature and activity rhythms 
between periods of control and low protein diets  
 CON PEM 
Temperature   
Acrophase (hr) 1.2 ± 0.3 0.9 ± 0.1 
Robustness (%) 61 ± 4 75 ± 4* 
Activity    
Acrophase (hr) 2.1 ± 0.3 1.2 ± 0.1* 
Robustness (%) 28 ± 4 42 ± 5* 
Acrophase Difference   
APH-D (hr) 1.1 ± 0.3 0.2 ± 0.1 
Acrophase and robustness were calculated for the 7d on CON diet and low protein diet (n=4). 
Values are expressed as mean ± SEM. Acrophase difference (APH-D) is the calculated time 
between the daily activity acrophase and temperature acrophase. *Indicates a significant 
difference between groups as detected by a paired sample t test (p < 0.05). 
 
4.5 Discussion  
Our study was designed to determine if PEM, which often co-exists with stroke (Davis et 
al., 2004; Martineau et al., 2005; Yoo et al., 2008), has sustained effects on physiological 
determinants of ischemic brain injury. PEM was induced by feeding a 2% protein diet. Total 
food intake and body weight over the 28d experimental period were depressed by 36% and 43%, 
respectively, and liver lipid content was increased by 647%. The early effects of the suboptimal 
protein intake were evident by d7 as a reduction in growth. However, the energy status of the rat 
was not yet compromised, given that voluntary reduction in food intake occurred during the 
second week on the low protein diet.  
The findings provide evidence that PEM can stimulate an acute-phase response, as 
demonstrated by an increase in serum A2M, a positive acute-phase protein, which is indicative of 
inflammation (Cray et al., 2009). The decrease in serum albumin, a major negative acute-phase 
protein, provides further evidence, with the caveat that the additional influence of decreased 
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dietary amino acid supply for synthesis prevents its use as a specific marker of inflammation (Qu 
et al., 1996). Thus, dietary protein depletion appears to act as an independent inflammatory 
stimulus, and the effects occur rapidly. One week on a low protein diet was sufficient time to 
induce alterations in both serum A2M and albumin. The evolution of PEM sustained alterations 
in these acute-phase reactants for 28d, which further suggests that the inflammation is chronic in 
nature.  
However, not all acute-phase proteins responded similarly to PEM. In response to 
systemic inflammation, the liver generally produces abundant levels of positive acute-phase 
proteins. In contrast to the influence of PEM on serum A2M, AGP was decreased after 28d, 
suggesting an aberrant acute-phase response. The inability to mount a complete acute-phase 
response is most likely due to limited amino acid availability for protein synthesis. Lyoumi et al. 
(1998) also observed varying effects of severe protein malnutrition on the induction and 
modulation of the acute-phase response in rats. Whereas AGP gene expression was not 
influenced by severe protein deficiency, A2M expression was elevated in the liver. These results 
suggest that A2M production has precedence over AGP synthesis when the animal is confronted 
with either acute or chronic exposure to low protein diet. The differential acute-phase protein 
response may be due to the specific inflammatory cytokine milieu, including IL-1 and IL-6, 
which modulate the acute-phase response. IL-1 mainly regulates AGP, a class 1 acute-phase 
protein, whereas A2M belongs to class 2 and is generally induced by IL-6 (Baumann et al., 
1989). A limitation of our study is the absence of serum cytokine measurements, which would 
have provided more direct evidence for inflammation and assisted interpretation of the variability 
in the acute-phase protein response. Previous study results indicate that PEM can trigger an 
elevation in circulating IL-6 (Ling et al., 2004), which could drive increased A2M production.  
Our data suggest that PEM-induced systemic inflammation does not extend to the 
hippocampus. No effects on the hippocampal NFB signaling pathway were detected by 
measuring the expression of 84 genes encoding members of the Rel, NFB, and IB families, 
receptors activating NFB signaling, and NFB-responsive genes. These results were 
unexpected, given our previous findings of augmented NFB activation in the hippocampus of 
protein-energy malnourished gerbils (Ji et al., 2008). The previous study relied on an 
electrophoretic mobility shift assay to assess the transcriptional activity of NFB by measuring 
the extent of binding of nuclear extracts to NFB consensus sequences (Ji et al., 2008). To 
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address whether this would alter transcription regulation, real time PCR arrays were used in the 
current study to measure NFB-responsive gene expression. There are several possible 
explanations for the apparent discrepancy in the findings. Although there may be increased 
localization of NFB to the nucleus with augmented transcription of target genes, this may be 
undetectable with PCR if mRNA stability is influenced by PEM, resulting in either rapid 
translation or degradation of the sequence. Another possible explanation is poor sensitivity of the 
microarray technique. Alternatively, hippocampal NFB activation may have been unaltered by 
the malnutrition paradigm used in the current study design. The 2% protein AIN-93G-based diet 
fed in the current study to rapidly growing adolescent rats generates a different degree of PEM 
than the previously used 2% protein AIN-93M-based diet fed for 28d to the slowly growing adult 
gerbil (Ji et al., 2008). Other inconsistencies in the literature might also be related to differences 
in the extent of malnutrition and tissue or cell type. Increased NFB activation has been reported 
in peritoneal macrophages from protein-energy malnourished mice, whereas this effect 
disappeared when the cells were stimulated ex vivo with LPS (Fock et al., 2010). In contrast, 
NFB activation was unaltered in unstimulated peritoneal macrophages from severely protein-
deficient mice (when the reduced energy intake was controlled for), while protein deficient cells 
showed decreased NFB activation when treated with LPS. Li et al. (2002) reported increased 
liver NFB activation in protein-energy malnourished mice stimulated in vivo with LPS. Further 
research is necessary to confirm whether PEM is an independent stimulus of NFB-mediated 
signaling in brain and whether co-existing malnutrition would exacerbate brain inflammation 
triggered by stroke. Given that the hypothalamus is likely responsible for the disturbances in core 
temperature discussed below, future investigations should examine the effects of PEM on 
hypothalamic NFB-mediated signaling and inflammation.  
A striking pattern of change in core temperature emerged as malnutrition evolved from 
an acute to chronic state. This observation was possible by the use of implantable temperature 
probes that monitor diurnal cycles in unanaesthetized animals without triggering a stress 
response. Exposure to a low protein diet caused an immediate small and transient increase in 
daily mean temperature and a larger sustained increase in temperature amplitude. Throughout the 
28d test period, chronically malnourished rats experienced warmer temperatures during the 
active period of the day and cooler temperatures during the sleep period, resulting in a persistent 
increase in daily amplitude. Following the initial ~2d increase, mean core temperature gradually 
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descended to below normal values as malnutrition progressed, resulting in a difference of 0.4-
0.5°C during the final week of malnutrition. Given the small magnitude, the temperature changes 
are not likely to alter ischemic brain injury (MacLellan et al., 2009). The absence of a clear 
febrile pattern in the presence of systemic inflammation is perplexing, but we hypothesize that 
the relationship between temperature and inflammation is lost when the inflammatory response is 
less pronounced.   
It is difficult to compare our chronic temperature results against the other two studies that 
have used telemetry probes to accurately measure core temperature changes in response to 
suboptimal diet (Castanon-Cervantes & Cintra, 2002; Duran et al., 2008). The low protein diets 
(6% casein) administered in the previous studies were fed from pregnancy through to 
adolescence or adulthood, and the malnutrition was poorly characterized. Castanon-Cervantes et 
al. (2002) reported short-term higher daily mean cortical temperature and amplitude in 
malnourished rats of comparable age to the rats used in our study. A decrease in mean core 
(Duran et al., 2008) but not cortical (Castanon-Cervantes & Cintra, 2002) temperature was 
observed when these rats were studied until ~550d of age, suggesting a dissociation of 
temperature regulation. If this is the case, the common practice of using core probes to estimate 
brain temperature changes after brain ischemia in rodent models of stroke (DeBow & Colbourne, 
2003) may be inaccurate for studies of post-ischemic malnutrition.   
Simultaneous measurements of body temperature and activity in the second study refuted 
the hypothesis that the initial transient rise in body temperature on exposure to low protein diet 
might be explained by hyperactivity associated with increased foraging behavior. The results 
clearly demonstrate that daily activity mean and amplitude were unaffected during the 7d on low 
protein diet, a finding in agreement with that from a study of more mildly malnourished 
adolescent mice (Dietrich et al., 2004). The transient rise in core temperature on exposure to the 
low protein diet may, in fact, be caused by the increased postabsorptive metabolic rate 
(thermogenesis) occurring with low dietary protein-to-energy ratio (Rothwell & Stock, 1987). 
Our data indirectly support this since rats initially experienced higher than normal temperatures 
during the active period of the day when food consumption is greatest, but experienced only 
slight decreases in temperature during the inactive phase. Daily fluctuation in temperature 
adjusted over time, as shown by cooler temperatures during the sleep cycle, resulting in normal 
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mean temperature. As malnutrition progressed further, core temperature gradually fell below 
normal.  
 Given that our study was designed to measure the immediate response to presentation of a 
low protein diet and measurements were obtained for 7d only, we cannot rule out the possibility 
that chronic PEM causes internal desynchrony between activity and temperature rhythms. In fact, 
exposure to low dietary protein did alter the timing of the activity circadian rhythm. Acrophase 
for the activity cycle occurred approximately 1hr earlier during the 7d interval on low protein 
diet than during the 7d on control diet. However, the phase relationship between activity and 
temperature was not significantly altered. A surprising finding was the stronger rhythm 
robustness for both activity and temperature when rats were on low protein diet. Since 
neurotransmitter and circadian systems interact (Ciarleglio et al., 2011; Meijer et al., 2010), the 
effects of the low protein diet on the circadian rhythms might be mediated by altered amino acid 
availability for neurotransmitter production. Although malnutrition-induced alterations in 
neurotransmitter systems, such as -aminobutyric acid and serotonin, have been most studied in 
the developing brain (Wiggins et al., 1984), there is also evidence for effects of a low protein diet 
provided during adolescence and adulthood (Andrade & Paula-Barbosa, 1996; Yokogoshi et al., 
1987).  
 In summary, exposure to low dietary protein with subsequent development of PEM has 
rapid and sustained effects on variables known to be key determinants of ischemic brain injury. 
This was demonstrated by a systemic inflammatory response and disruptions in the circadian 
rhythm of core temperature. Whereas an acute-phase response could contribute to poorer 
outcome when PEM co-exists with stroke, the persistent effects of protein-energy depletion on 
body temperature are small in magnitude and thus unlikely to directly influence ischemic brain 
injury. The current results suggest that the PEM-induced inflammation does not extend to the 
hippocampus, although other key brain regions such as hypothalamus should be studied. Finally, 
hyperactivity does not explain the immediate increase in core body temperature that occurs on 
exposure to a low protein diet.  
4.6 Experimental Progression of Thesis 
A major finding from this study was that PEM induces an atypical acute-phase response, 
which could be a mechanism by which PEM adversely affects outcome after brain ischemia 
(Dziedzic, 2008; Whiteley et al., 2009). However, the effects of PEM on the acute-phase 
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response may differ following brain ischemia. Previous evidence indicates that PEM can hinder 
the ability to mount a complete acute-phase response to injury or infection (Jennings & Elia, 
1996; Reid et al., 2002). A similar pattern may emerge when the stimulus is global brain 
ischemia or the associated surgical manipulations. Therefore, this relationship was assessed in 
the third study by determining whether the effects of PEM on the acute-phase response persist in 
the presence of global brain ischemia. In order to address this question, serum levels of acute-
phase proteins were measured in rats exposed to global brain ischemia and fed a low protein diet. 
In addition to the three acute-phase proteins reported in Chapter 4, haptoglobin was also assessed 
since it has been shown to be a sensitive and useful marker of acute inflammation in the rat 
(Giffen et al., 2003).  
Although no pronounced changes to the NFB cascade were detected in the hippocampus 
of protein-energy malnourished rats, the effects of PEM on neuroinflammation could be much 
greater in response to brain ischemia. Therefore, this relationship was assessed in the final study. 
Microglia and macroglia are the major inflammatory cells following global brain ischemia and 
remain activated in the hippocampus for extended periods of time (≥ 270d) (Langdon et al., 
2008). Therefore, the glial response was assessed in the third study to determine whether PEM 
that develops after global brain ischemia augments the chronic neuroinflammatory response and 
affects the neuroplastic response in the hippocampus. 
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CHAPTER 5: 
PROTEIN-ENERGY MALNUTRITION DEVELOPING AFTER GLOBAL BRAIN 
ISCHEMIA INDUCES AN ATYPICAL ACUTE-PHASE RESPONSE AND HINDERS 
NEUROPLASTICITY  
 
5.1 Abstract  
Protein-energy malnutrition (PEM), characterized by inadequate protein and energy 
status, is a common stroke co-morbidity that is associated with poor outcome. PEM is present in 
12-19% of stroke patients upon admission, with prevalence rates rising to 20-35% at one week 
and reaching 35-49% by the time of admission to a rehabilitation unit. PEM induces a systemic 
acute-phase response, and there is indirect evidence that co-existing PEM exacerbates 
neuroinflammation after global brain ischemia, both of which may adversely affect ischemic 
outcome. Since a heightened inflammatory response can hinder neuroplasticity, this effect of 
PEM may impede brain-remodeling processes following global brain ischemia. Therefore, the 
aim of this study was to investigate the degree to which post-ischemic PEM (developing after 
brain ischemia) alters neuro- and systemic inflammation and determine what impact this may 
have on neuroplasticity. Male, Sprague-Dawley rats (~9 wk old) were subjected to global 
forebrain ischemia via the 2-vessel occlusion model and either placed on a control (18% protein) 
or low protein (PEM, 2% protein) diet at 3d following surgery. A third group was exposed to 
control diet and sham surgery. To assess the immediate and longer-term effects of a low protein 
diet, samples were collected at either 5 or 21d post-surgery. No systemic acute-phase reaction 
attributable to global ischemia was detected, as reflected by serum concentrations of positive 
acute-phase proteins (alpha-2-macroglobulin [A2M], alpha-1-acid glycoprotein [AGP], and 
haptoglobin) and a negative acute-phase protein (albumin) (p  > 0.54). Acute exposure to a low 
protein diet after global ischemia decreased the serum concentrations of albumin (p<0.001) and 
haptoglobin (p<0.001) at 5d, with both proteins remaining significantly decreased at 21d. 
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Whereas serum concentrations of AGP were not influenced by PEM (p>0.26), A2M levels were 
significantly higher in malnourished rats at 21d (p=0.001). GFAP and Iba-1 immuno-labeling 
illustrated a strong hippocampal glial response to global brain ischemia, which was unaltered by 
PEM. Conversely, post-ischemic PEM decreased GAP-43 and synaptophysin within the CA3 
mossy fiber terminals at 21d following global brain ischemia. Thus, these findings demonstrate 
that exposure to PEM following global brain ischemia induces a persistent but aberrant acute-
phase response. Post-ischemic PEM hinders some key neuroplasticity mechanisms triggered by 
brain ischemia, but these changes do not appear to be related to an exacerbation of reactive 
gliosis.  
5.2 Introduction  
PEM, a common type of malnutrition characterized by inadequate protein and energy 
status, has been associated with poorer survival and functional outcome following stroke (Davis 
et al., 2004; Martineau et al., 2005; Yoo et al., 2008). Approximately 1 out of 6 stroke patients 
are protein-energy malnourished at the time of admission to the hospital (Davis et al., 2004; 
Martineau et al., 2005; Yoo et al., 2008). Nutritional status often worsens during post-stroke 
hospital stay, with prevalence rates reaching as high as 20-35% at one week (Brynningsen et al., 
2007; Yoo et al., 2008) and 35-49% by the time of admission to a rehabilitation unit (Finestone 
et al., 1995; Poels et al., 2006). No mechanistic studies have assessed the effects of PEM when it 
develops after brain ischemia (post-ischemic PEM) on post-stroke brain repair. Thus, with the 
use of a rat model of global brain ischemia, a major goal was to investigate whether post-
ischemic PEM influences the inflammatory response and determine the extent to which this 
affects neuroplasticity.  
The neuroinflammatory response to brain ischemia is thought to both contribute to 
neuronal injury and affect neuroplasticity (Kriz & Lalancette-Hébert, 2009). Microglia and 
macroglia, the predominant responders to cerebral ischemic injury, are triggered within hours 
following global brain ischemia (Morioka et al., 1991; Webster et al., 2009). The glial response 
is persistent and can remain heightened within the hippocampal CA1 subregion for up to 270 
days after global brain ischemia in the rat (Langdon et al., 2008). Previous findings suggest that 
co-existing PEM (PEM that is present at the time of insult) can exacerbate the glial response to 
global brain ischemia in the gerbil (Bobyn et al., 2005) and increase activation of the 
predominant pro-inflammatory transcription factor, NFB (Ji et al., 2008). When PEM does not 
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develop until after brain ischemia, the effects may be quite different, since there is less potential 
to affect the acute inflammatory response to brain ischemia. Nevertheless, since 
neuroinflammation following brain ischemia can have a marked chronic component (Langdon et 
al., 2008), it was hypothesized that post-ischemic PEM would exert adverse effects on cellular 
function by exacerbating and/or prolonging the inflammatory response. Interestingly, the effects 
of PEM on NFB activation, independent of global ischemia, have also been investigated, with 
inconsistencies in the findings. Although PEM independently increased NFB activation in the 
hippocampus of malnourished gerbils (Ji et al., 2008), the study described in Chapter 4 detected 
no alteration in NFB transcription regulation in the hippocampus of the protein-energy 
malnourished rat.  
Post-ischemic inflammation extending through the brain recovery phase can play a major 
role in regulating the innate repair processes that are engaged in the injured brain, known as 
neuroplasticity (Kriz & Lalancette-Hébert, 2009). Activated glial cells express and secrete 
various biomolecules that are capable of altering dendritic growth, synapse number and synaptic 
structure. Secretion of growth factors by microglia can promote neuroplasticity (Banati, 2002), 
while over-expression of pro-inflammatory cytokines can impair recovery processes (Bellinger et 
al., 1995; Katsuki et al., 1990). If the hypothesis that post-ischemic PEM will augment the 
inflammatory response to brain ischemia is correct, this in turn could impede brain remodeling. 
Chronic protein deprivation has been reported to induce neuroplastic deficits within the 
hippocampus. Protein deprivation during adulthood in rats can reduce the number of CA1 and 
CA3 pyramidal neurons, synapses within the CA3 mossy fiber region and CA3 dendritic 
branches (Andrade et al., 1991; Andrade et al., 1995; Andrade et al., 1996; Lukoyanov & 
Andrade, 2000; Paula-Barbosa et al., 1989). One previous study demonstrated increased 
hippocampal expression of the plasticity-associated proteins, GAP-43 and trkB, when PEM co-
existed with the onset of global brain ischemia (Prosser-Loose et al., 2010). While these findings 
do not support the hypothesis that PEM will hinder plasticity mechanisms, it is proposed that the 
effects will be different when PEM develops during the acute phase after brain ischemia, when 
brain remodeling is initiated. Also, whereas the previous study addressed only short post-
ischemic sampling times (1, 3 and 7d), the current study had the objective of assessing both early 
and later stages of brain remodeling. GAP-43 and synaptophysin were chosen as markers of 
brain remodeling, given their roles as plasticity-associated proteins that are up-regulated in the 
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hippocampus following global brain ischemia (Ishimaru et al., 2001; Prosser-Loose et al., 2010; 
Schmidt-Kastner et al., 1997).  
In addition to the detrimental role that neuroinflammation can have on neuronal function, 
the systemic response to brain ischemia may also influence outcome. The acute-phase response, 
which is systemic in nature, includes a subset of proteins whose plasma concentrations change 
by a factor of several fold in response to acute and chronic inflammation. Exposure to 
inflammatory conditions can result in elevated concentrations of various positive acute-phase 
proteins (e.g., alpha-2-macroglobulin [A2M], haptoglobin, alpha-1-acid glycoprotein [AGP], c-
reactive protein), while at the same time causing depleted levels of negative acute-phase proteins 
(e.g., albumin, transferrin). Cerebral ischemia can trigger an acute-phase reaction, although 
considerable variation in this systemic response exists between stroke patients (Dziedzic, 2008; 
Idicula et al., 2009; Ryu et al., 2009). Although clinical findings suggest that the extent of the 
acute-phase reaction predicts outcome in stroke patients (Dziedzic, 2008; Idicula et al., 2009; 
Ryu et al., 2009), it is unclear whether this response plays a detrimental role in the ischemic 
cascade or merely reflects insult severity. In contrast to stroke, the extent to which global brain 
ischemia stimulates an acute-phase response has not been characterized.  
The influence of declining nutritional status after brain ischemia on systemic 
inflammation is likely to be complex. While evidence from both clinical and animal studies 
suggests that PEM can blunt the ability to mount a controlled inflammatory response to injury or 
infection (Jennings et al., 1992; Jennings & Elia, 1996; Reid et al., 2002), evidence is also 
emerging that PEM can serve as an independent stimulus of systemic inflammation. Animal 
models have demonstrated increased serum levels of TNF-, IL-1, IL-6, AGP and A2M in rats 
fed a low protein diet (Ling et al., 2004; Lyoumi et al., 1998). Recent findings reported in 
Chapter 4 demonstrate that acute and chronic malnutrition can stimulate an acute-phase 
response; however, the effect of PEM on the production of individual acute-phase proteins is 
variable (Smith et al., 2013). Thus, the final objective was to investigate whether the effects of 
PEM on the acute-phase response would persist after global ischemia. This was examined using 
the rat 2-VO global brain ischemia model, in which any acute-phase reaction triggered by brain 
ischemia or the associated surgical manipulations has yet to be characterized.  
Given the high prevalence of PEM developing after stroke, the aim of this study was to 
address whether post-ischemic PEM alters brain and systemic inflammation and determine what 
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impact this may have on neuroplasticity. Global brain ischemia was modeled by 2-VO in the rat, 
with a low protein diet being introduced at 3 days post-surgery. Time-points of 5 and 21 days 
were used to investigate both the immediate response to a low protein diet, as well as the chronic 
effects of PEM. Serum levels of albumin, A2M, AGP, and haptoglobin were measured to assess 
the acute-phase response. Iba-1 and GFAP were measured to assess the glial response, while 
GAP-43 and synaptophysin were examined as markers of neuroplasticity.  
5.3 Materials and Methods 
5.3.1 Animals  
 Sixty-four male Sprague-Dawley rats (52-55d old) (Charles River Canada, QC, Canada) 
were acclimatized on rat chow for 2d before placement on a protein adequate control diet (CON, 
18% protein) (Smith et al., 2013). Rats were housed in groups of 2-4 and maintained on a 12hr 
light/dark cycle in a temperature controlled room with free access to food and water. This work 
was approved by the University of Saskatchewan’s Animal Research Ethics Board, and adhered 
to the Canadian Council on Animal Care guidelines for humane animal use. 
5.3.2 Global Brain Ischemia Surgery 
 Following a 4-6d acclimation period on CON diet, rats were subjected to either sham 
surgery (Sham) or transient forebrain ischemia via the 2-VO model (ISC), as previously 
described (Smith et al., 2011) and modified from Smith et al. (1984). Surgical procedures were 
performed aseptically under isoflurane anaesthesia (1.75-4% in 70% N2O and 30% O2). Before 
surgery, rats were fasted for ~16 hr to achieve consistent blood glucose levels. Following 
anaesthesia induction, animals were placed on a heated water blanket and a tympanic probe was 
inserted to estimate brain temperature (IT-18 flexible probe; Physitemp Instruments Inc. NJ, 
USA). Temperature was maintained close to 37.5°C with the use of an overhead infrared lamp 
(250W) controlled by an automated feedback temperature controller (CN9500; Omega 
Engineering Inc., CT, USA). Tail artery cannulation allowed for continuous measurement of 
mean arterial blood pressure (PressureMAT PDKTP4-PCS; PendoTech, NJ, USA) and collection 
of arterial blood samples (100 L) for measurement of blood gases, hematocrit, and glucose 
concentration. Both common carotid arteries were isolated and the right jugular vein was 
cannulated. Blood was withdrawn via the jugular vein into a warmed heparinized syringe until 
blood pressure reached ~35 mmHg. At this time, micro-aneurysm clips (S&T Vascular Clamps 
HD-S; Fine Science Tools, BC, Canada) were applied to both carotid arteries for 10 min. Blood 
 104 
pressure was maintained at 35-40 mmHg throughout the occlusion period by withdrawing or 
infusing blood as needed. After releasing the clamps, blood was slowly reinfused and incisions 
were sutured. A bupivacaine dose (2mg/kg) was divided equally for injection around the 2 
incision sites. Sham rats were treated identically except that carotid arteries were not occluded 
and hypotension was not induced. Rats were singly housed until post-surgical d3, at which time 
the rats were placed back with their original cage mates.  
5.3.3 Diet Assignment 
 At 3d following surgery, rats were randomly assigned to either a protein-deficient diet 
(PEM, 2% protein) or remained on the CON diet (18% protein) (Dyets, Inc., PA, USA). Diet 
composition is shown in Table 4.1. Rats of this age fed a 2% protein diet voluntarily reduce food 
consumption, thereby causing a deficit in both energy and protein intake (Prosser-Loose et al., 
2011; Smith et al., 2013). Diets were modified from the American Institute of Nutrition-93G diet 
(Reeves et al., 1993) to not contain the antioxidant, tertiary-butylhydroquinone (Smith et al., 
2013). Body weight and food intake were recorded on surgery day (d0), d1, and d2. Following 
diet assignment (d3), food intake was recorded daily and body weight recorded weekly and on 
perfusion day. The six experimental groups generated were: CON-Sham5d (n=9), CON-ISC5d 
(n=13), PEM-ISC5d (n=12), CON-Sham21d (n=8), CON-ISC21d (n=11), and PEM-ISC21d 
(n=11).  
5.3.4 Euthanasia and Histology 
 At 5 or 21d post-surgery, rats were anaesthetized under isoflurane (5% in 100% O2) and 
blood samples were collected via cardiac puncture. Rats were perfused transcardially with 0.9% 
saline followed by 4% paraformaldehyde. Intact heads were submerged into 4% 
paraformaldehyde and stored overnight at 4°C. Brains were removed and post-fixed in 
paraformaldehyde for an additional 24 hr. Following fixation, brains were submerged into a 20% 
sucrose solution and stored at 4°C for 3d to prevent ice crystal formation and tissue cracking. 
Fixed brains were placed in plastic cryomolds and embedded in Optimal Cutting Temperature 
(OCT) compound. Samples were flash frozen using dry ice-cooled isopentane and stored at -
80°C until sectioning. For each rat, the coronal section (14 m) corresponding to -3.8 mm from 
Bregma was stained with cresyl violet, while adjacent sections were used for 
immunofluorescence. Assessment of cell counts and immunofluorescence semi-quantification 
was blinded.  
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 Cresyl violet stained sections were examined under a light microscope (400x) using a 
200m square (10x10) microscope grid. Viable-looking pyramidal neurons, with intact nuclear 
and cellular membranes, were counted bilaterally in the medial, middle, and lateral sectors of the 
CA1 region (-3.8 mm relative to Bregma) (Paxinos & Watson, 1998). CA1 cell counts from the 
right and left hemisphere were summed to generate the total neuron count for each rat.  
5.3.5 Immunofluorescence  
 Identical protocols were performed using Shandon Sequenza Immunostaining Racks 
(Thermo Scientific, CHS, UK) to immuno-label coronal sections for astrocytes (GFAP), 
activated microglia (Iba-1), and neuroplasticity markers (synaptophysin and GAP-43). Sections 
were blocked with normal goat serum (5%; Sigma-Aldrich, ON, Canada) and incubated at 4°C 
overnight in a primary antibody either for astrocytes (Rabbit anti-GFAP, 1:400; Z0334, 
DakoCytomation, ON, Canada), microglia (Rabbit anti-Iba-1, 1:1000; 019-19741, Wako 
Chemicals, VA, USA), synaptophysin (Mouse anti-synaptophysin, 1:200; Millipore, clone SY38, 
Millipore, MA, USA) or GAP-43 (anti-GAP-43, 1:2500; 9-1E12 Ascites, Dr. David Schreyer). 
Following a wash step with PBS, slides were incubated in a secondary fluorescent antibody 
(Goat-anti-mouse AlexaFluor488, 1:200, 115-545-166, Jackson Laboratories, PA, USA; Goat-
anti-rabbit AlexaFluor 594, 1:500, A11012, Molecular Probes, Invitrogen) in the dark for 2 hr. 
Slides were washed with PBS and cover slipped with ProLong Gold Antifade Reagent with 
DAPI (P36931, Molecular Probes, Invitrogen) in order to visualize cell nuclei. Negative control 
sections were treated identically, except that the sections were not incubated in the primary 
antibody.  
Semi-quantification of each marker was completed using one section per hemisphere 
from every rat. The integrated density value (IDV=sum of pixel values in the region of interest) 
(ImageJ, U.S. National Institutes of Health, MD, USA) was measured for each region of interest 
using high magnification photographs captured from a fluorescent microscope. All densitometry 
measurements were adjusted for background staining, as calculated from negative control 
sections. GFAP and Iba-1 were measured within the CA1 hippocampal region by placing a box 
(pixel area = 265816) that included the CA1 pyramidal layer, stratum oriens and stratum 
radiatum. A second box was placed in the CA3 mossy fiber terminals (pixel area = 265816). 
Synaptophysin was predominantly within the CA3 region and therefore semi-quantification was 
only performed in the mossy fiber terminals (pixel area = 78402). GAP-43 was semi-quantified 
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in both the CA1 and CA3 hippocampal subregions. For stratum oriens and stratum radiatum 
analysis within the CA1 region, a box (pixel area = 45360 each) was placed along each layer and 
the values were summed. In the CA3 region, a box was placed in the mossy fiber terminals (pixel 
area = 141778) and another box was placed along the CA3 stratum oriens layer (pixel area = 
141778). For each marker and time-point, individual densitometry measurements were 
normalized by expressing them as a ratio to the mean IDV of the respective CON-Sham 
treatment group. Values from the right and left hemispheres were averaged. The photographs 
shown below were taken under identical conditions at higher magnification.  
5.3.6 Serum Acute-Phase Proteins 
Blood samples collected at the time of euthanasia were allowed to clot for 30 min at room 
temperature and then centrifuged at 1,500 x g for 10 min. Following centrifugation, serum was 
collected and stored at -80°C. Enzyme-linked immunosorbent assay (ELISA) kits were used to 
measure the serum concentrations of A2M, AGP, and haptoglobin (Immunology Consultants 
Laboratory, Inc., OR, USA). The bromocresol green method was utilized to measure serum 
concentration of albumin (Doumas et al., 1971). A volume of 25 L of blank, serum sample, or 
standard solution was added to 5.0 mL bromocresol green reagent (0.15 mmol/L bromocresol 
green, 0.075 mol/L succinate buffer, 30% Brij-35). After 30 min, absorbance was measured 
spectrophotometrically at 628 nm (Biochrom Ultrospec 3100 Pro). Linear regression was used to 
determine the albumin concentration of the sample. 
5.3.7 Statistical Analysis  
Statistical analyses were conducted using SPSS 20.0 for Windows. All data are presented 
as mean ± SEM and the significance set at p<0.05. Body weight and food intake differences 
between sham-operated and ischemic rats were analyzed on post-surgical d0, 1, 2, and 3 using an 
independent-sample Student’s t-test. Following assignment to experimental diet, food intake was 
analyzed for rats fed the low protein diet or CON diet on d4, 5, 6 and 7 using an independent-
sample Student’s t-test. Significant differences in body weight, CA1 neuronal cell counts, and 
serum acute-phase protein concentrations among the three treatment groups were determined for 
each time-point using a 1-factor ANOVA and Tukey’s test where indicated. 
Immunofluorescence data were analyzed using an independent-sample Student’s t-test.  
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5.4 Results 
5.4.1 Physiological Parameters Measured During Surgery 
Table 5.1 is a summary of the physiological parameters obtained during all 2-VO and 
sham surgeries. The three treatment groups are shown separately, in order to illustrate baseline 
data prior to treatment assignment, although all rats were still on CON diet at the time of surgery. 
Mean pre- and post-ischemic values for all physiological parameters were within the target 
range. Tympanic temperature and blood pressure were tightly regulated throughout the 10 min 
occlusion period and recorded at 1 min intervals. The resulting mean values for tympanic 
temperature and blood pressure in the two groups exposed to global ischemia were within the 
desired range; however, several individual rat values fell out of range for 1-2 consecutive 
readings. Five additional rats were excluded from the study due to surgical complications (e.g. 
blood pressure readings fell out of range for an extended period of time, complications with tail 
artery cannulation) or poor recovery (e.g. severe weight loss).  
5.4.2 Impact of Surgery on Food Intake and Body Weight  
Mean initial body weight on surgery day was not significantly different between sham 
and ischemic treatment groups, when all rats were on CON diet (p = 0.71; Sham, n=17; ISC, 
n=47). Following surgery, there was a significant difference in body weight on d1, 2 and 3 (p < 
0.001), with rats exposed to the 2-VO surgery weighing less than sham animals. Individual food 
intake was monitored on post-surgical d1, 2, and 3, which was possible due to individual rat 
housing (Sham, n=17; ISC, n=47). Daily food intake was significantly decreased in the ischemic 
treatment group compared to sham-operated rats on d1, 2 and 3 (p < 0.041).  
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Table 5.1. Physiological parameters measured during 2-VO and Sham surgeries  
 
Data are expressed as mean ± SEM (CON-ISC, n=24; PEM-ISC, n=23; CON-Sham, n=17). 
Mean pre- and post-ischemic values for all measured physiological parameters fell within the 
desired range for all surgical groups.  
 
5.4.3 Indices of PEM 
Figure 5.1A shows the pattern of body weight change starting on post-surgical d3, as a 
result of experimental diet assignment for rats in the 21d treatment groups (CON-Sham21d, n=8; 
CON-ISC21d, n=11; PEM-ISC21d, n=11). At 7d post-surgery (4d after diet assignment), there 
was a significant difference in body weight (p < 0.001), with PEM-ISC rats weighing 
significantly less than CON-Sham (p < 0.001) and CON-ISC (p <0.001) rats; this continued 
throughout the 21d post-surgical period (p < 0.001). Malnourished rats gained 6% of their initial 
body weight by d21, compared to a 59% increase observed in both the CON-ISC and CON-
Sham treatment groups. This resulted in a difference in final body weight between the PEM-ISC 
group and both CON-fed groups of 33%.  
Figure 5.1B shows mean (± SEM) daily food intake starting on post-surgical d4 (1d after 
diet assignment) for rats fed the low protein (PEM-ISC21d, n = 5 cages [2-3 rats/cage]) or CON 
diet (CON-Sham21d + CON-ISC21d, n = 8 cages [2-3 rats/cage]). Mean food intake was 
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calculated based on cage data (daily cage food intake/number of rats per cage). Since CON-ISC 
and CON-Sham rats were housed together, differences between these groups could not be 
analyzed. This also potentially biased the analysis due to the unequal sample sizes. A significant 
decrease in food intake in the PEM-ISC group was first reported on post-surgical d7 (4d after 
diet assignment), as compared to the other two CON groups combined (p = 0.026). Total food 
intake over 18 days on experimental diet was depressed by 21% in PEM-ISC rats. Rats in the 5d 
treatment groups presented with similar body weight and food intake patterns (data not shown).  
 
Figure 5.1. The protein-deficient diet introduced on d3 after global brain ischemia depressed 
body weight (A) and food intake (B). Data are shown as mean ± SEM for the 21d treatment 
groups. The dashed lines illustrate the day on which rats were assigned to experimental diet. 
Food intake was collected daily on a cage basis (CON-Sham21d + CON-ISC21d, n = 8 [2-3 
rats/cage]; PEM-ISC21d, n = 5 cages [2-3 rats/cage]). Food intake was calculated as daily cage 
food intake/number of rats per cage. Body weights are shown for d3, d7, d14 and d21 (CON-
Sham21d, n=8; CON-ISC21d, n=11; PEM-ISC21d, n=11). *Indicates a significant effect of 
experimental diet on body weight (PEM-ISC compared to CON-Sham and CON-ISC groups) as 
detected by 1-factor ANOVA and Tukey’s Test (p<0.05). Indicates the first day on which PEM-
ISC rats experienced a significant reduction in food intake, when compared to the other two 
CON groups combined, as detected by an independent-sample Student’s t-test (p<0.05).  
 110 
5.4.4 CA1 Neuronal Death  
Hippocampal CA1 neuronal counts are shown in Table 5.2. At both 5 and 21d post-
ischemia, there was extensive CA1 neuronal death in PEM-ISC and CON-ISC rats compared to 
CON-Sham rats (p < 0.001), but no significant differences between the PEM-ISC and CON-ISC 
rats (p > 0.87). Since the 2-VO model of global brain ischemia yields some variability in 
ischemic cell death, this statistical analysis excluded those rats exposed to 2-VO surgery that 
showed CA1 neuronal damage that was unilateral or minimal (<50% reduction in CA1 neurons 
in either hemisphere). This was done after first verifying that there were no significant 
differences in neuronal loss between the PEM-ISC and CON-ISC groups. That is, it was first 
demonstrated that excluding rats with incomplete forebrain ischemia did not bias the results by 
masking an effect of PEM on neuronal death at either time-point (t-test; p > 0.16). Out of the 47 
rats that underwent the 2-VO surgery, 9 rats showed unilateral CA1 neuronal death and 1 rat had 
no apparent damage (CON-ISC5d, n=2; PEM-ISC5d, n=4; CON-ISC21d, n=3; PEM-ISC, n=1). 
Analyses of the acute-phase response and immunofluorescence data were conducted exclusively 
on rats presenting with extensive bilateral hippocampal damage at 5d (CON-Sham, n=8; CON-
ISC, n=11; PEM-ISC, n=8) and 21d (CON-Sham, n=8; CON-ISC, n=7; PEM-ISC, n=10).  
 
Table 5.2: PEM initiated at 3d after global brain ischemia does not exacerbate hippocampal CA1 
neuronal cell death 
 
 CON-Sham CON-ISC PEM-ISC 
5d  258 ± 10 (n=8) 
a
 46 ± 7 (n=11) 
b
 41 ± 7 (n=8)
 b
 
21d  241 ± 10 (n=8) 
a
 27 ± 7 (n=7)
 b
 22 ± 4 (n=10)
 b
 
 
Data are presented as mean ± SEM. Only those rats demonstrating bilateral hippocampal injury 
were included in analysis. Groups within a row with different superscripts are significantly 
different by 1-factor ANOVA and Tukey's Test (p<0.001). 
 
5.4.5 Glial Response  
 Iba-1 was examined by immunofluorescence at 5 and 21d following global brain 
ischemia within the CA1 and CA3 subregions of the hippocampus (Figure 5.2A-B). At 5d 
following surgery, Iba-1 signal was increased by ~3.4 fold in the CON-ISC group (versus CON-
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Sham) within the CA1 hippocampal region, with no significant difference observed between the 
two ischemic experimental groups (p = 0.85). By d21, the effect of ischemia on Iba-1 signal 
within the CA1 region was more pronounced (~6.4 fold difference between CON-ISC and CON-
Sham), but dietary treatment had no effect (PEM-ISC versus CON-ISC; p = 0.95). Iba-1 was less 
increased by global ischemia in the CA3 subregion (1.8 fold difference between CON-ISC and 
CON-Sham at d21), with no significant differences between the two ischemic groups at either 
time-point (p > 0.49).  
 Figure 5.2C-D shows the results from GFAP immunofluorescence at 5 and 21d post-
surgery within the CA1 and CA3 subregions of the hippocampus. At post-surgical d5, GFAP 
immuno-staining was increased within the CA1 region by 1.8 fold in the CON-ISC group (versus 
CON-Sham), with no differences between the two ischemic experimental groups (p = 0.98). A 
similar response was present at the later time-point, with a fold increase of 1.7 in the CON-ISC 
group (versus CON-Sham), but dietary treatment had no effect (PEM-ISC versus CON-ISC; p = 
0.91). Within the CA3 subregion, the effects of ischemia on GFAP signal was marginal (1.2 fold 
difference between CON-ISC and CON-Sham at d21), and exposure to a low protein diet after 
brain ischemia did not alter the GFAP response at either time-point as compared to the CON-ISC 
group (p > 0.59).   
Figure A.1 shows the raw un-normalized data for Iba-1 and GFAP within the CA1 
hippocampal subregion, which corresponds to the normalized data (normalized to respective 
mean of CON-Sham) presented in Figure 5.2. The data are presented as the IDV (mean ± SEM) 
for CON-Sham, CON-ISC and PEM-ISC treatment groups at 5 and 21d.  
Representative photographs are presented in Figure 5.3 showing the distribution of Iba-1 
and GFAP within the CA1 hippocampal region for each experimental treatment group at 5 and 
21d.   
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Figure 5.2. PEM introduced at 3d post-surgery did not alter the hippocampal glial response that 
is elicited by global brain ischemia. The glial response was evaluated in the hippocampal CA1 
and CA3 subregions by immuno-labeling for Iba-1 at 5d (A) or 21d (B) and GFAP at 5d (C) or 
21d (D). Results are expressed as change in fluorescence relative to the respective mean of the 
CON-Sham treatment group. Results are shown as mean ± SEM integrated density value (IDV) 
for each hippocampal region examined.  
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Figure 5.3. PEM introduced at 3d following global brain ischemia did not significantly alter Iba-
1 (A) or GFAP (B) within the CA1 hippocampal region. Representative photographs of the CA1 
hippocampal region for each experimental treatment group at 5 and 21d show DAPI (blue; 
staining of cell nuclei) and either Iba-1 (red; activated microglia marker) or GFAP (red; 
astrocytic marker). Scale bar = 100 m.  
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5.4.6 Neuroplasticity  
GAP-43 was examined by immunofluorescence at 5 and 21d following global brain 
ischemia within the CA1 and CA3 subregions of the hippocampus (Figure 5.4.A-B). GAP-43 
signal within the CA1 hippocampal subfield was not different between the two ischemic groups 
at either time-point (p > 0.39). GAP-43 immuno-staining was predominantly within the CA3 
stratum oriens, but there was no difference between CON-ISC and PEM-ISC rats at 5d (p = 0.73) 
and 21d (p = 0.20). Within the CA3 mossy fiber terminals, GAP-43 did not differ between the 
two ischemic groups at 5d (p = 0.52). However, GAP-43 signal within the CA3 mossy fiber 
region at d21 was significantly decreased in the PEM-ISC rats when compared to CON-ISC 
animals (p = 0.017). 
Results from semi-quantification of synaptophysin immunofluorescence are shown in 
Figure 5.4C-D. At 5d, there were no significant differences in synaptophysin immuno-staining 
within the CA3 mossy fiber terminals between the two ischemic experimental groups (p = 0.47). 
However, by d21, synaptophysin signal within the CA3 mossy fiber terminals was significantly 
depressed in PEM-ISC rats as compared to the CON-ISC group (p = 0.042).  
Figure A.2 shows the raw un-normalized data for GAP-43 and synaptophysin within the 
CA3 mossy fiber region, which corresponds to the normalized data (normalized to respective 
mean of CON-Sham) presented in Figure 5.4. The data are presented as the IDV (mean ± SEM) 
for CON-Sham, CON-ISC and PEM-ISC treatment groups at 5 and 21d. 
Representative photographs are presented in Figure 5.5 showing the distribution of GAP-
43 and synaptophysin within the CA3 hippocampal region for each experimental treatment group 
at post-surgical d5 and 21.    
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Figure 5.4. PEM introduced at 3d post-surgery decreased GAP-43 and synaptophysin within the 
CA3 mossy fibers at d21 following global brain ischemia. GAP-43 was evaluated in both the 
CA1 and CA3 hippocampal subregions at 5d (A) and 21d (B). Synaptophysin was evaluated in 
the CA3 mossy fibers at 5d (C) and 21d (D). Results are expressed as change in fluorescence 
relative to the respective mean of the CON-Sham treatment group. Results are shown as mean ± 
SEM integrated density value (IDV) for each hippocampal region examined.  
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Figure 5.5. PEM developing after global brain ischemia significantly decreased GAP-43 (A) and 
synaptophysin (B) within the CA3 mossy fiber bundles at 21d. Representative photographs of the 
CA3 hippocampal region for each experimental treatment group at 5 and 21d show DAPI (blue; 
staining of cell nuclei) and either GAP-43 (green) or synaptophysin (green). Semi-quantification 
of immuno-staining was performed for the regions indicated (SO, stratum oriens; MF, mossy 
fibers). Scale bar = 100 m.                  
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5.4.7 Acute-Phase Response 
 Figure 5.6 shows the serum concentrations of the acute-phase proteins at 5 and 21d post-
surgery. Analysis of CON-ISC and CON-Sham rats for each time-point showed no significant 
differences between these two treatment groups for any protein, suggesting that this model of 
global brain ischemia does not induce an acute-phase response (p > 0.40). Two days of exposure 
to a low protein diet after global ischemia had no significant effect on serum A2M concentration 
compared to the CON-ISC group (p = 0.20), but levels were significantly increased at 21d in 
PEM-ISC rats (p < 0.004). The short-term exposure to the protein deficient diet following global 
brain ischemia caused significant decreases in serum concentrations of haptoglobin (p < 0.01) 
and albumin (p < 0.001) relative to CON-ISC levels. At d21, concentrations of both of these 
proteins remained low in the PEM-ISC group, but albumin concentration was significantly 
different between CON-ISC and PEM-ISC (p = 0.001), whereas haptoglobin concentration was 
not (p = 0.35). Serum AGP concentrations in the PEM-ISC group were not significantly altered 
relative to CON-ISC levels, at either time-point (p > 0.53).  
The raw data for the four acute-phase proteins are presented as scatter plots in Figure A.3 
showing the serum concentrations for individual animals. Data from individual rats are plotted to 
highlight the inter-animal variability within each treatment group. Inter-animal variability for 
serum albumin is much lower relative to the three positive acute-phase proteins measured. 
Although the results were not statistically analyzed by time, an apparent increase in A2M and 
haptoglobin at d5 in the CON-Sham and CON-ISC treatment groups, which was diminished by 
d21, suggests a surgical response.   
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Figure 5.6. PEM introduced at 3d following global brain ischemia causes an atypical acute-
phase response. Data are shown as mean ± SEM. Alpha-2-macroglobulin (A2M) (A), alpha-1-
acid glycoprotein (AGP) (B), and haptoglobin (C) are positive acute-phase proteins, while 
albumin (D) is a negative acute-phase protein. Experimental groups with different superscripts at 
the same time-point are significantly different, as detected by 1-factor ANOVA and Tukey’s test 
(p<0.05).  
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5.5 Discussion  
The major findings from this study were the effects of post-ischemic PEM on both the 
neuroplasticity and acute-phase responses following global brain ischemia. To assess the effects 
of post-ischemic PEM, a low protein diet was introduced at 3 days after surgery. Unlike the 
study described in Chapter 4 showing that healthy rats voluntarily reduce their food intake by 
week 2 on a diet containing 2% protein (Smith et al., 2013), the current study demonstrated that 
this response occurs more quickly when diet is introduced within days of brain ischemia. A 
significant decrease in food intake and body weight was evident by post-surgical day 7 (after 4 
days on low protein diet). Total food intake and body weight over the 18 day period on low 
protein diet were depressed by 21% and 33% respectively. The early effects of the suboptimal 
diet suggest that the malnourished rats were under additional stress during the acute period 
following brain ischemia. This theory is supported by the data demonstrating that exposure to the 
low protein diet for 2 days was sufficient time to significantly alter the serum concentrations of 
the acute-phase proteins, albumin and haptoglobin. 
 Stroke triggers an acute-phase reaction in a subset of patients, with considerable variation 
in the response existing between individuals (Dziedzic, 2008; Idicula et al., 2009; Ryu et al., 
2009; Smith et al., 2006). The rat model of global brain ischemia employed in the current study, 
however, does not appear to trigger an acute-phase response, since there were no differences 
between CON-ISC and CON-Sham rats for any of the serum acute-phase reactants measured. 
However, it is inferred that the surgical procedures required to induce brain ischemia do trigger 
an acute-phase response, given the considerably higher A2M and haptoglobin concentrations in 
the CON-Sham and CON-ISC groups at 5 days after surgery compared to the levels measured on 
post-surgical day 21. To definitively confirm that a surgical effect exists, serum levels of these 
acute-phase proteins would have to be compared with those of un-operated rats. This finding also 
raises an important limitation in using the currently available rat models of stroke to study an 
acute-phase response, since all major pre-clinical stroke models require a surgical approach.  
A major goal of this study was to address whether PEM would induce an acute-phase 
response when the experimental diet was introduced following global brain ischemia. Findings 
from this study demonstrate that the introduction of a low protein diet following global brain 
ischemia does cause both immediate and persistent changes to the circulating concentrations of 
certain acute-phase proteins. Serum albumin levels were appreciably lower in the PEM-ISC 
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group at 5 days following global ischemia. As malnutrition progressed, serum albumin levels 
remained decreased in PEM-ISC rats while serum concentrations of the positive acute-phase 
protein, A2M, were increased. However, not all acute-phase proteins responded similarly to 
PEM. Whereas AGP serum levels were not influenced by PEM, the positive acute-phase protein, 
haptoglobin, was immediately decreased by exposure to low dietary protein. This pattern was 
sustained up to day 21, with haptoglobin barely detected in PEM-ISC rats at this time. Given that 
haptoglobin is a positive acute-phase protein, these results suggest that post-ischemic PEM 
induces an aberrant acute-phase reaction. The latter results suggest that acute dietary protein 
deprivation and the evolution of PEM can diminish an acute-phase response to surgery, which is 
in agreement with reports that PEM can dampen the ability to mount a controlled inflammatory 
response to stimuli such as injury or infection (Jennings et al., 1992; Jennings & Elia, 1996; Reid 
et al., 2002). However, the addition of a PEM-Sham treatment group would have more clearly 
defined the interactions among global ischemia, surgery, and PEM on the acute-phase response.  
These findings are comparable to those observed for PEM independent of exposure to 
global ischemia (reported in Chapter 4) (Smith et al., 2013). Both studies reported decreased 
serum albumin concentrations and increased serum A2M levels in malnourished rats. Although 
the decrease in AGP previously reported with 28 days of feeding was not observed in the current 
study, it is speculated that a similar finding would have been obtained if the same time-point 
were used. Results from both studies suggest that when mounting an acute-phase reaction in 
response to PEM, A2M production has precedence over both AGP and haptoglobin synthesis. 
This notion is strengthened by the findings from Lyoumi et al. (1998), which reported an 
elevation in A2M expression within the liver of malnourished rats, while AGP production was 
unaltered. 
A limitation of the study is the absence of data on regulatory inflammatory cytokines. 
The aberrant acute-phase response observed in protein-energy malnourished rats in two 
independent studies (Chapter 4 and Chapter 5) is most likely associated with alterations in the 
circulating concentrations of regulatory inflammatory cytokines. Both AGP and haptoglobin are 
type 1 acute-phase proteins, which are mainly regulated by IL-1 and TNF-, while A2M is a 
type 2 acute-phase protein predominantly stimulated by IL-6 (Petersen et al., 2004). Together, 
the data reported here and in Chapter 4 suggest that production of type 2 acute-phase proteins has 
precedence over the synthesis of type 1 acute-phase proteins in malnourished rats. It is 
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speculated that exposure to a low protein diet triggers an elevation in IL-6, which in turn 
stimulates A2M synthesis. This notion is strengthened by the findings of Ling et al. (2004), who 
reported augmented IL-6 serum concentrations in protein-energy malnourished rats. Given that 
amino acid availability is limited in protein-energy malnourished rats, it is hypothesized that this 
reduction in specific type 1 acute-phase proteins is an attempt to conserve amino acids for 
producing proteins such as A2M more efficiently.  
Although post-ischemic PEM caused a systemic acute-phase reaction, the strong 
hippocampal glial response elicited by global brain ischemia appears to be unaffected by a low 
protein diet and the evolution of PEM over 18 days. Given that glial cells are the sole source of 
inflammatory cells following global brain ischemia (Kato, 2001), these findings lead to the 
conclusion that PEM arising after global brain ischemia does not exacerbate brain inflammation. 
Nevertheless, findings from this study assist in the characterization of the glial response elicited 
after global brain ischemia in the 2-VO model. Our results suggest that microglia and astrocytes 
remain within the CA1 subregion for up to 21 days after global brain ischemia. Given that Iba-1 
is a protein expressed by activated microglia (Suter et al., 2007), it is speculated that this 
population of inflammatory cells is comprised of phagocytic microglia participating in a strong 
immune response. Similarly, Silasi et al. (2011) demonstrated that microglial proliferation 
continues for at least 3 weeks within the CA1 hippocampal region following global brain 
ischemia. Furthermore, the hippocampal microglial response has been detected for up to 270 
days following global brain ischemia (Langdon et al., 2008), although it is unclear whether these 
inflammatory cells are in an activated state.  
PEM developing acutely after brain ischemia does appear to hinder neuroplasticity 
mechanisms typically triggered by global brain ischemia, since the increased signal for GAP-43 
and synaptophysin within the mossy fibers of CON-ISC rats after 21 days was not present in 
PEM-ISC rats. Notably, these alterations were not triggered by a greater extent of hippocampal 
CA1 or CA3 (data not shown) neuronal death in PEM-ISC rats, and the trigger does not appear 
to be increased brain inflammation. These findings suggest that post-ischemic PEM causes a loss 
of synapses in CA3 mossy fibers following global brain ischemia. A similar response has been 
reported in adult rats subjected to dietary protein deprivation. Chronic exposure to a low protein 
diet initiated during adulthood has been shown to cause a 30% reduction in the number of 
synapses within the CA3 mossy fiber terminals (Andrade et al., 1991; Andrade et al., 1995; 
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Lukoyanov & Andrade, 2000). Furthermore, protein deprivation in adult rats can result in 
decreased numbers of dendritic branches within the CA3 and dentate gyrus hippocampal 
subfields (Andrade et al., 1996), along with considerable loss of granule cells and pyramidal 
CA1 and CA3 neurons (Lukoyanov & Andrade, 2000; Paula-Barbosa et al., 1989). These 
hippocampal deficits were present in adult rats after prolonged periods on a low protein diet 
lasting between 6-18 months. Results from the current study, however, suggest that exposure to a 
low protein diet for a few weeks is sufficient time to cause alterations in the neuroplasticity 
response to brain ischemia. Together, these reports suggest that malnutrition could impede 
synaptic remodeling that occurs after brain ischemia. Ultimately, since plasticity promotes 
recovery from stroke damage, disruptions to these mechanisms could result in impaired outcome.  
In summary, exposure to a low protein diet within days of global brain ischemia triggers 
an aberrant acute-phase response. Dietary protein depletion after global ischemia caused serum 
levels of albumin and haptoglobin to decrease, while the circulating concentration of A2M was 
increased. In addition, post-ischemic PEM may be detrimental to recovery by diminishing the 
neuroplasticity mechanisms triggered by brain ischemia. However, these changes do not appear 
to be triggered by an increase in brain inflammation.  
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CHAPTER 6: 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
 
6.1 Introduction  
 Collectively, the three studies described in this thesis provide strong evidence that PEM 
alters key determinants of ischemic brain injury and brain recovery. To characterize the effects 
of PEM on global brain ischemia, three states of malnutrition were assessed and described in this 
thesis: PEM co-existing with global brain ischemia (Study 1), effects of PEM independent of 
brain ischemia (Study 2), and PEM developing after global brain ischemia (Study 3). Although 
this thesis is centered around the effects of PEM on the inflammatory response to global brain 
ischemia, mechanisms related to inflammation were also assessed, including effects on core 
temperature and neuroplasticity.  
6.2 Summary of Findings  
The study described in Chapter 3 was the first experiment performed in my laboratory 
exploring the effects of co-existing PEM on outcome from global brain ischemia induced by 2-
VO in rats. In light of this, it was necessary to verify that the effects of co-existing PEM could be 
reliably studied with the 2-VO model. An unfortunate and unexpected finding was that co-
existing PEM increased the inconsistency of the 2-VO model of global brain ischemia (Prosser-
Loose et al., 2011). As a result, the failure to achieve a consistent model of global brain ischemia 
prevented us from drawing conclusions on whether co-existing PEM exacerbates reactive gliosis.  
Despite the inability to assess the nutritional influence on reactive gliosis associated with 
global brain ischemia, this study yielded novel data highlighting the immediate effect of a low 
protein diet on core temperature. Within 24 hours of exposure, both mean temperature and 
fluctuation significantly increased and remained heightened throughout the 7 day pre-ischemic 
testing period. At the time of surgery, protein-energy malnourished rats were less able to 
maintain core temperature when exposed to anaesthesia. This was reflected by a greater decrease
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in core temperature during the immediate post-surgical period, which was independent of the 
type of surgery (sham or ischemia). These findings strongly suggest that protein-energy 
malnourished rats are unable to finely regulate their body temperature when faced with an 
environmental temperature stressor. To our knowledge, this is the first report demonstrating the 
immediate effect of a low protein diet on core temperature.  
Given that temperature is a key determinant of ischemic brain injury, core temperature 
recordings were collected for 28 days in the study described in Chapter 4 to provide a 
comprehensive assessment of the effects of PEM on the diurnal cycle of temperature. Continuous 
core temperature recordings demonstrated striking changes in temperature as malnutrition 
evolved from an acute to chronic state. Similar to the response observed in the first study, 
exposure to a low protein diet caused an immediate increase in temperature mean and 
temperature amplitude. Whereas the increase in temperature amplitude was sustained over 28 
days in the malnourished group, the rapid increase in mean temperature was a transient response. 
Following the initial peak, mean temperature declined as malnutrition progressed. During the 
final week of testing, malnourished rats were approximately 0.5 ºC cooler than rats fed a control 
diet. Although others have reported a cooling response in malnourished rodents and humans 
(Bastow et al., 1983; Brooke, 1973; Brooke, 1972; Duran et al., 2008), this is the first report to 
fully characterize the temperature response to PEM as it evolves over time. It was hypothesized 
that the immediate change in mean core temperature reflected a behavioural stress response to a 
suboptimal diet. However, there was no acute increase in activity that correlated with the rise in 
body temperature immediately following placement on a low protein diet. Thus, it is not clear 
what is triggering the immediate change in temperature.   
Since temperature and inflammation are closely related, the independent effects of PEM 
on neuro- and systemic inflammation were assessed in the study described in Chapter 4. Results 
from Real Time PCR arrays, which measured the expression levels of 84 genes involved in the 
NFB cascade, demonstrated that this hippocampal pathway was unaltered by either acute or 
chronic exposure to a low protein diet in the rat. To address whether PEM is an independent 
stimulus of systemic inflammation, the circulating concentration of various acute-phase proteins 
were also measured. PEM can stimulate an acute-phase response, as demonstrated by an increase 
in the positive acute-phase protein, A2M, and a decrease in the negative acute-phase protein, 
albumin. These changes were observed at day 7 and day 28 on the low protein diet, illustrating 
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that the acute-phase response is both immediate and persistent. However, this response appears 
to be aberrant, given that the positive acute-phase protein, AGP, was considerably decreased in 
the malnourished rats. These findings may have clinical significance, given that the extent of the 
acute-phase response predicts outcome in stroke patients (Dziedzic, 2008). Therefore, one 
objective of the final study was to determine if the ability of PEM to induce an acute-phase 
response differs following global brain ischemia.  
The third and final study of this thesis examined whether PEM arising after global brain 
ischemia altered the neuro- and systemic inflammatory responses and what impact this may have 
on neuroplasticity. The experimental design was intended to mimic the PEM that develops after 
and because of a stroke. To address these objectives, the 2-VO rat model of global brain 
ischemia was used, with a low protein diet being introduced at 3 days after brain ischemia. 
Findings from this study demonstrated that global brain ischemia induced by 2-VO does not 
elicit an acute-phase response; however, in rats fed control diet, the data suggested an acute-
phase response related to the surgical manipulations required for both sham surgery and global 
brain ischemia. Interestingly, malnourished rats exposed to the surgery required to induce global 
ischemia responded differently. These rats presented with an aberrant acute-phase response 
similar to what was observed in the second study without global brain ischemia. Exposure to a 
low protein diet following global brain ischemia caused a decrease in serum albumin and an 
increase in serum A2M. In addition, a decrease in the positive acute-phase protein, haptoglobin, 
strengthened the evidence that PEM causes an atypical acute-phase reaction. Finally, although a 
strong glial response was elicited by global brain ischemia within the CA1 hippocampal subfield, 
immunofluorescence staining of Iba-1 and GFAP demonstrated no effect of PEM. However, the 
neuroplasticity response triggered by global brain ischemia did appear to be influenced by 
malnutrition, as GAP-43 and synaptophysin were significantly lower within the CA3 mossy fiber 
terminals at day 21. Therefore, it is speculated that PEM developing after brain ischemia could 
impair brain remodeling, resulting in fewer functional synapses.  
In summary, the three studies described in this thesis highlight the effects of PEM on core 
temperature, the systemic acute-phase reaction and the neuroplasticity response to global brain 
ischemia. However, many unanswered questions remained, that are discussed in some detail 
below.  
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6.3 Limitations and Future Directions  
6.3.1 PEM and an Acute-Phase Reaction 
The research described in the thesis provides strong evidence that PEM induces an 
aberrant acute-phase response; however, a limitation of this work is that serum concentrations of 
regulatory inflammatory cytokines were not measured. IL-1 mainly regulates the synthesis of 
type 1 acute-phase proteins, including AGP and haptoglobin, while IL-6 stimulates the 
production of type 2 acute-phase proteins, such as A2M (Baumann et al., 1989; Petersen et al., 
2004). Given that the production of type 2 acute-phase proteins appears to have precedence over 
the synthesis of type 1 acute-phase proteins in malnourished rats, it is speculated that the stress 
response triggered by a low protein diet causes the upregulation of IL-6. To verify this theory, 
future studies should examine the concentrations of additional type 2 acute-phase proteins, such 
as fibrinogen and 1-antitrypsin, as well as measure IL-6 concentration in the serum and liver of 
protein-energy malnourished rats.   
During the second study described in this thesis, an attempt was made to measure IL-6 
serum concentrations with a commercially available ELISA kit. Unfortunately, the ELISA assay 
was not sensitive enough to quantify IL-6 levels reliably. Although ELISA assays are commonly 
employed to measure serum concentrations of inflammatory cytokines, it is important to note 
that this method of quantification can provide an inaccurate measurement of total cytokine 
concentration. A major limitation of the ELISA technique is that it only measures unbound 
cytokines (Malone et al., 2001). Given that most cytokines in the blood are bound to carrier 
proteins, the concentration measured from an ELISA is generally an underestimate of the actual 
total cytokine concentration (Malone et al., 2001). Therefore, to more accurately measure the 
serum concentration of IL-6 in protein-energy malnourished rats, future studies should use a 
competitive binding immunoassay. A major advantage of this technique is that it measures both 
free and bound cytokines. Malone et al. (2001) compared the standard ELISA technique with the 
competitive binding immunoassay and demonstrated that the new alternative method yielded IL-
1, IL-6 and IL-10 concentrations that were 10- to 500-fold higher than the ELISA measurements. 
An additional limitation of the ELISA technique is that it does not provide insight into the 
bioactivity of a cytokine. This information can be obtained through the use of bioassays, which, 
similar to competitive binding immunoassays, yield cytokine concentrations considerably higher 
than that obtained from the standard ELISA technique (Hillyer & Woodward, 2003).  
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In addition to selecting the appropriate quantification technique, it is also crucial that the 
correct sampling times are used. Inflammatory cytokines are short half-life molecules (Gruys et 
al., 2005), and therefore it is important to select the proper sampling time to capture the peak of 
the response. The circulating concentration of A2M is heightened within the first 48 hours of 
being on a low protein diet, when introduced during the acute period following global brain 
ischemia (Chapter 5). Therefore, future studies should use sampling time-points during this 2 day 
period to illustrate whether exposure to the suboptimal diet immediately triggers an increase in 
IL-6. Several time-points should be used to fully characterize the influence of PEM on cytokine 
concentrations, including sampling at later time-points since IL-6 also stimulates the production 
of acute-phase proteins under states of chronic inflammation (Gabay, 2006). In general, acute-
phase proteins have a half-life of several days (e.g. transferrin [2d; rat] (Schreiber et al., 1982), 
fibrinogen [1d; rat] (Ruckdeschel et al., 1972), albumin [2.5d; rat] (Schreiber et al., 1982), AGP 
[1.3d; rat ] (Schreiber et al., 1982)). Therefore, it is speculated that changes to the acute-phase 
response observed after weeks of exposure to low protein diet were not merely the remnants of 
the initial acute-phase response. Instead, a more likely explanation is that the stress caused by the 
suboptimal diet is persistent and continually stimulates the production of A2M. To determine 
whether A2M synthesis is continually increased in malnourished rats, future studies could 
measure the concentration of this acute-phase protein in the liver, in addition to serum 
concentrations.  
6.3.2 PEM and NFB-mediated signaling 
 A major limitation of the second study presented in this thesis is that NFB activity was 
not directly measured. The assumption was made that NFB activity is increased in the 
hippocampus of malnourished rats; however, this phenomenon had not yet been shown in rats. 
The original study showing that PEM increases NFB activity was performed in the gerbil (Ji et 
al., 2008), and therefore it is possible that PEM affects NFB signaling differently among 
species. Thus, future studies should first attempt to replicate these findings by employing 
electrophoretic mobility shift assays (EMSA) to measure hippocampal NFB activity in both 
non-operated malnourished rats and malnourished rats exposed to global brain ischemia. If 
positive results are obtained from EMSA analysis, then the effects of PEM on NFB -mediated 
gene expression can be re-examined using PCR. However, unlike the second study, which 
assessed the whole hippocampus, future experiments should assess hippocampal subfields 
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separately to avoid a dilution effect. Given that NFB is most commonly activated in injured 
neurons, astrocytes and microglia (Clemens et al., 1997; Gabriel et al., 1999; Schneider et al., 
1999; Stephenson et al., 2000), it is speculated that activation of this transcription factor is the 
most pronounced within the CA1 hippocampal subfield following global brain ischemia. Thus, 
the CA1 hippocampal subfield should be the primary region of interest in future Real-Time PCR 
experiments. Furthermore, experimental sample size should be increased, in an attempt to 
increase the power of the study.    
6.3.3 PEM and Neuroplasticity  
 In an attempt to strengthen the neuroplasticity results from Chapter 5 for publication, 
additional brain sections will be labeled for other neuroplastic markers, including SNAP-25, 
postsynaptic density-95 (PSD-95), and microtubule-associated protein-2 (MAP-2). Similar to 
synaptophysin, SNAP-25 is located within the presynaptic terminals of CA3 mossy fibers (Oyler 
et al., 1989) and is thought to play a crucial role in synaptic vesicle exocytosis (Rizo & Sudhof, 
2002). The postsynaptic protein, PSD-95, is a major scaffolding protein localized within 
glutamatergic synapses and is involved in the anchoring of synaptic proteins (Keith & El-
Husseini, 2008). MAP-2, which is present within the cell body and dendrites of neurons, 
stabilizes dendritic structural microtubules and plays a role in dendritic branching (Shafit-
Zagardo & Kalcheva, 1998). Examining additional synaptic markers, as well as a dendritic 
marker, will provide a more in-depth analysis of the effects of post-ischemic PEM on the repair 
processes occurring within CA3 mossy fibers following global brain ischemia.  
Although the immunofluorescence approach relied on in the thesis research provides 
valuable details about the chemical features of a neuron, a limitation of this procedure is that it 
does not highlight the morphological characteristics of a cell. Therefore, future studies should 
perform Golgi-Cox impregnation to assess whether PEM alters the morphology of neurons 
following brain ischemia. Golgi-Cox staining is a valuable technique, which can be used to 
quantify the number and density of dendritic spines. This technique has been used in 
combination with the 2-VO global brain ischemia model to demonstrate that a marked decrease 
in spine density occurs in the CA1 hippocampal subfield within 48 hours following insult (Nagy 
et al., 2011). The combined use of these two techniques will further our understanding of 
whether PEM developing after brain ischemia hinders dendritic regeneration within mossy fiber 
bundles, resulting in decreased numbers of functional synapses.  
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The largest limitation of the final study was the absence of functional testing to determine 
if the changes in plasticity-associated proteins translated into reduced functional recovery. To 
relate mechanistic findings to functional outcome, behavioural testing is considered the gold 
standard in stroke research. Although functional testing is achievable in the 2-VO model, rats 
appear to be rather resistant to cognitive changes and therefore sensitive behavioural paradigms 
are required (Langdon et al., 2008). Given the challenges with behavioural testing, 
electrophysiology should be considered for future studies to determine whether the extent of 
PEM-induced changes to plasticity markers is great enough to alter cell function. Extracellular 
field potentials should be measured to assess the collective activity of CA3 neurons. It is 
hypothesized that the electrophysiological studies will reveal deficits in the CA3 hippocampal 
region in protein-energy malnourished ischemic rats, which will correspond with the decrease in 
synaptic markers observed in the final study.  
6.3.4 Studying the Effects of PEM in a More Clinically Relevant Model of Stroke   
 The 2-VO global brain ischemia model, along with the adolescent age of rat required for 
its use, is a major limitation of this thesis work. Although global brain ischemia induces many of 
the same pathophysiological mechanisms of human stroke, it is a better representation of what 
occurs following cardiac arrest and resuscitation. The 2-VO ischemia model is commonly used 
for preliminary assessment and was selected for this thesis work since the surgical model is well 
characterized and the level of invasiveness has been reported as relatively minor. However, 
direct experience with the 2-VO global ischemia model has illustrated that the required surgery is 
quite invasive. Furthermore, only 70-80% of rats present with extensive bilateral damage in the 
CA1 hippocampal region following 2-VO surgery. Despite these limitations, findings from 
global ischemia models have yielded important information highlighting the effects of co-
existing PEM and post-ischemic PEM on brain biochemistry (Bobyn et al., 2005; Ji et al., 2008) 
(Chapter 3 and Chapter 5), repair mechanisms (Prosser-Loose et al., 2010) (Chapter 5) and 
functional outcome (Bobyn et al., 2005). Ultimately, these findings will be used to form the basis 
of hypotheses for future studies using a more clinically relevant model of stroke.    
Given that there are a wide variety of animal models currently used to study cerebral 
ischemia (Murphy & Corbett, 2009), it is important for researchers to diversify and replicate 
their findings in other stroke models. Therefore, future studies should employ a focal ischemia 
model to re-examine the effects of PEM on the inflammatory response. The rat photothrombotic 
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stroke model has recently been established in my laboratory and will be used in upcoming 
studies to assess the effects of PEM on stroke outcome. Unlike the 2-VO model, which generates 
extensive damage to regions of the hippocampus proper, the photothrombotic model produces a 
localized infarct in a specific cortical region. The photothrombotic model involves a vascular 
injection of a photoactive dye combined with irradiation of a specific area of cortex, using a light 
beam at a given wavelength. Irradiation of the circulating dye, such as rose bengal, produces free 
radicals and results in platelet aggregation and thrombus formation (Murphy & Corbett, 2009). 
Since there are notable differences between these two models, the effects of PEM following 
focal brain ischemia may be different from the findings reported in this thesis.  
Invasive surgical procedures are problematic for the nutritional studies undertaken in my 
laboratory, and therefore extra caution had to be made when selecting an appropriate brain 
ischemia model. Photothrombosis does not require a craniotomy, is relatively non-invasive, and 
has few surgical variables that need to be controlled, thus making it a suitable model for 
assessing our research objectives. Furthermore, aged rats can be used with the photothrombotic 
model, which better mimics human stroke victims. This focal model generates cerebral infarcts 
that are reproducible in size and location (Tatlisumak et al., 2007). Thus far, my laboratory has 
generated infarcts located within the motor cortex using the photothrombotic model and have 
assessed both histological and functional endpoints. Compared to the mild behavioural 
(cognitive) impairments commonly reported following 2-VO global brain ischemia (Langdon et 
al., 2008), functional (motor) deficits are more severe using the photothrombotic model and 
therefore easier to detect with behavioural tests. Widely used behavioural tests, such as the 
Montoya staircase test and cylinder test (Kleim et al., 2007), have been established and will be 
employed in future studies to assess the impact of PEM on functional recovery following focal 
ischemia. Another advantage of the photothrombotic focal model, as compared to the 2-VO 
model, is that it triggers an inflammatory response that is more comparable to the human 
condition of stroke (Schroeter et al., 1997; Schroeter et al., 2001; Tatlisumak et al., 2007).    
The effects of PEM on the inflammatory response to focal brain ischemia have not yet 
been characterized. Since photothrombosis is accompanied by damage to the blood-brain barrier 
resulting in the recruitment of systemic immune cells (Tatlisumak et al., 2007), these features 
make it a good model for studying the nutritional effects on neuroinflammation. Leukocyte 
recruitment appears to be delayed following photothrombosis (Schroeter et al., 2001), and 
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therefore this response may be influenced by both co-existing PEM and PEM that develops after 
brain ischemia. PEM will most likely have a greater impact on the inflammatory response to 
brain ischemia when there is systemic recruitment of immune cells. This hypothesis is based on 
the findings reported in Chapter 4 and 5 demonstrating that PEM stimulates a systemic acute-
phase response. The acute-phase reaction in malnourished rats is most likely triggered by a 
systemic inflammatory response, given that inflammatory cytokines regulate the synthesis of 
acute-phase proteins (Cray et al., 2009). Thus, it is speculated that a systemic inflammatory 
response in malnourished rats could in turn result in exacerbated neuroinflammation following 
focal ischemia. This theory should be assessed in future studies by immuno-labeling glial cells 
and leukocytes to determine whether the recruitment of resident and systemic immune cells is 
augmented in malnourished rats following focal ischemia.  
6.4 Clinical Implications 
 Although it is well recognized that co-morbidities, such as malnutrition, can have 
deleterious effects on patient recovery following stroke (FOOD Trial Collaboration, 2003), they 
are not being adequately managed by current post-stroke care. Therefore, it is imperative that 
pre-clinical research is performed to clarify if there is truly a cause-and-effect relationship 
between malnutrition and poor outcome. If so, this would emphasize to practitioners the 
importance of targeted nutritional interventions. The overarching aim of the thesis research was 
to investigate underlying mechanisms altered by PEM that could affect the extent of brain 
damage and recovery following brain ischemia. Together, the three studies provide considerable 
evidence that PEM alters body temperature, the acute-phase response, and mechanisms of 
neuroplasticity, all of which have clinical importance.  
Given that temperature is a key determinant of brain injury following stroke (MacLellan 
et al., 2009; Silasi & Colbourne, 2011; van der Worp et al., 2007; Wang et al., 2009), the 
findings in this thesis suggest that the pathophysiology of brain injury in malnourished stroke 
patients may be altered. While the PEM-induced temperature changes reported in Chapter 3 and 
Chapter 4 are not sizeable enough to alter ischemic brain injury, the effect of PEM on 
temperature may be amplified in the presence of stroke. PEM impairs the ability to finely 
regulate body temperature (Chapter 3), and therefore it is speculated that malnourished victims 
are among those patients that experience a fever during the acute period following stroke. 
Although the presence of a fever in stroke patients often coincides with an underlying infection 
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(e.g. urinary infection, sepsis, bronchopulmonary infection), noninfectious fevers have been 
reported in approximately 40% of hyperthermic stroke patients (Castillo et al., 1998). Post-
ischemic hyperthermia can significantly aggregate injury (Wang et al., 2009), with clinical 
evidence suggesting that the presence of a fever within 24 hours following a stroke doubles the 
odds of mortality (Prasad & Krishnan, 2010). Therefore, temperature should be closely 
monitored in all stroke patients, especially in malnourished individuals, and treated immediately 
with antipyretics if a fever develops. Another important consideration is whether the presence of 
PEM could interfere with therapeutic hypothermia. It has been repeatedly demonstrated in 
various models of global and focal brain ischemia that prolonged hypothermia is neuroprotective 
(Colbourne & Corbett, 1994; MacLellan et al., 2009; Silasi & Colbourne, 2011; van der Worp et 
al., 2007). Furthermore, therapeutic hypothermia improves neurologic outcome after cardiac 
arrest (Bernard et al., 2002; Hypothermia after Cardiac Arrest Study Group, 2002). Thus, 
therapeutic hypothermia is one of the most promising neuroprotective treatments for stroke 
patients. However, the therapeutic effects of hypothermia may vary among the patient 
population, and factors such as malnutrition may interfere with the beneficial effects of 
hypothermia. Therefore, it should be examined whether therapeutic hypothermia can be induced 
safely and effectively in protein-energy malnourished stroke victims. Also, further research 
should be employed to assess whether the mechanisms decreased by therapeutic hypothermia, 
such as inflammation (Silasi & Colbourne, 2011; Webster et al., 2009), are in fact reversed by 
PEM.  
The model of PEM used in the thesis research induces an aberrant acute-phase reaction, 
with a similar response being demonstrated in a small number of clinical studies (Dulger et al., 
2002; Sauerwein et al., 1997). However, the relationship has never been studied in malnourished 
stroke patients. It is hypothesized that the acute-phase response triggered by PEM is persistent 
during states of stress, such as after a stroke. Given the clinical findings showing that an acute-
phase reaction is present in a subset of individuals following cerebral ischemia (Dziedzic, 2008; 
Idicula et al., 2009; Ryu et al., 2009; Smith et al., 2006), it is speculated that protein-energy 
malnourished patients are among this population. Since the presence of an acute-phase response 
following cerebral ischemia is associated with poorer outcome (Dziedzic, 2008; Idicula et al., 
2009), these patients may require targeted interventions. Improving the nutritional status of a 
stroke patient may in turn subside the acute-phase response, and as a result improve outcome. 
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Although this relationship has not yet been explored, it has been demonstrated that intervening 
with the appropriate nutritional therapy can considerably improve the quality of life in 
undernourished stroke patients (Ha et al., 2010).  
International standards for conducting experimental stroke research has recommended 
including the influence of clinically relevant co-morbidity factors when investigating potential 
stroke treatments (Fisher et al., 2009). The research conducted in this thesis stresses the 
importance of this issue by highlighting the considerable impact that malnutrition has on various 
interrelated physiological systems. In addition, these results emphasize the challenges of 
studying co-morbidity factors in combination with stroke models. Findings from the first study 
demonstrate that clinically relevant stroke co-morbidity factors can interfere with well-validated 
experimental models of stroke (Prosser-Loose et al., 2011). Thus, stroke researchers need to be 
cautious when designing experiments and confirm that including a co-morbidity factor in the 
study design does not compromise the experimental stroke model.  
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APPENDIX  
 
Table A.1. Effects of feeding a low protein diet for 7 and 28d on NFB-mediated signaling in 
the hippocampus. 
  
Expression levels of 84 genes were determined using the Rat NFB Signaling Pathway RT2 
Profiler PCR Array (7d, n=5; 28d, n=6). No effect of diet was detected at either time-point by 
independent t test with Bonferroni correction.  
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Figure A.1. Raw data for Iba-1 (A) and GFAP (B) immuno-staining within the CA1 
hippocampal subregion. Data uncorrected for processing variability (i.e. not divided by the 
CON-Sham group mean) is shown to highlight the differences among the three treatment groups 
at 5 and 21d. Results are shown as mean ± SEM integrated density value (IDV) for the CA1 
hippocampal subfield.  
 
 
 
 
Figure A.2. Raw data for GAP-43 (A) and synaptophysin (B) immuno-staining within the CA3 
mossy fiber region. Data uncorrected for processing variability (i.e. not divided by the CON-
Sham group mean) is shown to highlight the differences among the three treatment groups at 5 
and 21. Results are shown as mean ± SEM integrated density value (IDV).  
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Figure A.3. Scatter plots of the individual serum concentrations of alpha-2-macroglobulin 
(A2M) (A), alpha-1-acid glycoprotein (AGP) (B), haptoglobin (C), and albumin (D). Data from 
individual animals are presented to highlight inter-animal variability within treatment groups. 
Mean ± SEM are represented by a horizontal line and error bars.  
 
 
